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It would be possible to describe everything scientifically, but it would make no sense. It 
would be a description without meaning, as if you described a Beethoven symphony as 
a variation of wave pressure. 
 
Albert Eistein 
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Summary 
 
The family Leporidae belongs to the order Lagomorpha and has 11 extant genera 
distributed worldwide. In Europe, two genera naturally occur: Lepus, originating from 
North America, and Oryctolagus, whose place of origin is Iberian Peninsula. Oryctolagus 
has a single extant taxon, the European rabbit (Oryctolagus cuniculus) and Lepus has 
six taxa inhabiting Europe, the most widespread being the European brown hare (Lepus 
europaeus). O. cuniculus and L. europaeus populations suffered severe declines in 
Europe. Along with other factors, the viral diseases rabbit hemorrhagic disease (RHD), 
affecting European rabbits, and European brown hare syndrome (EBHS), affecting 
hares, are responsible for these declines. 
The causative agents of RHD and EBHS are the rabbit hemorrhagic disease virus 
(RHDV) and the European brown hare syndrome virus (EBHSV), respectively. RHDV 
and EBHSV are single-stranded, positive-sense RNA viruses with ~ 7.4 kb in length, 
classified as Lagovirus from the family Caliciviridae. For RHDV, several genogroups (G1-
G6) were identified, as well as non-pathogenic forms. The information available for the 
Iberian Peninsula until 2011 indicated the circulation of G1 in wild populations. In 2010, 
outbreaks of RHD with unique features were recorded in France, and a new RHDV 
variant was identified. The emergence of this new RHDV variant, related to, but highly 
distinct from the genogroups previously identified, triggered the study of the new RHDV 
variant within the scope of the host-pathogen interactions of lagoviruses. 
The first cases of the new RHDV variant in Portugal mainland date back to late 
2012 in the north and early 2013 in the south. Analysis of a partial fragment of the capsid 
protein gene revealed 99 % of nucleotide identity with a strain of the new variant 
previously identified in Spain. Phylogenetic analysis positioned the new variant in an 
independent cluster in between non-pathogenic rabbit caliciviruses. In the following 
years, samples from rabbits found dead in the field were collected and the screening of 
these samples revealed a replacement of the former circulating G1 by the new RHDV 
variant. A selective advantage of the new RHDV variant over other genogroups, possibly 
by overcoming the existing immunity against older strains, might be at the origin of this 
replacement. 
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The evolution of RNA viruses and the generation of genetic variability is often 
associated with recombination. Recombination might assist the emergence of new 
pathogenic viruses and the increase of pathogenic potential and virulence in pre-existing 
strains. Recombination was previously described for RHDV with recombination 
breakpoints located in several regions of the genome, including within the polymerase 
and the capsid. A striking pattern of recombination between non-structural and structural 
proteins was recovered for Iberian strains identified as new RHDV variant. While for the 
structural proteins these strains belonged to the new RHDV variant cluster, for the non-
structural backbone they clustered either with non-pathogenic rabbit caliciviruses or with 
the pathogenic G1 strains. This suggested at least two independent recombination 
events. These results further imply the presence of non-pathogenic rabbit caliciviruses 
in the Iberian Peninsula that remain undetected. The G1 recombinant was later detected 
in Azores, a Portuguese archipelago in the middle of the Atlantic Ocean. This likely man-
mediated introduction caused severe damage in Azorean rabbit populations and 
replaced the unique G3-G5 like strains that circulated in the archipelago before the arrival 
of the new RHDV variant. 
Knowledge on EBHSV lags behind that on RHDV. To overcome this and better 
understand the evolution of EBHSV, full-genome sequences were obtained for two 
samples collected in the early 1980s in Sweden, the site of original diagnosis. These 
correspond to the oldest sequences of EBHSV and added information to the few 
available sequences. The genomic organization of these samples is similar to that 
reported for a more recent French strain, and most of the cleavage sites were conserved. 
As expected, most amino acid differences were located in the VP60 protein, confirming 
the exposed nature of this protein. 
Evolution of EBHSV was further characterized with a molecular study using 
samples collected in Sweden, spanning the first years of outbreaks until 2008. The 
molecular clock dating reinforces the hypothesis that EBHSV circulation predates its 
emergence. Phylogenetic analysis including other European strains revealed two 
EBHSV lineages, one that disappeared in Sweden and another more recent that was 
able to persist and spread within Europe. Signatures of positive selection in codons 
located in exposed regions of the capsid and antigenic differences between lineages 
indicated a possible role for immune-mediated selection. 
The first interactions of the virus with the surface of host cells determine viral 
tropism and are mediated by host molecules acting as attachment factors. Previous 
works identified histo-blood group antigens (HBGAs) as attachment factors for RHDV. 
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These carbohydrates are present on the epithelial cells of the upper respiratory and 
digestive tracts, where the virus first contacts with the host. Although other receptors are 
likely involved in the process of virus entry to the cell, this was an important first step 
towards unraveling the RHDV infectious process. The phylogenetic proximity of RHDV 
and EBHSV might foresee the same pathways of virus entry, thus the binding of EBHSV 
to glycans was tested. Our findings showed that EBHSV seems to use GlcNAc-
terminated O-glycans to establish the first contact with the cell, which represents a 
distinct feature comparing to RHDV that might be central for the EBHSV infectious cycle. 
Lagoviruses are considered specialist viruses, affecting only their natural hosts. 
However, the new RHDV variant has challenged this view and several episodes of host 
jumps have been described. Additionally, we reported a spillover event in the Lagovirus 
genus, corresponding to the earliest evidence of RHDV affecting a species other than 
the European rabbit. Investigation of two hare samples, collected in the Iberian Peninsula 
in the 1990s, with clinical findings consistent with a Lagovirus infection at necropsy, 
revealed two independent RHDV host jumps. Phylogenetic analysis further confirmed 
that G1 strains were responsible for both cases and analysis of nuclear and 
mitochondrial markers confirmed the species as L. granatensis. The mechanisms 
underlying the ability of RHDV to host switch are not yet fully understood. 
RHDV and EBHSV emerged in the 1980s, but their origins are still uncertain. There 
are several indications of a former presence in Europe, such as the existence of 
antibodies against both viruses in samples collected before their emergence. These data 
suggest an evolution from a non-pathogenic form that, for reasons yet uncovered, 
acquired virulence. Another hypothesis for RHDV and EBHSV emergence is a species 
jump from Sylvilagus floridanus. This is consistent with the introduction of this species in 
Europe a few years before the emergence of these viruses. Since host jumps are 
relatively frequent in the evolution of single-stranded RNA viruses, are more likely 
between phylogenetically-related hosts, and the adaptation to a novel host might be 
assisted by recombination, we investigated possible host jumps in the Lagovirus genus. 
A comprehensive study on host binding of non-pathogenic viruses and the new 
RHDV variant was performed. Their binding to Oryctolagus, Lepus and Sylvilagus 
tissues of the upper respiratory and digestive tracts was similar to that already observed 
for the classical RHDV. The new RHDV variant and the non-pathogenic strains tested 
also use HBGAs to attach to host cells, but a strong binding affinity to heparin was also 
observed. The affinity of each strain to HBGAs varies and might be related with 
adaptation and co-evolution with the host. 
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Sumário 
 
A família Leporidae pertence à ordem Lagomorpha e é composta por 11 géneros 
distribuídos por todo o mundo, dois dos quais ocorrem naturalmente na Europa: o 
género Lepus, originário da América do Norte, e o género Oryctolagus, cuja origem está 
na Península Ibérica. Este último tem um único taxon, o coelho-bravo (Oryctolagus 
cuniculus), enquanto o género Lepus tem seis taxa presentes na Europa, com a lebre 
parda (Lepus europaeus) a ocupar a maior área geográfica. As populações destas duas 
espécies viram os seus efetivos reduzirem-se nas últimas décadas na Europa. A doença 
hemorrágica viral (DHV) e a síndrome da lebre parda (SLP), duas doenças de origem 
viral que afetam o coelho-bravo e a lebre parda, respetivamente, são dois fatores 
importantes no declínio destas populações. 
Os agentes responsáveis pela DHV e pela SLP são respetivamente o vírus da 
doença hemorrágica viral (VDHV) e o vírus da síndrome da lebre parda (VSLP). O VDHV 
e o VSLP são vírus de cadeia simples, de sentido positivo, cujo material genético é ARN 
e com ~ 7.4 kb, classificados como Lagovirus da família Caliciviridae. Para o VDHV 
foram identificados vários genogrupos (G1-G6), assim como formas não-patogénicas. 
Até 2011, a informação disponível para a Península Ibérica indicava uma circulação de 
G1 em populações selvagens. Em 2010, surgiram em França surtos de DHV com 
características únicas, levando à identificação de uma nova variante, relacionada mas 
altamente distinta dos genogrupos previamente identificados. O seu aparecimento 
originou o estudo da nova variante no âmbito das interações patogénio-hospedeiro dos 
lagovírus. 
Os primeiros casos da nova variante da DHV em Portugal continental datam de 
2012 no norte e início de 2013 no sul. A análise de um fragmento do gene que codifica 
a proteína da cápside revelou 99 % de identidade nucleotídica com uma estirpe da nova 
variante previamente identificada em Espanha. A análise filogenética posicionou a nova 
variante num grupo independente, entre as formas não-patogénicas do VDHV. Nos anos 
seguintes, a recolha e análise de amostras de coelhos encontrados mortos no campo 
revelou uma substituição da estirpe circulante, G1, pela nova variante. Uma vantagem 
seletiva da nova variante sobre os outros genogrupos pode estar na origem desta 
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substituição, possivelmente por conseguir ultrapassar a imunidade desenvolvida contra 
as estirpes anteriores. 
A evolução dos vírus de ARN e o aumento de variabilidade genética pode estar 
associada à recombinação. Este fenómeno facilita o aparecimento de novos vírus e o 
aumento do potencial patogénico e da virulência de estirpes pré-existentes. Para o 
VDHV foram previamente descritos eventos de recombinação, cujos pontos de 
recombinação estão localizados em várias regiões do genoma, incluindo nos genes da 
polimerase e da proteína da cápside. Em estirpes ibéricas identificadas como 
pertencentes à nova variante da DHV foi encontrado um padrão de recombinação entre 
proteínas não-estruturais e proteínas estruturais. Enquanto para as proteínas estruturais 
estas estirpes pertenciam ao grupo da nova variante, para as proteínas não-estruturais 
estas estirpes agrupavam com formas não-patogénicas ou com estirpes G1. Estes 
resultados sugerem pelo menos dois eventos de recombinação independentes e 
implicam ainda a presença de formas não-patogénicas na Península Ibérica. O 
recombinante G1/nova variante foi mais tarde detetado nos Açores. A introdução da 
nova variante neste arquipélago, com uma origem provavelmente antropogénica, 
causou declínios severos nas populações e levou a uma aparente substituição das 
estirpes G3-G5 like que circulavam no arquipélago anteriormente. 
O conhecimento acerca do VSLP é substancialmente menor que o do VDHV. Para 
colmatar este desconhecimento e melhor compreender a evolução do VSLP, foram 
obtidas sequências completas de duas amostras recolhidas em 1982 na Suécia, o 
primeiro país onde foi descrita a doença, sendo por isso as sequências mais antigas 
disponíveis para o VSLP. A organização do genoma destas amostras é semelhante à 
observada para uma estirpe francesa mais recente, e a maioria dos locais de clivagem 
no genoma são conservados. Tal como esperado, a maioria das diferenças 
aminoacídicas estão localizadas na proteína da cápside, região do vírus que está mais 
exposta a uma resposta imunitária do hospedeiro. 
A evolução do VSLP foi ainda estudada em amostras recolhidas na Suécia desde 
os primeiros surtos até 2008. A calibração do relógio molecular reforçou a hipótese de 
uma circulação do vírus que antecede a sua emergência. A análise filogenética, que 
incluiu outras estirpes europeias, revelou duas linhagens do VSLP: uma específica das 
amostras da Suécia e que terá desaparecido, e outra, mais recente, que persistiu e se 
difundiu nos restantes países europeus. Os sinais de seleção positiva em codões 
localizados em regiões expostas da cápside e as diferenças antigénicas entre linhagens 
sugerem a existência de uma pressão seletiva exercida pelo sistema imunitário. 
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As primeiras interações do vírus com a superfície das células do hospedeiro 
determinam o tropismo viral e são mediadas por moléculas do hospedeiro que atuam 
como fatores de ligação. Trabalhos anteriores identificaram os antigénios do grupo 
sanguíneo ABH como fatores de ligação para o VDHV. Estes carbohidratos estão 
presentes nas células epiteliais do aparelho respiratório superior e do aparelho 
digestivo, onde o vírus estabelece o primeiro contacto com o hospedeiro. Embora outros 
recetores possam estar envolvidos no processo de entrada do vírus, esta informação 
ajudou na compreensão do processo infecioso do VDHV. A proximidade filogenética do 
VDHV e do VSLP fazem prever modos de entrada na célula semelhantes; assim, foi 
testada a ligação do VSLP aos referidos carbohidratos. Os nossos resultados mostraram 
que, no estabelecimento do primeiro contacto com a célula, o VSLP parece preferir 
carbohidratos O-glicosilados com uma cadeia terminal de N-acetilglicosamina. Este 
padrão de ligação ao hospedeiro constitui uma diferença relativamente ao VDHV que 
pode ser central no processo infecioso do VSLP. 
Os lagovírus são considerados vírus especialistas, isto é, que afetam apenas os 
seus hospedeiros naturais. A nova variante tem desafiado esta visão, uma vez que têm 
sido descritos vários episódios de species jumps para esta variante. Adicionalmente, foi 
possível observar a presença de G1 em lebres ibéricas, o que corresponde à evidência 
mais antiga de um lagovírus a infetar outra espécie que não o seu hospedeiro natural. 
A confirmação dos animais como lebres ibéricas foi realizada através de marcadores 
nucleares e mitocondriais. A análise de duas amostras de lebre ibérica, recolhidas na 
Península Ibérica nos anos 1990 com sinais clínicos consistentes com uma infeção por 
um lagovírus, permitiram verificar dois eventos independentes. A análise filogenética 
confirmou que diferentes estirpes G1 estiveram na origem destes casos. Os 
mecanismos que permitiram ao VDHV transitar de uma espécie para outra não são 
ainda totalmente compreendidos. 
O VDHV e o VSLP emergiram na década de 1980, mas as suas origens 
permanecem incertas. Existem várias indicações de uma presença anterior na Europa, 
como por exemplo a existência de anticorpos contra ambos os vírus em amostras 
recolhidas antes das datas aceites como início dos surtos destas doenças. Estes 
resultados sugerem uma evolução a partir de uma forma não-patogénica que, por 
razões ainda não totalmente esclarecidas, adquiriu virulência. Outra hipótese para 
explicar o aparecimento destes vírus é um species jump a partir de Sylvilagus floridanus. 
A introdução desta espécie na Europa alguns anos antes do aparecimento do VDHV e 
do VSLP reforça esta hipótese. A investigação da ocorrência de species jumps em 
lagovírus foi conduzida tendo em conta que estes fenómenos são relativamente 
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frequentes na evolução dos vírus de ARN de cadeia simples e entre hospedeiros 
filogeneticamente próximos, e ainda que a adaptação a um novo hospedeiro pode ser 
facilitada pela existência de recombinação. 
Tendo em conta as hipóteses acima mencionadas de aparecimento dos lagovírus, 
estudou-se a ligação ao hospedeiro de formas não-patogénicas e da nova variante da 
DHV. A sua ligação a tecidos dos aparelhos respiratório superior e digestivo de 
Oryctolagus, Lepus e Sylvilagus é semelhante à já observada para a variante clássica 
da DHV. A nova variante e as estirpes não-patogénicas testadas usam igualmente 
antigénios do grupo sanguíneo ABH para se ligar às células do hospedeiro. No entanto, 
foi também observada uma grande afinidade com a heparina. A afinidade de cada 
estirpe para os antigénios do grupo sanguíneo ABH varia e pode estar relacionada com 
a adaptação e co-evolução com o hospedeiro. 
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Thesis framework 
 
Two viral diseases, rabbit hemorrhagic disease (RHD) and European brown hare 
syndrome (EBHS), are the main causes of the wild populations’ decline of European 
rabbit (Oryctolagus cuniculus) and European brown hare (Lepus europaeus), 
respectively. These are valuable ecological and economic species due to their role as 
prey and game species. The etiological agents of RHD and EBHS are rabbit hemorrhagic 
disease virus (RHDV) and European brown hare syndrome virus (EBHSV), respectively, 
and belong to the genus Lagovirus, family Caliciviridae. 
Understanding the mechanisms at the origin of virulence emergence of lagoviruses 
is crucial to study the host resistance. The work presented in this dissertation was thus 
integrated in the project entitled “Evaluation of the virulence of RHDV (rabbit hemorrhagic 
disease virus) and mechanisms of host resistance” (FCT-ANR/BIA-BIC/0043/2012), 
supported by the Fundação para a Ciência e Tecnologia (Portugal) and the Agence 
Nationale de la Recherche (France). 
 
The work developed in this thesis aimed at contributing to the current knowledge 
on the host-pathogen interactions of lagoviruses. Therefore, the evolution of the virus 
and the genetic aspects of viruses that might be relevant for host resistance are the main 
subjects presented here. The thesis is organized in five chapters and includes nine 
scientific manuscripts, of which seven were already published in journals indexed in the 
Science Citation Index (SCI) and two are in preparation. 
 
The first chapter, entitled Chapter 1. General Introduction, contains a revision of 
the literature on key aspects of host-pathogen interaction: (i) co-evolution and the Red 
Queen hypothesis, (ii) virus attachment and entry to the host cells, (iii) recombination in 
RNA viruses and how it generates variability, and (iv) virus host shifts as a mechanism 
to expand host range. A brief revision of the main findings on the epidemiology of RHD 
and EBHS and on the evolution and genome organization of RHDV and EBHSV is also 
presented. Finally, the phylogeographic history of leporids is discussed, focusing on the 
historical events associated with leporids in Europe. 
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The recent emergence of a new RHDV variant in France that rapidly spread to 
other European countries was the main topic of our research on RHDV for this thesis. 
After being described in Spain and Italy, the emergence of the new RHDV variant in 
Portugal allowed us to study its dissemination patterns, characteristic features and 
associated epidemiology. A complete analysis of full-length genomes of Iberian strains 
revealed the existence of several events of recombination. The recombination pattern of 
the new RHDV variant allowed us to trace the introduction of the new RHDV variant to 
the Portuguese archipelago of Azores, and to determine that anthropogenic factors are 
likely at the origin of the arrival of the new RHDV variant to Azores. The resulting scientific 
manuscripts are compiled in Chapter 2. Insights into the emergence and evolution of the 
new RHDV variant in Portugal and are the following: 
 
Paper I. Abrantes J, Lopes AM, Dalton KP, Melo P, Correia JJ, Ramada M, Alves PC, 
Parra F, Esteves PJ: New variant of rabbit hemorrhagic disease virus, 
Portugal, 2012-2013. Emerging Infectious Diseases 2013, 19:1900-1902. 
Paper II. Lopes AM, Correia J, Abrantes J, Melo P, Ramada M, Magalhães MJ, Alves 
PC, Esteves PJ: Is the new variant RHDV replacing genogroup 1 in 
Portuguese wild rabbit populations? Viruses 2015, 7:27-36. 
Paper III. Lopes AM, Dalton KP, Magalhães MJ, Parra F, Esteves PJ, Holmes EC, 
Abrantes J: Full genomic analysis of new variant rabbit hemorrhagic 
disease virus revealed multiple recombination events. Journal of General 
Virology 2015, 96:1309-1319. 
Paper IV. Almeida T, Lopes AM, Magalhães MJ, Neves F, Pinheiro A, Gonçalves D, 
Leitão M, Esteves PJ, Abrantes J: Tracking the evolution of the G1/RHDVb 
recombinant strains introduced from the Iberian Peninsula to the Azores 
islands, Portugal. Infection, Genetics and Evolution 2015, 34:307-313 
 
The Chapter 3. EBHSV: virus evolution and attachment factors starts with the 
description of a genome walking approach for obtaining a full-length genome sequence 
of the virus and allowed comparison with RHDV. Next, the molecular evolution of EBHSV 
was assessed by looking for signatures of positive selection, by estimating the time to 
the most recent common ancestor (tMRCA) and by performing an epitope mapping. 
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Finally, the study of EBHSV attachment to its host revealed interesting differences in the 
binding of these lagoviruses. The results are presented in three scientific papers as 
follows: 
 
Paper V. Lopes AM, Gavier-Widén D, Le Gall-Reculé G, Esteves PJ, Abrantes J: 
Complete coding sequences of European brown hare syndrome virus 
(EBHSV) strains isolated in 1982 in Sweden. Archives of Virology 2013, 
158:2193-2196. 
Paper VI. Lopes AM, Capucci L, Gavier-Widén D, Le Gall-Reculé G, Brocchi E, Barbieri 
I, Quéménér A, Le Pendu J, Geoghegan JL, Holmes EC, et al.: Molecular 
evolution and antigenic variation of European brown hare syndrome 
virus (EBHSV). Virology 2014, 468-470:104-112. 
Paper VII. Lopes AM, Lora M, Le Moullac-Vaidye B, Ruvoën-Clouet N, Breiman A, 
Galanina OE, Bovin NV, Esteves PJ, Abrantes J, Le Pendu J: A new 
attachment factor in the Lagovirus genus: the European brown hare 
syndrome virus (EBHSV) uses N-acetylglucosamine O-glycans to attach 
to host cells. In preparation. 
 
Virus evolution is often punctuated by host shift events, allowing the virus to 
establish and adapt to a naïve population. Spillover events were not known for RHDV, 
but a study conducted on Iberian hares with symptoms characteristic of a Lagovirus 
infection revealed an infection by an RHDV strain circulating in Portugal at the time of 
sample collection. Two competing hypotheses for the emergence of RHDV and EBHSV 
had been postulated: either the evolution from non-pathogenic forms or a species jump 
from Sylvilagus floridanus. The binding patterns and glycan affinities of pathogenic and 
non-pathogenic strains were analyzed in light of the two hypotheses. The results of these 
works are in Chapter 4. The impact of host shifts in Lagovirus evolution and are the 
following: 
 
Paper VIII. Lopes AM, Marques S, Silva E, Magalhaes MJ, Pinheiro A, Alves PC, Le 
Pendu J, Esteves PJ, Thompson G, Abrantes J: Detection of RHDV strains 
in the Iberian hare (Lepus granatensis): earliest evidence of rabbit 
lagovirus cross-species infection. Veterinary Research 2014, 45:94 
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Paper IX. Lopes AM, Lora M, Le Moullac-Vaidye B, Galanina OE, Breiman A, Strive T, 
Marchandeau S, Le Gall-Reculé G, Bovin NV, Ruvoën-Clouet N, Esteves PJ, 
Abrantes J, Le Pendu J: Leporids tissue binding and glycan specificities 
of the new RHDV variant and non-pathogenic related viruses. In 
preparation. 
 
In Chapter 5. Final considerations, the results obtained within the thesis are 
analyzed. The major conclusions and insights of this dissertation, as well as the 
implications for future research, are presented, and future directions of the work are also 
discussed. 
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1. Host-pathogen interactions 
 
Host-pathogen co-evolution 
The dynamic interplay between the pathogen and its host is a powerful tool to study 
evolution and its practical implications in nature. The emergence of several RNA viruses, 
such as HIV, foot-and-mouth disease virus and barley yellow dwarf virus, represents 
major threats to animal and plant populations whilst providing examples of acting 
evolutionary forces [1-3], though the factors underlying their emergence are mostly still 
unclear. Whereas host extinction due to emerging pathogens is rare [4], endangered 
species may be at a higher risk [see for example the impact of Ebola virus on African 
apes; 5]. Both epidemiologists’ and evolutionary biologists’ research is focused on the 
mechanisms of RNA viruses evolution and on the epidemiological history of viruses. The 
complete understanding of the forces promoting virus origin, emergence, and spread, 
together with experimental analyses, may shed light on how viruses will evolve in the 
future. 
Pathogens are part of natural systems and, as such, influence host genetic 
diversity and population dynamics. These effects on host fitness, together with their rapid 
spread and evolution, make pathogens key selective agents that are capable of either 
maintain host genetic variation or prompt genetic shifts in host traits [6]. Host evolution 
is linked to pathogen evolution and vice-versa, in a dynamic process of co-evolution (Fig. 
1.1). Selection acts on the host as a result of the pressure to evolve resistance to 
pathogens. In turn, changes in pathogens occur in order to counteract host defenses, 
and are also driven by selection (Fig. 1.1). Traits involved in co-evolution are typically 
found at pathogen’s loci related with virulence, resistance and host evasion, and at loci 
of the host related with the immune system and escaping to pathogens [7-9]. Woolhouse 
et al. [10] defined three pre-requisites for the occurrence of co-evolution: genetic 
variation in relevant traits, reciprocal effects on the fitnesses of the interacting species 
and dependence of the outcome of these interactions on the genotypes. 
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Figure 1.1 Schematic representation of co-evolution between host and pathogen. Green arrows indicate intra-
specific selection; solid blue arrows indicate increased selection for host resistance/pathogen infectivity; dashed blue 
arrows indicate reduced selection for host resistance/pathogen infectivity. Adapted from [10]. 
 
In 1973, Van Valen proposed an evolutionary theory known as the Red Queen 
hypothesis, which owes its name to the character of the book Through the Looking Glass, 
by Lewis Carrol. This theory highlighted that the cyclical adaptation of hosts and 
pathogens maintains relative fitness constant (“It takes all the running you can do, to 
keep in the same place”), converting this in a ‘zero-sum game’ [11]. Recently, three 
classes of the Red Queen dynamics were defined (Fig. 1.2) [11], summarized as follows: 
(i) Fluctuating Red Queen, whereby selection favors rare alleles. For instance, 
the pathogen is adapted to the most common host genotype and fails to 
infect hosts with a rare allele; 
(ii) Escalatory Red Queen, whereby selection proceeds through selective 
sweeps, resulting in an escalation of traits. It is usually associated with 
polygenic or quantitative traits; 
(iii) Chase Red Queen, whereby selection pressure reduces genetic diversity 
within populations but increases divergence between populations. 
Complex polygenic traits are associated with this mode of Red Queen 
dynamics. 
 
The Red Queen hypothesis is challenged by multiple host-pathogen interactions 
that affect the selection pressures exerted on hosts and pathogens. For instance, the 
selection pressure acting on the pathogen may be diminished if it has multiple hosts and 
evolving infectivity in another host requires less effort than evading resistance of the 
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current host. This ultimately leads to host switching, which is favored by the ability of 
viruses to exploit, for example, different cell receptors [reviewed in 10]. 
 
 
Figure 1.2 Allele frequencies associated with the Red Queen scenarios. On the left is shown the fluctuating selection 
mode of the Fluctuating Red Queen, associated with oscillations on the allele frequency dynamics. On the right, the 
selective sweeps of the Escalatory Red Queen and the Chase Red Queen are shown. Although presenting the same 
variation in the allele frequency dynamics, these two scenarios differ by the uni- or multi-dimensional character of the 
selection mode, respectively. The blue line represents the host alleles and the red line represents the pathogen alleles. 
Adapted from [11] and [12]. 
 
A trade-off between transmission and virulence also accompanies pathogen 
evolution [13]. Pathogens must evolve towards an intermediate level of virulence, which 
is favored because pathogens with low virulence do not produce sufficiently high viral 
loads and pathogens with high virulence kill hosts too fast, both situations compromising 
transmission. Although controversial, natural selection favors strains with the better 
balance between these two factors, which maximizes the basic reproduction number 
(average number of cases that a single virus strain generates on an uninfected 
population [14], measuring the transmission potential of a virus) of the pathogen [15]. 
However, the transmission mode influences virulence [16], as well as the period of intra-
host evolution, i.e., if the host is infected by other strains the competition between strains 
will increase, and consequently virulence [17].  
Infectious diseases have long been considered a major selective force shaping 
genetic diversity [18]. Nonetheless, demonstrating co-evolution in practice is challenging, 
since asymmetries in genetic variation and generation times, multiple hosts/multiple 
pathogens, phenotypic plasticity, environmental factors, etc, mask its effects [10]. The 
introduction of myxomatosis and rabbit hemorrhagic disease in Australia are valuable 
tools to study emergence and evolution of a pathogen in a naïve host population, by the 
study of host resistance and interaction with co-circulating viruses [19,20]. Moreover, the 
European rabbit is a model species for both nature and laboratory studies, facilitating the 
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identification of traits related to virulence (laboratory studies per se are sometimes limited 
since they do not mimic the conditions that occur in nature [21]). 
 
Virus entry 
Viruses drive their genome from infected to uninfected cells and their ability to 
spread determines the replication success. Virus life cycle is initiated with binding and 
entry to host cells, which can be hampered by several barriers. By overcoming the 
epithelial barriers of the respiratory, digestive or reproductive tracts (the most likely entry 
doors), viruses gain access to the host replication cellular machinery [22]. Interactions 
with receptors at the cell surface determine virus attachment, entry pathways and 
trafficking in the cell. Almost all mammalian cell types are targets for virus infection if 
possessing appropriate receptors. Their absence at the cell surface restricts infection, 
determines cell and tissue tropism and defines the nature of the virus-induced diseases 
[23]. 
The skin, mucosal surfaces and blood/lymphatic circulation are the first line of 
protection of the host against the virus, either through mechanical action or host factors, 
such as glycans or lectins [24]. Interestingly, whereas lectins play a role in the immune 
defense on one side, they can also be doors of entry and spreading for several viruses, 
as they are receptors for HIV-1, hepatitis C and Ebola viruses, among others [25-28]. A 
strategy of the virus to escape from the immune system is to protect its nucleic acid by 
a membrane and/or protein shell. In this case, viral particles are resistant to protect the 
genome but also unstable enough to ensure the release of the genetic cargo on the 
target cell [22]. 
The first interaction between the host and the pathogen is via attachment factors 
present in susceptible cells. Attachment factors might simply bind to the particles to 
establish a contact point at the cell membrane, helping to concentrate the virus on the 
cell surface [29]. Association between viral proteins and the cell is often electrostatic and 
thus lacks specificity, albeit some viruses have specific binding requirements [22]. To 
attach to host cell factors, the virus may form projections or depressions on its surface 
that will interact with the cell surface molecules. 
The cell has on its surface a wide range of proteins, lipids and glycans that can be 
used for attachment and entry, including ion transporters, adhesion factors and signaling 
proteins (Fig. 1.3) [29]. Certain cell surface proteins, such as glycoproteins, are 
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attachment factors par excellence. These include proteins in the integrins’ family and 
immunoglobulins, the latter mainly associated with cell adhesion [30]. Viruses that use 
the gastrointestinal tract commonly use glycolipids to bind to the target cells. 
Glycoproteins and glycolipids are present in the glycocalyx, which is frequently the first 
structure encountered by viruses at the cell surface [31]. The negatively charged nature 
of the glycocalyx is conferred by the presence of proteoglycans. The great diversity of 
proteoglycans is given by glycosaminoglycans (sulfated glycan side chains with variable 
degree of sulfation), which are attached to the core protein. One of the 
glycosaminoglycans widely used as a viral attachment factor is the heparan sulfate (Fig. 
1.3) [e.g. 32,33-37]. Several authors identified viral consensus binding motifs to 
glycosaminoglycans that are mainly characterized by the presence of basic amino acids 
[38,39]. 
Cell surface carbohydrates also mediate cellular binding and are recognized by 
several viruses. For example, sialic acid is the first contact of Influenza virus with the cell 
[40], but other important pathogens also use sialic acid to attach to the host [41]. The 
long side chains of carbohydrates allow them to be relatively far from the cell surface, 
becoming likely to be primarily encountered by the virus. Furthermore, carbohydrates 
are expressed in a wide range of cell types and their charges attract viruses’ charged 
residues promoting a rapid interaction. Similarly, glycans such as histo-blood group 
antigens (HBGAs) may function as virus attachment factors [42]. For example, human 
noroviruses interact in a first approach with HBGAs and with heparan sulfate [reviewed 
in 43]. 
When interactions with host attachment factors serve only as a foothold for the 
virus, specific receptors are then recruited. In the Caliciviridae family, for example, feline 
calicivirus (FCV; genus Vesivirus) attaches first to sialic acid and then uses a cell surface 
protein as a receptor, the junctional adhesion molecule 1 (JAM-1), for penetration and 
entry into the host cells [44-46]. Entry receptors will trigger signaling pathways in the cell, 
actively promote virus endocytosis and mediate conformational changes in the virus 
particle that lead to uncoating and release of the viral genome into the cell [30]. These 
interactions, unlike attachment, are highly specific, but of low affinity [47]. Receptors 
often accompany the virus into the cell, and penetration is achieved after a series of 
conformational changes triggered by exposure to low pH, lipid composition, proteolytic 
cleavage and redox reactions [reviewed in 23].  
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Figure 1.3 Main attachment factors and receptors used by viruses. HSPG: heparan sulfate proteoglycan; LDLR: low 
density lipoprotein receptor; DC-SIGN: dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin; 
CD4: cluster of differentiation 4; CCR5: C-C motif chemokine receptor type 5; CXCR4: C-X-C motif chemokine receptor 
type 4; CAR: coxsackievirus and adenovirus receptor. Adapted from [23]. 
 
Molecules used as entry receptors usually have critical roles in cellular function, 
thus are strongly conserved and selection acts on the virus to maintain binding to 
receptor motifs [31]. Nonetheless, viruses with high mutation rates are more apt to switch 
receptors or use alternative receptors in the absence of the primary receptor, as it was 
shown for Sindbis virus [48]. Viruses usually bind to multiple receptors, either at the same 
time or in cascade, enhancing avidity and activating endocytosis. Different viruses might 
recognize the same cellular receptors, and, conversely, viruses from the same family 
might use different receptors [see a review in 22]. 
The attachment and entry of a virus to its host is an optimal target for drug 
application and, although complex, their potential as targets for antiviral therapeutics 
makes it worth to try new approaches of studying the virus-host interactions. Antiviral 
therapy may be used in two ways, either by blocking virus attachment through the use 
of synthetic molecules that bind to receptors, or by using synthetic receptors that bind to 
the virus and block attachment. Nonetheless, these approaches have some limitations 
due to the ability of viruses to escape the blocking effect by generating resistant variants. 
Furthermore, the interactions between viruses and receptors are determinants in viral 
tropism and associated with host switching, an important aspect of virus-host interactions 
that will be discussed in detail further on.  
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Recombination as a source of variability in RNA viruses 
The high mutation rates of RNA viruses, combined with their short generation times 
and large population sizes, make them highly variable. Along with mutation, 
recombination is an important mechanism in RNA viruses evolution as it quickly 
generates genetic variability [49]. Such importance is reflected in the fact that several 
emerging viruses are the result of past recombination events between genetically distinct 
viruses [50-52]. Briefly, recombination is the process by which one ‘donor’ sequence 
exchanges genetic information with an ‘acceptor’ sequence, resulting in a mosaic RNA 
from at least two ‘parents’. Recombination does not create new mutations in the genome, 
but creates new genome combinations, on a single infectious cycle, by reshuffling the 
ones that are already present in the population [53]. If this process occurs on viruses 
possessing a segmented genome and the entire genomic segments are exchanged, is 
termed reassortment, a very common process in Influenza virus [e.g. 54,55]. 
 
 
Figure 1.4 Evolutionary effects of recombination. On the left, recombination generated a functional genome from 
damaged parental strains; in the middle, recombination removed deleterious mutations (red circles); on the right, 
recombination created advantageous mutations (yellow circles). Blue circles indicate the wild type loci. Adapted from [56]. 
 
Higher recombination frequencies might quickly generate high fitness genotypes 
that are better adapted to evolving hosts, either by mixing viable genotypes or by 
eliminating deleterious mutations that can decrease virus fitness [57]. This generates 
adaptive value by acting as a genetic repair mechanism in viruses such as RNA viruses 
with a double-stranded genome. Depending on the parental genotypes, three scenarios 
may occur: (i) generation of a functional genome from damaged parental genomes; (ii) 
removal of deleterious mutations, leading to a selective advantage of the recombinant 
molecule; and (iii) generation of advantageous combinations of mutations, increasing the 
rate of adaptive evolution (Fig. 1.4) [56]. On contrary, RNA recombination might also be 
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disadvantageous if it affects the integrity of the viral genome. Recombination can create 
a high proportion of non-viable genomes due to simultaneously introduced deleterious 
mutations. As no clear answer is yet available, the hypothesis that recombination in RNA 
viruses is only a consequence of the replication machinery and mechanism or is driven 
by ecological circumstances cannot be excluded [58]. 
Considering the mechanism at the origin, recombination is divided in replicative 
(copy-choice) and non-replicative (breakage-rejoining) [59]. The replicative model 
involves the switch of the viral polymerase (RNA-dependent RNA polymerase or reverse 
transcriptase) from the ‘donor’ molecule to the ‘acceptor’ molecule during synthesis (Fig. 
1.5). This is the most accepted model of RNA recombination and the most likely to 
produce viable molecules [59]. Template switching is influenced by sequence homology: 
higher degree of identity usually means higher probability of exchanging templates [60]. 
Secondary structures as hairpins also facilitate template switching. The viral polymerase 
stops at these regions, which thus constitute recombination hotspots. There are also 
terminators that release the viral polymerase from the donor template. The ‘donor’ 
template likely participates in template switching by forcing the pause of the viral 
polymerase and the ‘nascent’ RNA selects the reinitiation site on the ‘acceptor’ template 
[57]. 
In the non-replicative mechanism, RNAs are randomly cleaved by mechanical 
forces or by enzymatic activity, generating 3’-P and 5’-OH ends, and then self-ligated or 
ligated by cellular ligases (Fig. 1.5) [61]. This type of recombination is most likely to occur 
in double-stranded DNA viruses and, due to its stochastic nature, it is more likely to 
produce non-homologous recombinants [59]. Nonetheless, it has been experimentally 
confirmed for several RNA viruses such as flaviviruses, polioviruses and pestiviruses 
[62-64]. The breakage-rejoining mechanism may occur between fragments of a virus, 
different viruses and even between viral and cellular RNAs [61]. The non-replicative 
mechanism presumes recombination in the absence of a viral polymerase, since it 
occurs prior to the synthesis of the polymerase [63]. 
Based on the structure of the crossover junction, recombination is considered 
homologous or non-homologous [61]. If the breakpoint is on the same site on both 
parental molecules, recombination is homologous and the resultant molecule has the 
same structure as the parental strains. Strikingly, the crossover site might not be at the 
region with most sequence similarity [56]. The non-homologous recombination occurs 
between highly dissimilar genomic regions or molecules and often produces deleterious 
genotypes due to its aberrant structures, with insertions, deletions and/or duplications. 
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Homologous recombinants are the most likely to generate functional proteins and 
replicate in the cell, and consequently to produce viable progeny [61]. 
 
 
Figure 1.5 Mechanisms of recombination. On the left is represented the replicative (copy-choice) recombination, where 
the nascent strain is dissociated from the template and the polymerase finds another template to continue synthesis. On 
the right is represented the non-replicative (breakage-rejoining) recombination, where genomic fragments are cleaved 
and later rejoined, in this case by a cellular ligase. Adapted from [61]. 
 
Recombination is associated with emergence of new pathogenic circulating viruses 
and with increases in pathogenic potential and virulence of pre-existing strains [65-67], 
as well as to the expansion of viral host range [68,69]. Furthermore, it is also associated 
with alteration of transmission vector specificities and modification of tissue tropism, 
which ultimately lead to evasion of host immunity and evolution of resistance to antivirals 
[70,71]. Recombination is thus a mechanism associated with major changes during virus 
adaptation that has an impact on virus evolution, emergence and epidemiology. 
There are several pre-requisites that determine the occurrence of recombination 
between strains. The first to be fulfilled is co-circulation of viruses in the same 
geographical area. In turn, this potentiates co-infection of the same individual/cell, as 
long as the prevalence of circulating strains is reasonably high [61]. Notably, viruses 
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associated with chronic infections might have higher rates of recombination due to the 
increased opportunity of co-infections [56]. In the cases that viral recombination is 
replication-dependent, high viral loads in the host organism will increase the probability 
of exchange genetic information [72]. The genetic homology between strains is also 
important, and closely related strains are more likely to produce viable recombinants 
[e.g. 73,74]. Finally, the genome structure and organization of the virus can also facilitate 
recombination. This is the case of several pseudodiploid viruses, for example, that 
package two viral genomic RNAs in a single virion, allowing the co-existence of different 
strains in the same virion; the recombinants are progeny of these heterozygous virions. 
If the recombinant represents an evolutionary advantage relatively to the parental 
genomes, it will become predominant in the population due to natural selection [61]. 
Frequencies of recombination are extremely variable between viruses [53]. 
Negative-sense, single-stranded RNA viruses are the less prone to recombine, probably 
due to their RNA-packaging mechanism. On contrary, positive-sense, single-stranded 
RNA viruses vary in the extent of recombination, with Picornaviridae showing high rates 
and Leviviridae with no reports of occurrence of recombination [56,75]. The highest 
recombination rates are found in retroviruses, such as HIV, which is an exceptional case, 
with recombination rates exceeding the mutation rates [76,77].  
Recombination also has a role in species jumps. Cross-species transmission is 
relatively common in RNA viruses, and the adaptation to a novel host might be assisted 
by recombination, in the way that several genome combinations are tested [49]. 
Consequently, the likelihood of having a virus strain with increased fitness for the new 
host will increase. Remarkable examples of recombination associated with host shifting 
include Influenza A virus [55], SARS CoV [50] and turkey coronavirus [78]. However, 
establishing a direct link between recombination and host jumps is often difficult. 
Recombination is undetectable when very similar strains recombine, but it can be 
detected when enough genetic variation exists. Evidences for recombination are found 
through the phylogenetic incongruences generated by the recombinants, albeit more 
powerful methods are available, involving the detection of substitution patterns or 
incompatibility among sites [79]. If recombination is not taken into account, the inferred 
phylogenies will not represent the true history of that particular region/gene (Fig. 1.6), 
depending on the relatedness of the sequences and on the size of the affected regions 
[80,81]. Older recombination events might be more obscure and difficult to trace, since 
subsequent mutation mitigates their effects [79]. Another problem arises with the advent 
of the new techniques of Next Generation Sequencing. This comprehensive analysis of 
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the genome relies on the assembly of very short fragments into contigs, which may 
produce artefactual recombination signals [82]. 
 
 
Figure 1.6 Effect of recombination on phylogenies. If recombination occurs between “B” and “C” (with ”B” as donor 
template and “C” as acceptor template), it generates a recombinant “R” that clusters with “B” at the 5’ region of the 
recombination breakpoint and with “C” at the 3’ region. Adapted from [81]. 
 
In conclusion, there is growing evidence of the consequences of recombination in 
animal, plant and bacterial RNA viruses, by influencing evolution and epidemiology. 
Whether recombination represents a significant phenomenon in viruses’ evolution is 
currently unknown, but recombination events are likely to be underestimated [79]. 
Understanding recombination events is critical due to their role on RNA virus emergence, 
but also for clinical practice, namely in evaluating the efficacy of drug therapies and 
vaccine campaigns. 
 
Crossing the species boundaries 
When a pathogen successfully jumps from its original host to a novel species, the 
outcome is unpredictable, the most severe being the emergence of a new viral disease 
that can affect humans and wildlife. Host jumps are mostly short-term spillover events 
affecting few individuals, with no onward transmission [83], but can occasionally take the 
form of local outbreaks, with transmission chains at a limited scale or, eventually, develop 
epidemic transmission of the disease in the new host, causing severe damage [24]. The 
HIV jump from chimpanzees to humans [84], the Influenza A virus jump from birds to 
humans [85] and the Ebola virus, with a recent outbreak with devastating consequences 
[86], are some extreme examples of the latter (Table 1.1). 
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Table 1.1 Examples of viruses that transferred between hosts to gain new host ranges. 
Virus classification Family Virus Original host New host 
(-)ssRNA Filoviridae Ebola virus Unknown (bats?) Chimpanzees; humans 
(-)ssRNA Henipavirus Hendra virus Fruit bats Horses; humans 
(-)ssRNA Henipavirus Nipah virus Bats Pigs; humans 
(-)ssRNA Orthomyxoviridae Influenza virus Water birds Pigs; horses; humans 
(-)ssRNA Paramyxoviridae CDV / PDV Canids Seals 
(-)ssRNA Paramyxoviridae Measles virus Possibly cattle Humans 
(-)ssRNA Paramyxoviridae Rinderpest Eurasian cattle African ruminants 
(-)ssRNA Rhabdoviridae Australian bat lyssavirus Bats Humans 
(+)ssRNA Coronaviridae SARS coronavirus Bats Palm civets or related carnivores; humans 
(+)ssRNA Flaviviridae Dengue virus Old World primates Humans 
ssRNA-RT Retroviridae SIV / HIV-1 Old World primates, chimpanzees Humans 
ssRNA-RT Retroviridae SIV / HIV-2 Sooty mangabey Humans 
ssDNA Parvoviridae FPV / CPV Cats or similar carnivores Dogs 
dsDNA Leporipoxvirus Myxoma virus Brush rabbit; Brazilian rabbit European rabbits 
dsDNA Poxviridae Monkeypox virus Prairie dogs Humans 
dsDNA Poxviridae Smallpox virus Other primates or camels (?) Humans 
CDV: canine distemper virus 
PDV: phocine distemper virus 
SIV: simian immunodeficiency virus 
HIV: human immunodeficiency virus 
FPV: feline panleukopenia virus 
CPV: canine parvovirus 
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For the virus to achieve successful infection and transmission in the novel host and 
become established, three types of interactions are mandatory: contact points between 
hosts, virus-host interactions and interactions within the new host [87]. The first contact 
between the donor/infected host and the recipient host is affected by factors such as host 
distribution, host ecology and behavioral separation of the species involved in the cross-
transmission (Fig. 1.7). Several of these factors have an anthropogenic cause, such as 
species movements/introductions and agricultural development, although natural causes 
can be at the origin of new contacts between hosts, e.g., climate changes [88,89]. 
Furthermore, a role for intermediate and amplifier hosts is also predicted for SARS CoV 
and Influenza A virus, for example [90,91]. All these changes bring together species that 
were not formerly in contact. 
 
 
Figure 1.7 Types of interactions and steps involved in a virus host jump. For each step, the main host and pathogen 
factors/processes involved in the host switch are listed. Based on data from [87] and adapted from [24]. 
 
The mode of transmission of a “jumping” virus might be important in its ability to 
successfully switch host. While sexually transmitted or blood-borne viruses have lower 
probability of exposure, respiratory or vector-borne viruses are more likely to be 
successful [49]. However, the higher probability of host exposure to vector-borne viruses 
does not necessarily correlate with the ability of these viruses to establish infection. Their 
stronger selective constraints and antagonistic pleiotropy (beneficial mutations for one 
organism are detrimental to another) may limit their ability to host jump [12,92,93]. 
 
16 FCUP 
General Introduction 
 
Considering the new host population, if the basic reproduction number, R0, is 
greater than 1, each initial infection generates at least two secondary infections and there 
is potential for an epidemic; if R0 is lower than 1, the initial case is not capable to replace 
itself and (even when the pathogen frequently jumps to the new host population) only 
minor outbreaks occur [94]. R0 changes in function of host ecology, behavior, 
environment and phenotype [87]. The pathogen host range is also important when 
studying the possibility of host jumps. While specialist viruses (with one or a few natural 
hosts) are restricted by the receptors and replication mechanisms of a new host, 
generalist viruses (with several natural hosts) are adapted to different host cell 
mechanisms, thus it is expected an increased likelihood to host jump [24]. 
The closer the natural and the potential new host species are, the more likely is to 
occur a successful species jump (Fig. 1.8) [95,96]. Although susceptibility of potential 
hosts can vary, the phylogenetic proximity of hosts brings a more similar environment for 
the pathogen regarding cell types, receptors and other key components [96]. Besides 
phylogenetic relationships, which are undoubtedly a force guiding the success or failure 
of host switches, the intensity of contact between hosts and the density of the new host 
to promote onward transmission are also of extreme importance [24]. 
 
 
Figure 1.8 Effect of host relatedness in the pathogen’s ability to jump between hosts. The length of the bars at the 
tips of the trees correlates with the success of pathogen infection; bars in red correspond to the natural host. In the tree 
on the left, the success of the pathogen is successively lower with higher host phylogenetic distance. In the tree on the 
right, highly susceptible clades are scattered across the host phylogeny, independently of the phylogenetic distance from 
the natural host. Adapted from [97]. 
 
The rule of closer phylogenetic hosts/higher probability of jumping between hosts 
is often challenged, since closely related species may have cross-immunity that protects 
FCUP 
General Introduction 
17 
 
 
the new host (Fig. 1.8) [24]. Moreover, the geographic proximity and probability of 
exposure are not directly correlated with the phylogenetic relatedness. For example, 
humans are phylogenetically closer to other primates, but have greater exposure to 
rodents and, thus, are more likely to become infected by a pathogen that has in rodents 
its natural reservoir [98]. Indeed, the contact between viruses and a new potential host 
is occasionally prevented by the limited contact between the hosts [24]. There are 
several examples of viruses that successfully infected species that are phylogenetically 
distant from their natural hosts, including the SARS CoV-like virus from bats to humans 
[99] and the tobacco ringspot virus from plants to honeybees [100]. 
Changes in host receptor binding are key in the virus adaptation process, so that 
the virus might lose or reduce its ability to bind to the natural host [97]. Indeed, cell and 
tissue tropism is the result of the interactions between the virus and host cell receptors 
(Fig. 1.7) [101]. Those first interactions determine host specificity and several changes 
in the virus might occur until it is adapted to the new host, even if it does not ensure 
sustained transmission [58]. For example, influenza A virus has in birds its natural host 
and main reservoir. Usually, it is not capable to infect humans but, when it does, human-
to-human transmission is not possible and 13 mutations would be required [102]. On 
contrary, a minor genetic change of a single mutation is enough for the Venezuelan 
equine encephalitis virus to jump from rodents to horses [103]. Similarly, in order to bind 
to canine receptors, the capsid gene of feline parvovirus gained at least two mutations 
which prevented its ability to infect cats, although it was later recovered [104,105].  
After attachment to the host cell surface receptors, other barriers need to be 
overcome by the virus, i.e. entry in the cell, trafficking and replication using the host cell’s 
machinery, where it may encounter several intracellular restriction factors. Finally, virus 
shedding is crucial for propagation to other cells of the new host. The virus also needs 
to avoid or suppress the host immune antiviral response. When viruses start infection 
after a host jump, they are usually not well adapted, and hence replicate less and 
transmission is not as efficient [24]. The level of infectivity, length of infection and 
transmission period, and level of genetic variation also play a role in adaptation to the 
new host. The time spanning until the entire process of adaptation to a new host is 
complete varies, with some viruses taking years until they are fully adapted and others, 
which do not require evolutionary changes on the virus, being more time-efficient. 
Pathogen emergence in the new host species is difficult to predict and hence 
effective surveillance is the most efficient way to monitor it. However, there are some 
predictions that can be made based on past events, which show that the majority of 
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pathogens able to cross the species boundaries are single-stranded RNA viruses [e.g. 
84,86,106]. RNA viruses are exceptional candidates to switch hosts due to their high 
mutation rates, short generation times and large population sizes [58,87]. Thus, their 
rapidly evolving genomes are capable of quickly adapting to a new host and explain why 
they are prone to host shift. While most mutations can be deleterious, other beneficial 
mutations will be selected to optimize the use of cellular machinery, virulence, 
transmission potential and also to avoid immune system responses [97]. Adaptation to a 
new host is dependent on a multitude of factors and, in many cases, these viruses only 
establish spillover infections and do not completely adapt to the new host [107]. 
Phylogenies recovered from several pathogens evidence that host shifts are 
relatively frequent in their evolution [97]. Indeed, if the phylogeny of the virus does not 
mirror the phylogeny of the natural host, it is therefore likely that a host shift occurred in 
the past. Those phylogenetic incongruences are very common and long-term co-
speciation is a rare phenomenon [108]. Predicting where, when and what pathogens will 
emerge in a near future and whether a host jump will be a spillover or will largely spread 
is of extreme importance to prevent emerging diseases and epidemics, but also a difficult 
task and prone to fail, leading to an inappropriate use of resources [98]. This 
understanding of how ecological disturbance affects genetics, ultimately leading to a host 
shift, will give clues on the origin of new viruses. 
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2. Lagoviruses and associated diseases 
 
Rabbit hemorrhagic disease (RHD) 
The Jiangsu southern province of People’s Republic of China was the first to 
acknowledge a new viral disease in European rabbits (Oryctolagus cuniculus, Linnaeus, 
1758) in 1984, with probable origin in Angora rabbits imported from Germany [109]. 
Then, the disease rapidly spread to the entire country, as well as to Korea, due to rabbit 
fur importation from China. Two years later, rabbit hemorrhagic disease (RHD) reached 
Europe through Italy [110]. From there, RHD spread to several other European countries, 
affecting wild and domestic rabbits [reviewed by 111,112]. In the Iberian Peninsula, the 
disease was first reported in 1988 in Spain [113] and in 1989 in Portugal [114]. In 1988, 
contaminated frozen rabbit carcasses imported into Mexico brought RHD to the 
American continent. Currently, RHD has been reported in all continents and is endemic 
in most parts of the world [115]. 
RHD is a highly contagious, acute and fulminating disease, being in most cases 
fatal in adult rabbits. About 30 vertebrate species were used to test host range, but all of 
them failed to produce disease [116]. Thus, only Oryctolagus cuniculus seems to be 
susceptible to RHD, albeit other species may seroconvert or act as reservoirs [117,118]. 
The incubation period of RHD varies between one and three days and the clinical 
evolution of the disease can be classified into peracute, acute, subacute or chronic. 
In the RHD peracute form, no clinical signs are observed [119]. On contrary, rabbits 
with an acute infection present several clinical signs and usually die 12-36h after the 
onset of fever. Clinical signs include some neurological signs (such as convulsion, ataxia 
and paralysis), dullness, prostration, apathy, anorexia and, 24h before death, they can 
start to present increased heart and respiratory rates. Bloody diarrhea, blood in the nares 
and/or mouth and hematuria may also be present [115,119]. In the subacute course, 
rabbits present the same but milder symptoms, surviving for a week or more and in some 
cases recovering. When an outbreak occurs, 5-10 % of the rabbits may show a chronic 
evolution of RHD, characterized by severe jaundice, loss of weight and lethargy. Rabbits 
may either die one or two weeks later, likely because of liver dysfunction, or recover and 
seroconvert, developing high titers of antibodies against the virus that last for at least 
one year [120]. Rabbits that survive may present chronic liver disease, e.g., cirrhosis. 
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Circulatory and degenerative disorders are the main pathological lesions 
associated with RHD, including liver necrosis and splenomegaly. The liver appears pale, 
swollen and with a marked lobular pattern; periportal hepatocytes are necrotic, and 
damage may extend further to midzonal or internal areas. The spleen is swollen as well, 
engorged with blood and with rounded edges. In general, viscera often present fibrin 
thrombi, and are congested and hemorrhagic due to massive disseminated intravascular 
coagulation (DIC). The tracheal mucosa is hyperemic, containing abundant bloody foam. 
Discoloration of the ears, conjunctiva and subcutis are visible in the subacute and chronic 
courses of RHD [112,121,122]. 
Severe leukopenia (decrease in lymphocytes and heterophils) and marked 
increase of liver enzymes (lactate dehydrogenase, alanine aminotransferase, aspartate 
aminotransferase, alkaline phosphatase and γ-glutamyltransferase) and 
proinflammatory cytokines (TNF-α) are observed a few hours prior to death. Serum 
bilirubin and triglyceride concentration are also abnormally high [123-126]. Histologically, 
lymphocytes’ depletion and apoptotic cell death of hepatocytes is visible at the periphery 
of the lobule. Liver cirrhosis is also observed in rabbits with a subacute or subclinical 
form of RHD [127]. 
Due to a great capacity of spread, RHD causes severe losses in farms, with a 
strong impact on the economy that relies on rabbit fur and meat production, particularly 
in Asia and central Europe [128]. The ecological impact of RHD is also of concern, since 
the decrease in wild rabbit populations impacts the survival of rabbit-dependent 
predators, some of them highly endangered [129,130]. Mortality rates vary between 70 
and 90 %, but can reach up to 100 % in adult rabbits from naïve populations. 
Susceptibility to RHD varies according to the age of the animals. Animals younger than 
two months of age do not develop RHD, probably because they acquire maternal passive 
immunity, but support some viral replication [131,132]. Susceptibility begins in the 5-6th 
week of life, with only 50 % of these rabbits producing infection and disease, and 
progressively rabbits become more susceptible up to the 8-9th week when they are fully 
susceptible [112]. 
Differences in the innate immune response triggered after RHD infection may 
account for the distinct resistance/susceptibility to infection of young and adult rabbits 
[123,133]. Indeed, young rabbits develop an adequate inflammatory immune response 
that may limit viral replication and allow the rabbit to establish a specific immune 
response against the virus [134], while adult rabbits die too quickly and do not have time 
to mount the specific response. Strikingly, when immunosuppressed young rabbits are 
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challenged, the resistance is lost and fulminant hepatitis causes death after three days 
[135], further confirming the importance of the innate immune response in the resistance 
against the virus. 
The impact of RHD is dependent on several factors. Interaction with myxomatosis, 
rabbit population dynamics and the time of the breeding season are related with RHD 
incidence [136,137]. Arid regions are more affected than areas with higher rainfall in 
Australia, most probably due to cross-protection induced by circulating non-pathogenic 
rabbit caliciviruses [138,139]. In Australia, rabbits are an ecological and economic pest 
and disease introduction was equated as a biological agent to control rabbit numbers. In 
1995, the virus escaped from quarantine, reached the mainland and rapidly spread [140]; 
in some areas, rabbit numbers fell by ~ 95 % [130].  
On contrary, in southern Europe, rabbit conservation is of major interest, not only 
because rabbit is a keystone species in the Mediterranean ecosystem, but also due to 
its importance as a game species, and dramatic decreases in rabbit numbers represent 
a serious concern [129,141]. In the old continent, translocation of rabbits should be 
prevented, and meat and fur importation from RHD endemic areas should be highly 
restricted. While in wild populations eradication is not possible, in domestic rabbits 
quarantine, surveillance, vaccination and proper sanitary measures may eradicate the 
virus. Interestingly, Mexico managed to eradicate the disease with an intense control 
program [142]. The recovery of the populations after an outbreak is also multifactorial, 
with hunting pressure, initial rabbit densities, food availability and predator presence 
influencing the outcome [143-145]. 
A rational vaccination program is the most efficient way to control outbreaks in 
rabbitries, since no available treatment exists. However, experimental treatments were 
able to reduce liver damage and increase survival rates [146,147]. Commercial vaccines 
are available since the 1990s and provide protection for up to 12 months; booster 
vaccination guarantees further protection. After vaccination, rabbits produce systemic 
but not mucosal immunity, therefore, no protection against infection is ensured. Vaccines 
are produced with inactivated virus from liver suspensions of infected rabbits; 
alternatively, there are recombinant myxoma virus vaccines expressing the RHD virus 
capsid protein. The efficacy of vaccination programs was assessed in wild populations, 
but the results were quite discouraging [148]. 
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Rabbit hemorrhagic disease virus (RHDV) 
The etiological agent of RHD is rabbit hemorrhagic disease virus (RHDV), a 
Lagovirus belonging to the family Caliciviridae. This family includes also the genera 
Nebovirus, Sapovirus, Vesivirus and Norovirus [149]. RHDV virions are spherical and 
non-enveloped particles, whose diameter varies between 27 and 35 nm. Particles are 
arranged in a T = 3 icosahedral symmetry and present the characteristic cup-shaped 
depressions of the caliciviruses (Fig. 1.9b and c) [150,151].  
The capsid protein VP60, a ~ 60 kDa molecule, is composed of an N-terminal arm, 
a shell (S) and a protrusion (P) domains. The S domain protects the inner RNA, and the 
P domain, further subdivided into P1 and P2, is exposed and is mainly associated with 
host cell attachment and antigenicity [152]. While the S domain is highly conserved and 
shares great sequence homology with the S domain of other caliciviruses, the exposed 
P domain is more variable among caliciviruses, due to host immune pressure, and the 
existence of putative pockets that bind to host cell receptors [153]. Consistent with this, 
signatures of positive selection were found in the P2 subdomain of the capsid protein 
[154]. 
RHDV is a polyadenylated, single-stranded and positive-sense RNA virus, with two 
open reading frames (ORFs) and a full genome of 7437 nucleotides (Fig. 1.9a) [155]. 
ORF1 (nucleotides 10-7044) codes for a polyprotein of ~ 257 kDa and 2344 amino acids 
that after proteolytic cleavage produces the non-structural proteins (including an 
helicase, a protease and the polymerase) and the capsid protein. ORF2 (nucleotides 
7025-7378) is located at the extreme 3’ end, slightly overlapping ORF1, and encodes a 
minor structural protein, VP10, with 117 amino acids and ~ 10 kDa, which is a component 
of RHDV virions [156]. A subgenomic RNA of 2.2 kb at the 3’ end of the genome is the 
major source of VP60 production (Fig. 1.9a) [157]. Both genomic and subgenomic RNAs 
have a viral genome-linked protein (VPg) covalently attached to the 5’ end. The VPg and 
the 5’ untranslated region (UTR) might play a role in RHDV replication and/or translation 
[158]. 
The oral, nasal or conjunctival are the most likely routes of RHDV transmission. 
Experimentally, subcutaneous, intramuscular and intravenous routes are also possible 
[159]. Infected rabbits shed RHDV in all secretions and infected carcasses, contaminated 
food, bedding and water are also sources of the virus [111]. Indirect infection also occurs, 
for example through predators, which excrete RHDV derived from ingested infected 
animals, and scavenger birds that are able to spread the virus over long distances. 
Mechanical transmission occurs via fleas, flies and mosquitoes [160]. Notably, flies 
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feeding on rabbit carcasses were probably the vector responsible for facilitating RHDV 
escape from quarantine in Australia [160]. Finally, fomites, contaminated people and 
rabbit products or tissues help disseminating the virus. Virus transmission is facilitated 
by its high stability and resistance [161]. Indeed, RHDV remains infectious after several 
months in decomposing carcasses and clothes and is resistant to a wide range of 
temperatures and pH. 
 
 
Figure 1.9 RHDV genomic organization and 3D arrangement of the capsid monomers. (a) Scheme of the 
organization of RHDV genome, with the expected cleavage sites and the encoded proteins indicated. ORF1 and ORF2 
slightly overlap. A subgenomic RNA also produces the VP60 capsid protein and the minor structural protein VP10. (b) 
Model of the arrangement of the three capsomers that form the RHDV capsid. (c) Reconstructed cryoEM map of the 
RHDV virion. The letters A, B and C correspond to the arrangement of the capsomers shown in (b). (a) adapted from 
[162]; (b) and (c) adapted from [153]. 
 
In order to start the infectious process, RHDV uses HBGAs to attach to host cells. 
RHDV binds to A, B and H type 2 epitopes present on the epithelial cells of the upper 
respiratory and digestive tracts, although other receptors must be recruited to reach the 
main site of replication (hepatocytes), which do not express HBGAs on their surface 
[163,164]. At the moment no receptors are identified for RHDV. However, a few surface 
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protein genes that might facilitate virus entry into liver cells were identified [165], but 
remain to be tested. The affinity to different HBGAs is dependent on the RHDV strain 
and rabbits lacking these ligands are resistant to infection with low doses of RHDV [163]. 
Other caliciviruses, including human norovirus, also use HBGAs as attachment factors 
[e.g. 166,167]. Interestingly, HBGAs polymorphisms determine the ability of Norovirus 
strains to start infection [168].  
Polymorphisms in the rabbit genes responsible for the synthesis of HBGAs, namely 
the α1,2-fucosyltransferase genes Fut1, Fut2 and Sec1, and a possible association with 
resistance/susceptibility to RHDV, were investigated. An association between a weakly 
functional Sec1 variant and survival to an RHDV outbreak was observed, although it was 
always associated with functional Fut2 variants [169]. Additionally, an inactive Sec1 
protein was shown to act as dominant-negative of the functional Fut1 protein that is the 
main contributor for the synthesis of RHDV attachment factors [170]. Ruvoën-Clouet and 
co-workers further hypothesized that young rabbits’ resistance was associated with the 
HBGAs expression. Indeed, tissues of young rabbits lacked HBGAs expression and very 
weak binding was observed [164]. However, while HBGAs density is important to 
susceptibility to RHDV, their low expression confers only partial protection.  
The lack of a cell culture system that efficiently replicates RHDV in vitro has been 
hampering epidemiological and virus transmission assays. Electron microscopy, 
enzyme-linked immunosorbent assays (ELISA), RT-PCR, hemagglutination and 
hemagglutination inhibition tests are some of the most widely used methods to determine 
RHDV infection. However, while it was firstly accepted that RHDV agglutinates human 
type O erythrocytes, in the last years some non-hemagglutinating strains were identified 
[171,172]. Moreover, this test can produce false-negative results in rabbits with a chronic 
form of the disease due to interference of anti-RHDV IgM and virus-like particles (VLPs) 
[159]. Determination of IgM, IgA and IgG titers by ELISA helps to distinguish between 
vaccinated, re-infected or first-infected rabbits [173]. Therefore, with this test, the 
population status and ability to resist infection can be assessed. 
Throughout the years, several authors tried to assess the phylogenetic history of 
RHDV. However, its emergence is still not well understood and inference may be 
misguided due to recombination, a mechanism that has been described in RHDV strains 
from Europe and Australia [174-176]. Most phylogenetic studies relied on partial VP60 
sequences although only full-length VP60 sequences provide enough information to a 
reliable and robust phylogenetic inference [177]. Several genogroups, following a 
temporal distribution, were identified in European strains, and a successive replacement 
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of older genogroups was observed in France [178,179]. These genogroups were 
nominated from G1 to G6 and form a single serotype with two subtypes: G1-G5 and G6 
(Fig. 1.10), although G3, G4 and G5 genogroups were more recently considered a single 
group [177,180]. 
The genogroup G6 corresponds to RHDVa, an antigenic variant described in late 
1990s in Italy and Germany [181,182], but already present in China since at least 1985 
[180]. Cross-protection between RHDV and RHDVa is almost complete [181]. RHDVa is 
mainly associated with rabbitries and, in some areas, it seems to have replaced the 
original strains [183-185]. While in France the older genogroups were replaced, in the 
Iberian Peninsula only G1 strains are found in wild rabbit populations, although also 
evolving following a temporal pattern [186-188]. In addition, in the Portuguese 
archipelago of Azores a G3-G5 like variant was recently described, suggesting an 
independent evolution in the islands for more than 17 years [189,190].  
 
 
Figure 1.10 Phylogenetic relationships among lagoviruses. The tree was obtained using nucleotide sequences of the 
capsid gene from lagoviruses’ strains representative of their diversity. The Maximum Likelihood method with 500 
bootstraps and the GTR+G+I model were used. Only bootstrap values greater than 0.9 are shown. 
 
26 FCUP 
General Introduction 
 
After the initial description of pathogenic RHDV, non-pathogenic and moderately 
pathogenic lagoviruses started to be described. These strains are genetically related but 
distant from RHDV presenting > 20 % of nucleotide diversity (Fig. 1.10). The first 
evidences of the circulation of non-pathogenic viruses were reported in Europe, with 
serological studies showing that rabbit populations, where no mortality due to RHD was 
reported, presented antibodies against RHDV [191-193]. Non-pathogenic strains were 
later genetically characterized in Europe [194-197] and Australia [198]. An evolutionary 
analysis including the non-pathogenic Australian strain suggested that this non-
pathogenic virus was present in the island for ~ 150 years, when the first wild rabbits 
arrived [199]. A moderately pathogenic lagovirus was identified in the USA [200], 
although its phylogenetic position and pathogenicity remain doubtful [200,201]. Non-
pathogenic strains appear to provide a gradient of cross-protection against RHDV, from 
non-protective to fully protective [139,194,195,198,202], but cross-protection seems to 
depend on the time spanning between non-pathogenic and pathogenic infection and not 
on the titers of the antibodies that cross-react [139].  
In the last few years, several attempts were made to estimate the RHDV 
substitution rate. Estimates range from 5.48 x 10-4 to 4.0 x 10-3 nucleotide substitutions 
per site per year (subs/site/year) [176,177,188,203]. Likewise, there is not a consensus 
on the time to the most recent common ancestor (tMRCA) estimates, which range from 
several decades to only a few years before RHDV emergence [177,180]. A very recent 
study from Eden and co-workers [204] reanalyzed RHDV sequences and showed that 
RHDV emerged in the late 1970s/beginning of 1980s, only shortly before the initial 
description in China. Interestingly, this emergence date is coincident with the introduction 
of the eastern cottontail (Sylvilagus floridanus, Allen, 1890) in Europe (see discussion 
below).  
The factors that determine RHDV virulence are not known, but an association 
between mutations in the non-structural protein p16 and highly virulent strains was 
recently established [205], although the biological role of p16 remains to be determined. 
Other mutations might also be responsible for RHDV virulence, including at receptor 
binding, virus entry and virus replication [205]. Di Giallonardo and Holmes [21] pointed 
out that while MYXV, whose transmission is dependent on mosquitoes and fleas and live 
animals, has a trade-off between virulence and transmission, RHDV transmission relies 
both on the oral-fecal route and on flies feeding on animal carcasses, i.e., host death 
ensures transmission and hence requires a higher virulence. Similarly, non-pathogenic 
rabbit caliciviruses evolve towards low virulence, since the oral-fecal route does not 
require host mortality for transmission (Fig. 1.11) [21]. 
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Because of its high virulence, RHDV provides a unique model to study the 
mechanisms of co-evolution between host and pathogen, such as the evolutionary 
changes occurring in the host to overcome the virulence of RHDV, and the variations in 
the virus that accompany host changes. The role of non-pathogenic circulating strains 
and of young rabbits in disease dissemination is starting to be considered [206,207] and 
remains a key to develop strategies to either increase rabbit numbers, in Europe, or 
control them, in Australia. 
 
 
Figure 1.11 Possible relationship between virulence and transmission in rabbit viruses. Host mortality rates are a 
measure of virulence and range from 0 (benign) to 1 (always lethal). The bell-shaped distributions represent the likely 
relationship between mortality and hypothetical viral titers, represented by vertical bars. MYXV: myxoma virus; RHDV: 
rabbit hemorrhagic disease virus; RCV-A1: Australian rabbit calicivirus. Adapted from [21]. 
 
The emergence of a new RHDV variant 
In 2010, unexpected outbreaks in rabbitries from north-western France caused 
high mortalities in vaccinated and non-vaccinated animals [208]. Additionally, wild rabbits 
from the same geographical region experienced severe outbreaks, with mortalities 
estimated in 80 to 90 %, numbers that resembled early RHDV mortalities in naïve 
populations in France [208]. Rapidly, the same unusual outbreaks were reported in 
Spain, Italy and Great Britain [209-211]. Sequencing of the capsid protein gene of the 
virus responsible for these outbreaks revealed ~ 80-82 % of nucleotide identity with other 
rabbit lagoviruses, including pathogenic (genogroups G1-G6) and non-pathogenic 
strains [211]. Thus, a new variant of RHDV was identified, that was related but highly 
distinct from the other known RHDV strains. 
The epidemiology of RHD changed with the appearance of the new RHDV variant. 
Experimental results showed a longer course of the disease, highly variable but lower 
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mortality rates and higher occurrence of subacute/chronic forms [211]. Strikingly, the 
new variant infects and causes death in rabbit kittens, which present macroscopic lesions 
usually observed in adult rabbits [209]. Furthermore, it expanded the host range of RHDV 
by causing fatal hepatitis in cape hares (Lepus capensis, Linnaeus, 1758) and Corsican 
hares (Lepus corsicanus, de Winton, 1898), species where the older RHDV strains were 
never detected [212,213]. 
The efficacy of former commercial vaccines is limited against the new RHDV 
variant [208,211,214]. The limited immune response in vaccinated rabbits might be 
related with mutations at critical amino acids of the virus capsid protein. Indeed, a survey 
with several monoclonal antibodies showed different recognition patterns relatively to the 
older strains [211,212]. Analysis of the amino acid sequences of former RHDV strains 
and the new variant further showed that the majority of the amino acid differences reside 
in the C-terminus of the VP60, a region that constitutes the P domain and where the 
main antigenic regions are located [153,215]. Moreover, different epitopes are 
recognized by older RHDV strains and the new variant, and signatures of positive 
selection at sites previously detected for RHDV were not found for the new variant strains 
[154,177], although a new site was detected [214]. This site was located in the E region, 
according to the nomenclature of Neill [216], where the major antigenic determinants are 
thought to be located. More studies are required to confirm if these differences are 
associated with the existence of different epitopes. 
Hemagglutination properties of this new variant were assessed, though contrasting 
results were found [209,211]. Nonetheless, agglutination patterns are somehow different 
from older RHDV strains, predicting changes in the receptors’ specificity, which might 
help to explain differences in pathogenicity [163,209]. The binding site of the new variant 
to HBGAs was modeled by X-ray crystallography by Leuthold et al. [217], and showed 
that the residues directly interacting with the ABH-fucose of the HBGAs are highly 
conserved among RHDV strains. 
Phylogenetically, the new RHDV variant forms an independent cluster, separated 
from the pathogenic, older strains (genogroups G1-G6) and from the non-pathogenic 
strains (Fig. 1.10) [211,214]. Although an outbreak with both the new variant and a G1 
strain was recorded [214], it is highly likely that the new variant is replacing the circulating 
strains due to a competitive advantage [211,214,218]. Evolution from a non-pathogenic 
virus and a species jump were hypothesized for the emergence of the new RHDV variant 
[211], but the events leading to the emergence of this new variant are unknown. The 
remarkable rapid spread of the new RHDV variant, with devastating effects on rabbit 
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populations [219], highlights the urgent need of the development of strategies to slow 
down the spread of the virus, namely the development of new vaccines directed 
specifically towards the new variant. 
 
European brown hare syndrome (EBHS) 
In 1980, an unknown epidemic disease, associated with acute liver necrosis, 
caused death in the European brown hare populations (Lepus europaeus, Pallas, 1778) 
of the Swedish island of Gotland [220]. Given the unknown origin, the disease was called 
“fältharesjuka” or European brown hare syndrome (EBHS). Its origin remained a mystery 
for a while and several bacteriological, parasitological and virological hypothesis were 
considered: an association with a new variety of the oilseed rape (Brassica napus, 
Linnaeus) with low glucosinolate content was hypothesized, but also mycotoxins, 
selenium deficiency and agricultural pesticides were investigated [220]. 
The disease rapidly spread in the following years, reaching the southern part of 
Sweden in the early 1980s. It extended northwards until reaching the ‘Nordic limit’, a 
border marking a climate transition and associated with changes in fauna and flora [221]. 
Denmark followed in reporting the disease, and by 1990s several other European 
countries also described the same disease (Fig. 1.12) [222-236]. The disease is currently 
endemic in Europe and was also reported in L. europaeus populations introduced in 
South America [237]. 
Strikingly, there are indications of the presence of EBHS in Europe several years 
before the first diagnosis in Sweden, including: (i) descriptions of outbreaks in England 
from 1976, with hares presenting lesions consistent with EBHS pathology [238]; (ii) 
Scandinavian hunters knew the disease since the early 1970s; (iii) the virus was detected 
by PCR in Swedish hare samples collected before 1980 [239]; (iv) since 1962, antibodies 
against EBHS were detected in archived sera of hares in England [240]. Evidence that 
EBHS was caused by a virus was found by Lavazza and Vecchi, that observed viral 
particles similar to RHDV in the liver of dead hares by electron microscopy [233]. 
Although occurring both in wild and captive hares [220], EBHS is mainly prevalent 
in free-living hares. Finding carcasses is thus less frequent and the diagnosis of the 
disease is sometimes problematic due to an advanced state of decomposition [120]. The 
main reservoir species of EBHS is L. europaeus. Infection of mountain hares (Lepus 
timidus, Linnaeus, 1758) also occurs in areas where the distribution range of both 
species overlaps [221]. European brown hares with chronic forms of EBHS may act as 
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long-term carriers and shed the virus for long periods, whereas mountain hares die 
acutely suggesting that the virus could still be adapting to this species [221]. 
 
 
Figure 1.12 Distribution map of European countries reporting EBHS. The blue gradient correlates with the year of 
the first description of the disease in each country from dark (earlier) to light (later); countries in grey never reported the 
disease (based in published data only). Adapted from [241]. 
 
As for RHD, only adults appear to succumb and young hares (less than 50 days) 
do not develop EBHS, probably due to the presence of antibodies against EBHS virus 
transferred through the placenta by passive immunity [220]. The maternally inherited 
antibodies disappear after weaning. Subadults usually do not develop clinical disease 
even if infected [112]. Mortality occurs throughout the year but is highest in the fall, 
between October and December [221]. Unfavorable weather conditions, high population 
density and concentration of hares in marginal areas after harvesting may account for 
the highest observed mortality [221]. Additionally, at this time of the year, when hunters 
are out in the fields, the probability of carcasses to be found is higher, and the young of 
the year have also lost the maternal protective antibodies, becoming susceptible [221]. 
Interestingly, in Finland, where L. timidus is the main affected species, EBHS cases were 
reported mainly in spring and summer [242].  
When an EBHS outbreak occurs in naïve populations, mortality rates can be up to 
100 % in the first two weeks, but in endemic areas mortality rates are low [243]. No 
FCUP 
General Introduction 
31 
 
 
correlation of EBHS susceptibility and sex, matrilinear inheritance or inbreeding 
coefficient was found [221,222,244]. Following the first outbreak, hare populations seem 
to reach stability due to protective immunity developed by surviving hares that may either 
have recovered from the clinical disease or have been infected as young hares 
[112,245]. In highly endemic areas, the prevalence of antibodies against the virus in wild 
hare populations can be ~ 90 % [246,247]. Interestingly, a study on farmed hares showed 
higher antibody titers in 1-3-years old hares, with hares less than one year dying before 
developing humoral response and old hares not being capable to have a rapid immune 
response due to reduced stem cell population [244]. 
The impact of EBHS in European brown hare populations is not easy to assess. 
Indeed, the population dynamics and their reproductive status are affected by factors 
other than EBHS, such as fox densities, hunting and agricultural structure [244]. 
However, low hare densities (less than 8 hares/km2) are associated with a severe impact 
of EBHS on the population dynamics [245]. This problem can be addressed by increasing 
hare densities to ~ 15 adults/km2 [245]. Hares from areas with high density have higher 
antibody titers comparing with hares from areas with low density, resulting in a protective 
effect of the populations [248]. Moreover, in high density areas, the virus circulates 
endemically, and young hares are in contact with the virus before losing maternal 
antibodies [249]. 
EBHS pathology, symptomatology and pathogenicity is similar to RHD [121]. 
Likewise, and based on the morphology of the liver lesions, several forms of the disease 
can be recognized. In a peracute form, no clinical signs are visible and hares die quickly. 
An acute form is characterized by a short clinical course and, after the appearance of 
the clinical signs, hares die within 2-3 days, but it can last until 7 days post-infection. A 
subacute or subclinical course may also occur. Hares affected by a chronic form of the 
disease die after several days or eventually recover [241]. Poor body condition is 
associated with EBHS infection, having two possible explanations: the disease may 
cause weight loss or hares with lower weight, caused by poor nutrition, pesticides or 
other diseases, may have higher susceptibility to infection [221]. 
Typical characteristics of EBHS infection are the loss of fear of dogs and people, 
adoption of abnormal postures, jumping into the air, staggering, incoordination and 
running in circles [243]. Respiratory distress, apathy versus excitement, depression, 
anorexia and convulsion, probably due to hepatic encephalopathy, are other clinical 
signs [220,234,238,250]. The liver is the target organ of this disease, but in acute 
infections gross lesions may be difficult to identify [112]. The diagnosis is sometimes 
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hampered since other acute infections present the same signs in terminal stages. 
Furthermore, the chronic form of the disease is only identified by chance, when hares 
die of other causes [112]. 
European brown hare syndrome causes generalized hemorrhages and congestion 
in the inner organs (Fig. 1.13). Liver is usually swollen, pale, yellow, necrotic and with 
marked lobules. In chronic infections, hares develop jaundice and chronic hepatitis, but 
the liver presents less extensive necrosis. Hares that recover may have liver fibrosis. 
Histologically, fatty content change is observed in hepatocytes and hepatocyte necrosis 
is visible in periportal areas and sometimes in the midzonal areas [e.g. 120,220,251]. 
Mitochondrial mineralization precedes necrosis and the presence of acidophilic bodies 
indicates hepatocyte apoptosis [252]. For hares infected experimentally, a decrease in 
the number of leukocytes and lymphocytes is observed 24h after infection [112]. Before 
death, a sharp increase of aspartate aminotransferase, alanine aminotransferase, 
bilirubin and γ-glutamyltranspeptidase is observed at four days post-infection (dpi) [253].  
 
 
Figure 1.13 Main pathological and histopathological lesions associated with EBHS. Green boxes: lesions in organs 
of the digestive system; yellow: lesions in organs of the excretory system; orange: lesions in organs of the lymphatic 
system and blue: lesions in organs of the respiratory system. 
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This highly contagious disease demands appropriate control measures. Although 
no commercial vaccines or specific treatments exist for EBHS infection, in farms, 
vaccines can be produced from livers of hares that died first during the outbreak to 
immunize the remaining hares [243]. Other containing methods should be applied, 
including serological tests on new introduced hares, quarantine of these hares and 
prevention of contact with wild hares and predators by using fencings [243]. Indirect 
transmission, through contaminated clothes, shoes, grass or hay, should also be 
avoided. In the wild, eradication is not possible and spread to contiguous naïve 
populations is difficult to prevent, but translocation of hares to EBHS-free regions should 
be kept to a minimum. The serological status of the translocated populations should be 
evaluated and populations must be kept in quarantine with susceptible hares to detected 
possible incubating or carrier animals [112]. 
 
European brown hare syndrome virus (EBHSV) 
The viral particles found by Lavazza and Vecchi allowed to identify the similarities 
between EBHSV and RHDV [233]. The virus was called European brown hare syndrome 
virus (EBHSV), and later identified as a Lagovirus of the family Caliciviridae [149]. The 
biochemical features of EBHSV are typical of the Caliciviridae family. Viral particles are 
small (30-35 nm), icosahedral, with the typical cup-shaped surface depressions of the 
Caliciviridae. This non-enveloped RNA virus has a single major capsid protein of ~ 60 
kDa that shares epitopes with the capsid protein of RHDV, showing that these viruses 
are antigenically related [120,254]. 
The genome of EBHSV was later cloned and sequenced and has the same 
organization as RHDV. This positive-sense, single-stranded RNA virus is 7442 base 
pairs long, but Northern hybridizations showed also the presence of a 2.2 kb subgenomic 
RNA that probably functions as mRNA for capsid protein synthesis [255,256]. Two 
slightly overlapping ORFs were determined for EBHSV: ORF1 is the largest and encodes 
a polyprotein of 2334 amino acids, encompassing the non-structural proteins and the 
capsid protein, with a predicted molecular mass of 256 kDa, and it shares four cleavage 
sites with RHDV [256]. The short ORF2 at the 3’ end encodes a polypeptide of 114 amino 
acids and has a predicted molecular mass of 12.4 kDa [255]. A short UTR at the 5’ end 
(8 nucleotides) contrasts with the 92 base pairs long 3’UTR, which is considerably larger 
than that of RHDV (59 nucleotides). Similarly to RHDV, EBHSV genome has a 
polyadenylated tail at the 3’ end. 
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Overall, RHDV and EBHSV have 71 % of nucleotide identity and 76 % if 
considering only the capsid protein gene (Fig. 1.10). Comparison of RHDV and EBHSV 
capsid proteins revealed a deletion of four amino acids near the N terminus and an 
insertion of one amino acid near the C terminus of the EBHSV sequence. Interestingly, 
the highest variability within the capsid is located in the central portion, and it was 
hypothesized that this central portion is located at the surface of the virion [255]. Further 
comparison with RHDV showed a similar degree of variation on the non-structural 
proteins: no major differences on the homology level were observed between structural 
and non-structural proteins [256,257]. 
While some authors failed to induce disease in rabbits inoculated with EBHSV (and 
vice-versa), though a low serological, non-protective, response was observed 
[120,253,258], others were able to replicate the disease [235,259]. Vaccination of rabbits 
with EBHSV also gave contradictory results: either EBHSV virus-like particles do not 
protect against RHDV challenge [260] or induce partial protection [254]. However, 
experimental infections of cottontails (Sylvilagus floridanus) with a virulent EBHSV strain 
induced mortality [261]. Recently, cottontail populations tested seropositive for EBHSV, 
albeit with low titers, and one cottontail was found dead during an outbreak of EBHS 
[262]. 
EBHSV is a highly contagious virus, preferentially transmitted directly via the oro-
fecal route or the respiratory route [241]. Indirect transmission through grass or hay 
contaminated with excreta or through contaminated clothes or shoes may also occur 
[112]. Although no reservoir hosts have been yet identified, mechanical vectors may 
spread the disease. Insects and carnivores are included, as well as birds, since EBHSV 
was identified in separate islands in Denmark and Sweden [263]. Humans are also 
possible mechanical vectors, especially hunters that may facilitate virus dissemination. 
As the virus is very resistant (it resists to pH=3 and inactivation by heat), it may persist 
several months in the field and still remain infectious.  
The lack of a proper culture system to grow the virus in vitro impairs its use as a 
diagnostic tool. Testing the infectivity and isolate the virus is only achieved by 
experimental inoculation [120]. Alternatively, other methods may be used to establish the 
cause of death. Diagnostic tests include electron microscopy, PCR, ELISA and 
hemagglutination [120,220,239]. As the liver is the target organ of EBHSV, it contains 
the highest viral titer and is the most suitable for virus identification. Due to intense 
viremia, other organs contain virus particles in a direct proportion to vascularization, thus 
spleen and serum are also targets for diagnosis. Interestingly, in hares that die from a 
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subacute or chronic form of the disease, higher levels of subviral particles can be 
detected in the spleen [241].  
Despite the morphological and antigenic similarities between EBHSV and RHDV, 
the hemagglutination activity of EBHSV is somewhat dissimilar of that of RHDV. In order 
to hemagglutinate human type O red blood cells, a modified protocol must be performed: 
the liver homogenate requires a treatment with an equal volume of chloroform, and steps 
should be carried out at 4 ºC and pH 6.5 [120]. Even using the modified protocol, only 
50 % of the samples give positive results. This is likely due to constant lower viral loads 
when comparing with RHDV and virus degradation, which in turn is probably related to 
the more frequent subacute and chronic courses of the disease [247]. 
Few studies have addressed the phylogenetic relationships of EBHSV strains and 
their evolution. The first phylogenetic reconstruction of EBHSV strains used partial 
sequences of the capsid protein gene and revealed that old Swedish samples clustered 
together and apart from other European samples [236]. Other studies evidenced that 
European samples isolated in the same year were more similar to each other, indicating 
a relationship with the time of isolation [264-266]. An analysis of French EBHSV samples, 
using complete sequences of the capsid gene, revealed a correlation between the 
geographical and the temporal distributions, with older EBHSV strains persisting in the 
population [267]. These earlier strains coexist with new strains, increasing the genetic 
diversity. Such pattern contrasts with RHDV evolution, which the authors attributed to 
not only differences in population densities and absence of vaccination pressure for 
EBHSV, but also to stronger incidence of the chronic form of EBHS that might facilitate 
the survival of the earlier strains [267]. Nonetheless, all EBHSV isolates belong to a 
single serotype. 
The origin and emergence of EBHSV and RHDV is difficult to trace. A former 
presence of non-pathogenic or less pathogenic forms that mutated and acquired 
virulence was hypothesized [237,240]. This hypothesis is supported by several 
indications of a former circulation of the viruses [191,238-240,268]. Furthermore, Frölich 
and colleagues suggested that importation of European hares in the 19th century to South 
America is associated with virus presence in that continent, that remained apathogenic 
until a few years ago [237]. Another possible scenario for the emergence of EBHSV and 
RHDV is a species jump from eastern cottontails (Sylvilagus floridanus), imported for 
recreational activities in the 1960s and the 1970s [269,270]. Despite the lack of 
knowledge on the emergence of EBHSV, its origin seems to be Scandinavia with a later 
spread to western, eastern and southern Europe [222]. 
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3. The order Lagomorpha 
 
The order Lagomorpha was recognized in 1912 and is constituted by two extant 
families: the Ochotonidae (pikas) and the Leporidae (rabbits and hares). Lagomorphs 
are widespread and very successful [271]. Despite some controversy [see, for example, 
272,273], Rodentia and Lagomorpha are usually grouped in the superorder Glires. This 
grouping was first proposed by Linnaeus in 1758, based on the shared traits between 
the two orders [272]. The Cretaceous-Tertiary boundary likely marked the split between 
Glires and other mammals [274,275]. Rodents and lagomorphs started to diverge only 
at the beginning of the Tertiary (~ 65 million years ago, mya), and are anatomically 
separated by the number of incisors [271,274]. An Asian origin of Lagomorpha is widely 
accepted and indeed the oldest known Lagomorpha fossil record is from the early 
Eocene (~ 53 mya) and was found in central India [276]. 
The families Ochotonidae and Leporidae are differentiated by the number of teeth 
(Ochotonidae 26, Leporidae 28) and by the tail and ear length [271]. The two families 
may have diverged in the early Eocene according to fossil and molecular studies 
[276,277]. Ochotonids were more diverse during the Miocene, but currently have a single 
extant genus, Ochotona, with 30 recognized species, inhabiting Asia and North America 
[278,279]. Leporids have 62 extant species distributed by 11 genera and occupy large 
areas of Eurasia, Africa, North America and Central America. Seven genera are 
monotypic and have a geographically restricted distribution (Brachylagus, Pentalagus, 
Caprolagus, Bunolagus, Poelagus, Romerolagus and Oryctolagus). Regarding the 
remaining genera, Nesolagus has two species, Pronolagus four, Sylvilagus 17 and 
Lepus 32 species [279]. 
 
The family Leporidae 
The phylogenetic history of leporids was assessed in the last decades based on 
morphological features, analysis of mitochondrial DNA (mtDNA) and chromosomal 
painting [280-284]. However, Matthee and colleagues [285] pointed out that several 
constraints, such as the convergence of anatomical features, the incomplete fossil record 
and the saturation of mtDNA sequences impair a good resolving power of the 
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phylogenies. Based on a complete analysis of five nuclear and two mitochondrial 
markers, these authors proposed that the current distribution of this family results from 
nine dispersal and five vicariance events that occurred mainly during the Miocene and 
after the origin of the group in North America or Asia (Fig. 1.14) [281,285]. The dispersal 
events between North America and Asia were facilitated by the formation of land bridges 
in the Bering strait and the melting of Antarctic ice sheets, at ~ 20 mya [286,287]. 
 
 
Figure 1.14 Main events in lagomorphs’ history and evolutionary relationships among them. In each node of the 
phylogeny and in the time bar, the time is given in million years. Phylogeny based in data from [285]. 
 
Ecological data also support the phylogeny inferred by Matthee and colleagues 
[285]. Indeed, the basal taxa Nesolagus and Romerolagus inhabit only regions with 
dense vegetation, consistent with an ancestral leporid origin in forested environments 
[288,289]. Moreover, all leporids are obligate herbivores, but the specific diet varies 
among genera. While the early diverged Nesolagus and Brachylagus, for example, 
depend mainly on C3 plants, the later diverged Caprolagus prefers C4 plants. The 
expansion of C4 plants in the late Miocene (~ 7 to 5 mya) and the formation of the 
Antarctic ice sheet at ~ 6.5 mya are associated with the increased size and wide range 
expansion of Lepus, also facilitated by the development of characteristics suitable for an 
open habitat [278,285,290]. 
From the late Miocene until the Pliocene leporids largely differentiated, and 
expansion to Africa and South America during the Pliocene and Pleistocene promoted 
the leporid blooming [278]. After the Pleistocene, and due to not only the extreme climate 
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conditions of the quaternary glaciations but also to the anthropogenic interference, the 
number of leporid genera decreased substantially [278]. Notwithstanding, leporids are 
currently widely distributed, occupying the biggest land masses and most islands 
southeast of Asia. This broad occurrence is largely due to human introductions [271,289], 
but some introduced species succeeded in new habitats (see, for example, the cases of 
Sylvilagus floridanus in Italy or Oryctolagus cuniculus in Australia, that will be further 
discussed) [130,291]. 
 
The European rabbit: a key species versus a pest 
The fossil records suggest an Iberian origin for the contemporary species of the 
genus Oryctolagus, the species Oryctolagus cuniculus [292]. Prior to the Pleistocene ice 
ages, a southern European distribution is hypothesized [271]. However, during the 
glaciations, several species had to be confined in southern refugia, such as the Iberian 
Peninsula [293]. Quaternary glaciations left two main refugia in Iberian Peninsula: one 
largest refugium in the southwest, close to the Gibraltar strait, and one smaller in the 
eastern Mediterranean coast [294]. These two refugia were responsible for the 
differentiation of the two rabbit subspecies that diverged at ~ 1.8 mya, the Oryctolagus 
cuniculus algirus in the southwest and the Oryctolagus cuniculus cuniculus in the 
northeast [295,296].  
The species that differentiated in the larger refugium, O. c. algirus, has more 
genetic variability than the species that differentiated in the smaller refugium, O. c. 
cuniculus [296]. After the last glacial maximum, the latter expanded from northern Spain 
to France, where it still remains present [297]. The difficulties in overcoming the 
geographical barrier of the Pyrenees created a bottleneck in the gene pool of the 
individuals and the French wild rabbit population has lower genetic diversity, being a 
subset of the O. c. cuniculus Iberian population [296,297]. Although the subspecies are 
genetically differentiated, the climatic oscillations (glacial and interglacial periods) in the 
late Pleistocene allowed contact and admixture [294], and the occurrence of gene flow 
[295,298]. Currently, O. c. algirus and O. c. cuniculus share a contact zone from the 
northwest to the southeast of Iberia [299]. 
The Portuguese discoveries during the 15th and 16th centuries had repercussions 
in the rabbit history. Indeed, Portuguese settlers introduced wild rabbits from the 
subspecies O. c. algirus in the archipelago of Azores [300-303]. A strong bottleneck 
effect is observed in these populations [296]. The algirus subspecies is also present in 
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other Atlantic islands. The cuniculus subspecies was introduced in several islands in 
historical times, as a source of meat for the navigators and colonizers [299]. Human-
mediated expansion of rabbits turned them one of the mammals with the most impressive 
geographical expansion, and colonization was successful all around the world [304]. 
A founder population of a few hundreds of individuals of the subspecies O. c. 
cuniculus was at the beginning of rabbit domestication. However, the extensive gene 
flow between the two subspecies before the domestication of rabbits resulted in the 
introgression of O. c. algirus haplotypes in the gene pool of the domestic founder 
individuals. O. c. algirus is therefore an indirect contributor for the domestic gene pool 
[305]. The origin of domestic rabbits is attributed to French monks that started to 
domesticate rabbits in the monasteries ~ 1400 years ago [306]. The genetic basis 
underlying domestication is a subject of interest to many authors, and it was recently 
shown that domestication was the result of small changes in several genes and not 
drastic changes in a few genes, leading to the modification of phenotypic characteristics 
such as the flight response [307]. Due to successive bottlenecks, domestic rabbits 
present lower genetic diversity than wild rabbits. 
In Europe, rabbit is a key species for the ecosystem as several predators, most of 
them threatened, depend on it to survive. That is the case of the endangered Iberian lynx 
(Lynx pardinus, Temminck, 1827) and of the vulnerable Spanish Imperial eagle (Aquila 
adalberti, Brehm, 1861), both specialist predators on the European rabbit, but other 
species are affected as well [129,308]. The main cause for the decline of rabbit 
populations is RHD, although overhunting and habitat loss and fragmentation had also 
an impact on the population density, even before the emergence of RHD [141,309]. In 
addition to the ecological impact, a huge economic burden is associated with rabbit 
decline in Europe, since rabbits are an important game species [310]. 
While in Europe the conservation of European rabbit is of utmost importance, in 
Australia rabbits are seen as a pest. As in many other regions of the world, introduction 
of rabbits was man-mediated and started to occur in the beginning of the 19th century for 
hunting purposes [130,311]. The pre-existent burrows from native animals helped the 
rapid dispersal of wild rabbits, at an incredible rate of 70 km/year, slowly leading to the 
decrease in the numbers and even extinction of native species due to competition for 
food and shelter [312,313]. The European rabbit is an agricultural pest in Australia and 
has significantly affected the fauna and flora of that region, changing dramatically the 
Australian landscape [312,314,315]. Biocontrol measures had to be taken to control the 
pest, such as the introduction of myxomatosis and later RHD [316]. Rabbits were also 
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responsible for the extinction of native species in other locations where they were 
introduced [e.g. 317]. 
The economic importance of European rabbit also relies on its commercial value 
as a source of meat and fur. Furthermore, European rabbit is a valuable laboratory model 
to study several human diseases, as well as toxicology, fertilization and immunology 
[318-320]. Additionally, myxomatosis and rabbit hemorrhagic disease make rabbits a 
textbook example to study host-pathogen co-evolution [e.g. 205,321]. 
 
The widespread genus Lepus 
The cosmopolitan genus Lepus probably originated in North America and is the 
most widely distributed lagomorph [278,285]. In Europe, six hare species are present. 
The broom hare (Lepus castroviejoi, Palacios, 1977) is geographically restricted, 
occurring only in Cantabrian Mountains, northern Iberia. The Cape hare (Lepus 
capensis) was introduced in Sardinia from Africa, where it has a wider distribution. The 
Corsican hare (Lepus corsicanus) occurs in Italy and in Corsica and the Iberian hare 
(Lepus granatensis, Rosenhauer, 1856) is an Iberian endemic species and covers the 
whole Peninsula. In the northeast, this species has a narrow contact zone with the 
European brown hare (Lepus europaeus), whose distribution covers all Europe with the 
exception of the northern part of Scandinavia. Here, L. europaeus has a contact zone 
with the mountain hare (Lepus timidus), a species that extends from Scandinavia to the 
eastern part of Europe, and then has some isolated populations in Ireland, Scotland and 
in the Alps [279,322]. 
Although L. timidus is not present in Iberian Peninsula, mtDNA lineages of this 
species were found among L. granatensis [323,324]. Similarly, L. castroviejoi 
populations and Swedish and Iberian populations of L. europaeus have introgressed 
mtDNA from L. timidus [323,325-327]. Strikingly, no introgressed mtDNA was detected 
in L. europaeus from central Europe [328]. This phenomenon of introgression likely 
results from ancient hybridization between these species, when L. timidus populations 
were still present in Iberia – the fossil record suggests they became locally extinct at the 
end of the last glacial period [323,326]. The preservation of these mtDNA lineages 
allowed them to survive until our days, and considerable frequencies are found in 
northern and central Iberia. These data further suggest that L. granatensis colonized the 
northern and southern Iberia from a central glacial refugium [reviewed by 329]. 
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Hare population densities are the result of an interplay between abiotic, biotic, 
anthropogenic and internal factors [330]. Habitat requirements vary along the year and 
the habitat diversity guarantees food and shelter for the year-round. Hares are more 
commonly found near arable farming areas, albeit the decrease in hare numbers where 
intensive agriculture is practiced [331 and references therein]. Nonetheless, European 
brown hares are adapted to a variety of habitats and were successfully introduced in 
more exotic regions, like South America, Oceania, Reunion Island and the Falklands 
[279]. These animals have an important economic role in Europe, where they are 
considered major game species and thousands of animals are harvested every year 
[329,332]. On the other hand, the scarcity of European rabbit in some areas in Iberian 
Peninsula due to viral diseases prompted predators like the Spanish Imperial eagle to 
choose L. granatensis as an alternative prey [129,329]. 
 
The introduction of eastern cottontails in Europe 
The eastern cottontail (Sylvilagus floridanus) is a native American lagomorph, but 
in the 1950s, 1960s and 1970s this species was successively introduced in Europe, 
particularly in France and Italy [269,270] for hunting purposes, since rabbit numbers were 
decreasing because of myxomatosis. At that time, it was expected that cottontails would 
replace the European rabbit, as myxomatosis is benign in the Sylvilagus genus, but that 
did not occur [333]. In Italy, where it is currently widespread, the eastern cottontail shows 
a great capacity of dispersal and reproductive performance in the introduced populations. 
Because of that, the eastern cottontail has occupied the ecological niche of L. europaeus 
[291]. 
Interspecific competition between S. floridanus and the autochthonous species O. 
cuniculus and L. europaeus limits these populations and might occur by searching for 
food and shelter, limited during the winter, by land occupation, or by direct interactions 
between individuals [291]. For the latter, body size (higher in hares, successively 
followed by rabbits and cottontails) is an important factor determining the success of 
aggressive interactions [334]. In areas where eastern cottontails and European brown 
hares are sympatric, the introduced species is pointed as the causative agent of the 
declining of hare populations [335]. Moreover, the interactions between this introduced 
species and the others present in Europe need attentive investigation, because of the 
possible role of eastern cottontail in acting as a reservoir of viral diseases and in their 
transmission [336]. 
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New variant of rabbit hemorrhagic disease virus, Portugal, 
2012–2013 
 
J. Abrantes, A. M. Lopes, K. P. Dalton, P. Melo, J. J. Correia, M. Ramada, P. C. Alves, F. Parra & P. J. 
Esteves 
 
1. To the Editor: During November 2012–February 2013, rabbit hemorrhagic 
disease virus (RHDV) strains belonging to the new variant RHDV were isolated in 
Portugal from wild European rabbits (Oryctolagus cuniculus subsp. algirus). The major 
capsid protein, VP60, of these strains was partially characterized. RHDV had been 
previously been detected in Portugal in 1989 [1]. Before 2011, RHDV outbreaks in wild 
European rabbit (O. cuniculus) populations in the Iberian Peninsula were exclusively 
caused by strains belonging to genogroup 1 [2,3].  
In the Iberian Peninsula, 2 subspecies of European rabbit are found, O. cuniculus 
subsp. algirus and O. cuniculus subsp. cuniculus. These subspecies are equally 
susceptible to RHDV [3]. In 2011, a new variant was isolated in young rabbits belonging 
to O. cuniculus subsp. cuniculus from a rabbitry in the province of Navarra, Spain [4]. 
The topology of the variant’s phylogenetic tree and the susceptibility of kits < 2 months 
old suggest that this strain is similar to that described in France in 2010 [5]. 
Before the new variant of RHDV emerged and, on the basis of phylogenetic 
relationships, RHDV strains had been divided into 6 genogroups (G1–G6) [1], with 
strains of G6, or RHDVa, having a distinct antigenic profile [6]. All of these strains 
replicate in the liver and are responsible for causing death in rabbits > 2 months of age. 
Non-pathogenic and weakly pathogenic RHDV-related strains have also been described. 
The non-pathogenic and weakly pathogenic strains are phylogenetically distinct from the 
G1–G6 strains with ~ 20 % of nucleotide divergence [7]; they typically replicate in the 
intestines [8,9]. New variant RHDV causes death in kits as young as 30 days old and 
affects vaccinated and unvaccinated animals [4]. Phylogenetically, this new variant falls 
between the non-pathogenic groups [4,5]. 
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During November 2012–February 2013, our laboratory, CIBIO, Universidade do 
Porto, Portugal, received liver samples from wild adult rabbits and kits, belonging to O. 
cuniculus subsp. algirus, from three areas of Portugal, Valpaços, Barrancos, and 
Algarve. The rabbits had appeared dead and had clinical signs suggesting rabbit 
hemorrhagic disease (RHD). We analyzed the samples for RHDV by reverse 
transcription PCR. For this process, total RNA was extracted by using the RNeasy Mini 
Kit (QIAGEN, Hilden, Germany), according to the manufacturer’s instructions. Reverse 
transcription was performed by using oligo(dT) as primer (Invitrogen, Carlsbad, CA, 
USA) and SuperScriptTM III Reverse Transcriptase (Invitrogen) as recommended by the 
manufacturer. Screening of the samples consisted of PCR with a pair of primers as 
described by Dalton et al. [4]. This pair amplifies a 738-bp fragment of the gene encoding 
the capsid protein, VP60 (PCR conditions are available on request). After purification, 
PCR products were sequenced on an automatic sequencer ABI PRISM 310 Genetic 
Analyzer (PE Applied Biosystems, Foster City, CA, USA) with the same pair of primers. 
The virus was detected in 15 samples, five from each locality. The obtained 
sequences were aligned with those available from public databases. Retrieved 
sequences represent the RHDV groups G1–G6, the non-pathogenic groups, and the 
new variant (GenBank accession nos. KF442960–KF442964). A phylogenetic tree was 
inferred in MEGA5 [10] by using a Maximum Likelihood (ML) approach. Reliability of the 
nodes was assessed with a bootstrap resampling procedure consisting of 500 replicates 
of the ML trees. The best-fit nucleotide substitution model was determined by using 
MEGA5. 
Our sequences exhibit the highest nucleotide sequence identity with the RHDV 
N11 strain from Spain (99 %; GenBank accession no. JX133161.1), which corresponds 
to the new RHDV variant. Thirteen nucleotide substitutions were detected in comparison 
to the Spanish sequence, 3 of which were non-synonymous. The inferred ML 
phylogenetic tree is in agreement with those published [1,3,9]. G1–G6 (pathogenic) 
RHDV strains and non-pathogenic and weakly pathogenic RHDV-related strains 
(generally referred to as RCV) form 2 groups (Fig. 2.1). The non-pathogenic strain from 
Australia (RCV-A1_Australia_MIC-07) does not cluster with other non-pathogenic 
groups and European brown hare syndrome virus (EBHSV_France) appears in a basal 
position in the tree. As described, the new variant (N11_Spain) appears between RCV 
and the non-pathogenic Australian strain [4,5]. The strains isolated from rabbits in 
Portugal cluster with the new variant and form a highly supported group (bootstrap value 
1.00). These results support the conclusion that the virus recovered in Portugal belongs 
to the new variant RHDV described in Spain and France. 
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Figure 2.1 Maximum likelihood phylogenetic tree of 95 partial sequences of the rabbit hemorrhagic disease virus 
(RHDV) capsid gene. Bootstrap values appear next to the nodes and are shown only for the major groups: G1–G6 
(GenBank accession nos. AB300693, AF231353, AF258618, AF453761, AJ006019, AJ302016, AJ303106, AJ495856, 
AJ535092, AJ535094, AJ969628, AM085133, AY269825, AY523410, AY926883, AY928268, AY928269, DQ069280, 
DQ069281, DQ069282, DQ189077, DQ189078, DQ205345, DQ280493, DQ530363, DQ841708, EF363035, EF558572, 
EF558573, EF558574, EF558575, EF558576, EF558577, EF558578, EF558581, EF558582, EF558583, EF558584, 
EU003578, EU003579, EU003580, EU003581, EU003582, EU250330, EU650679, EU650680, FJ212322, FJ212323, 
FJ794179, FJ794180, FN552800, FR823354, FR823355, GU339228, GU373617, GU373618, GU564448, HE963222, 
HM623309, HQ917923, JF412629, JF438967, JN165233, JN165234, JN165235, JN165236, JN851729, JN851730, 
JN851731, JN851732, JN851733, JN851734, JN851735, JQ815391, JQ995154, L48547, M67473, RHU49726, X87607, 
Y15424, Y15427, Z24757, Z29514, Z49271), RCV (GenBank accession nos. GQ166866; AM268419; X96868) and new 
variant RHDV (GenBank accession no. X133161). European brown hare syndrome virus (EBHSV) was used to root the 
tree (GenBank accession no. NC_002615). A non-pathogenic strain from Australia was also included (GenBank accession 
no. EU871528). The samples isolated from the rabbits found in Portugal appear in bold (Valpaços16_Portugal, 
Algarve1_Portugal, Algarve3_Portugal, Barrancos7-13_Portugal, Barrancos10A-13_Portugal, GenBank accession nos.: 
KF442960–KF442964. Scale bar indicates nucleotide substitutions per site. 
 
This confirms the presence of the virus in wild rabbits on the Iberian Peninsula. We 
also confirm that both European rabbit subspecies are susceptible to the new variant. 
The appearance and rapid spread of the new variant RHDV into the Iberian wild rabbit 
populations raise concern for the survival of these populations in this region. These 
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conservation concerns are particular highlighted for the O. cuniculus subsp. algirus, 
because it only occurs in the southwestern part of the Iberian Peninsula, and it is a key 
prey species for several carnivores, namely, for the most endangered feline, the Iberian 
Lynx (Lynx pardinus). Therefore, monitoring the spread and evolution of this new variant 
is crucial in determining the most appropriate conservation measures. 
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Is the new variant RHDV replacing genogroup 1 in Portuguese 
wild rabbit populations? 
 
A. M. Lopes, J. Correia, J. Abrantes, P. Melo, M. Ramada, M. J. Magalhães, P. C. Alves & P. J. Esteves 
 
1. Abstract 
The Lagovirus rabbit hemorrhagic disease virus (RHDV), a member of the family 
Caliciviridae, severely affects European rabbit (Oryctolagus cuniculus) populations by 
causing rabbit hemorrhagic disease (RHD). RHDV is subdivided in six genogroups but, 
more recently, a new RHDV variant with a unique genetic and antigenic profile emerged. 
We performed a study in rabbits found dead in the field during 2013 and 2014 in Portugal 
to determine the prevalence of this new variant versus the classical RHDV. Fifty-seven 
liver samples were screened for the presence of RHDV and positive samples were 
genotyped. All cases of RHDV infection were caused by the new variant. The only former 
genogroup circulating in Portugal, G1, was not detected. We hence conclude that the 
new RHDV variant is replacing G1 in Portugal, probably due to a selective advantage. 
This sudden and rapid replacement emphasizes the necessity of continued monitoring 
of wild rabbit populations. 
 
2. Introduction 
Rabbit hemorrhagic disease virus (RHDV), a member of the genus Lagovirus, 
family Caliciviridae, is responsible for causing rabbit hemorrhagic disease (RHD). RHD 
was first reported in China in 1984 [1] and is a highly contagious and fatal disease for 
European rabbit (Oryctolagus cuniculus). The acute form of the disease can cause up to 
80 – 100 % of mortality within 1–3 days [2,3]. RHD is associated with hepatic necrosis, 
hemorrhages and congestion in several organs, including the upper respiratory tract and 
lungs, and splenomegaly [2]. The disease became endemic in several European 
countries, where it was first reported in 1986 [4], and in Australia and New Zealand, 
84 FCUP 
Insights into the emergence and evolution of the new RHDV variant in Portugal 
 
where it was introduced as biological control agent [5]. In Portugal, RHD was described 
in 1989 [reviewed in 3]. 
RHDV is a non-enveloped, positive-sense, single-stranded RNA virus, with a 
genome of ~ 7.4 kb organized in two ORFs, with ORF1 encoding the major structural 
capsid protein gene, VP60. Historically, six RHDV genogroups were recognized based 
on the VP60: genogroups 1–5 (G1–G5) and the antigenic variant RHDVa or G6 [6,7]. 
However, more recent studies showed that G3, G4 and G5 belong to the same genetic 
cluster [8,9]. Furthermore, weak pathogenic and non-pathogenic forms of the virus exist, 
which are genetically different from the pathogenic RHDV, exhibiting ~ 20 % divergence 
[10-14]. The other member of the genus Lagovirus, the closely related European brown 
hare syndrome virus (EBHSV), has a similar organization of the genome, albeit 
presenting ~ 30 % divergence from RHDV [15]. 
In 2010, a new RHDV variant emerged in France [16], tentatively named RHDV2 
or RHDVb, that rapidly spread to several European countries including Portugal, where 
it was described in 2012 [17-21]. With a unique antigenic profile, it causes mortality in 
young rabbits (less than two months) and vaccinated rabbits, that are typically not 
susceptible to G1–G6 strains [17]. Vaccinated rabbits appear to be less susceptible to 
this new variant, albeit protection conferred by the vaccine is not complete [19]. Before 
the emergence of the new variant, only G1 strains were known to circulate in Portugal 
[22-24]. RHDVa was also described in the Iberian Peninsula [25], but this description 
refers only to domestic rabbits and no reported cases exist in wild animals. 
The Iberian Peninsula is inhabited by two subspecies of O. cuniculus: one 
occupying the northeastern part (O. c. cuniculus) and the other restricted to the 
southwest and the islands of Madeira, Azores and Canaries (O. c. algirus) [reviewed in 
26]. Both subspecies are equally affected by RHDV [22], but the susceptibility of the 
subspecies O. c. algirus acquires special importance since its distribution is restricted to 
the Iberian Peninsula. Thus, this subspecies is more vulnerable to severe outbreaks, 
which might have implications on its conservation status. 
In this work, we performed a genetic study to determine the prevalence of the new 
variant comparing to G1 in Portuguese rabbit populations and a histopathological study 
to characterize the lesions found in young rabbits. Our results confirm that the new 
variant has replaced G1 in Portugal in the last two years, possibly reflecting a selective 
advantage. 
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Figure 2.2 Map of Portugal with sampling localities indicated. Localities sampled in 2013 appear underlined; in 
parenthesis, the number of positive samples per total number of samples is shown. The approximate locations of the first 
descriptions of the new variant’s presence in Portugal according to [18] are marked by the black stars. 
 
3. Methods 
Fifty-seven liver samples were collected in 12 localities covering from north to 
south of Portugal, between 2013 and 2014 (Fig. 2.2), and frozen at −20 °C. All rabbits 
were found dead in the field with lesions consistent with RHD and, based on the 
geographical distribution, belong to the subspecies O. c. algirus [26]. In addition, for 
seven young wild rabbits, carcasses were submitted to necropsy and samples of lung, 
liver, thymus, trachea, kidney and spleen were collected for histopathological exam. 
Tissue samples were fixed in 10 % buffered formalin and embedded in paraffin. Sections 
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of 3 μm thick were stained with hematoxylin and eosin for routine microscopical 
examination. 
Total RNA was extracted from the liver of all samples with the RNeasy Mini Kit 
(Qiagen, Hilden, Germany). Up to 30 mg of liver were collected and tissue was 
homogenized in a rotor-stator homogenizer (Mixer Mill MM400 from Retsch, Haan, 
Germany) at 30 Hz for 7 min. RNA extraction followed the manufacturer’s instructions. 
Viral cDNA was synthesized using oligo(dT) primers and SuperScriptTM III Reverse 
Transcriptase (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s instructions. 
A screening to test for the presence of RHDV was performed with two pairs of primers: 
the first pair is specific for the new variant: RHNavF 5'-GTTCGTCAAATGTACTTGAGC-
3' and RHNavR 5'-GTGTACGTAATGGCACTACTG-3' [27]. Samples that tested 
negative were screened with a second more general pair of primers (RHDV4831F 5'-
GTGTATGCCATGACTCCGAT-3' and RHDV_VP60_0467R 5'-
GCGTCGATGACAACATGAG-3'). These primers were used in previous studies and 
successfully amplified several RHDV strains including G1, RHDVa and G3–G5 like 
[24,25,28,29]. For positive samples, the complete capsid protein gene, VP60, with 1740 
base pairs, was amplified (PCR primers and conditions are available upon request). After 
purification, PCR products were sequenced on an automatic sequencer ABI PRISM 310 
Genetic Analyzer (PE Applied Biosystems, Foster City, CA, USA) with the amplification 
primers. These sequences were deposited in GenBank with the accession numbers 
KM115667-KM115716 and aligned in BioEdit version 7.0.9.0 [30]. Each sequence was 
compared and blasted against publicly available sequences in NBCI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). In order to facilitate visualization and the 
subsequent analyses, a maximum of ten sequences of the main RHDV groups were 
used (G1–G6, the new variant, non-pathogenic RCV-A1 and weakly pathogenic MRCV; 
EBHSV was also included). Genetic distances between our samples and each RHDV 
group were calculated in MEGA6 (p-distance method, 1000 replicates) [31]. Additionally, 
a Maximum Likelihood (ML) tree, using a representative of each unique haplotype found, 
was estimated using the same software. The best-fit nucleotide substitution model as 
determined in MEGA6 (GTR+G+I) and a bootstrap resampling analysis of 1000 
replicates, were used to reconstruct the phylogeny. 
 
4. Results and Discussion 
Between 2013 and 2014, Portuguese wild rabbit populations suffered severe RHD 
outbreaks. Indeed, during that period, we received in our laboratory rabbit samples from 
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several Portuguese localities (Fig. 2.2) that were shown to be positive for the new RHDV 
variant. This new variant was described in Portugal in 2012 [18]. Interestingly, before 
that, G1 was the only genogroup known to be circulating in Portugal [22-24]. 
While the macroscopic and histopathological alterations caused by RHDV are well-
known, little is known on how the new RHDV variant affects wild animals. As this is a 
new and emergent virus, monitoring these alterations might give insights on eventual 
changes in lesions. At necropsy, the alterations and histopathological lesions observed 
were similar to those observed for other animals infected with the new RHDV variant and 
that are typical of a RHDV infection [16,17,19]. Necropsy of the seven young rabbits 
revealed epistaxis, hemorrhagic tracheitis with sero-hemorrhagic exudate in the lumen 
of the trachea, sero-hemorrhagic pleurisy, pulmonary congestion (predominantly in the 
dorsal region), and multiple hemorrhages scattered throughout the organs. Livers were 
predominantly pale in appearance and in some cases were congested. The thymus, 
spleen and kidneys showed also congestion. Histopathology revealed hemorrhagic 
pneumonia and tracheitis, congestion of the liver and diffuse necrotizing hepatitis (Fig. 
2.3A,B). This first establishment of a diagnosis and consequent cause of death was then 
confirmed by the molecular techniques. 
 
Figure 2.3 Histopathological characterization of the new rabbit hemorrhagic disease virus (RHDV) variant in 
Portuguese samples. (A) Liver section of a healthy rabbit. Staining H&E, scale bar = 20 μm; (B) Liver with lesions of 
microvacuolar degeneration and necrotizing hepatitis with karyolysis. Staining H&E, scale bar = 20 μm. 
 
Of the 57 rabbit liver samples, 50 were positive for the new variant (87.7 %; Fig. 
2.2); all but one were successfully amplified for the entire capsid gene. The 143 
nucleotide differences defined 33 unique haplotypes, with an overall identity of 98.7 % 
(± 0.1%). None of the samples was positive for G1 or for any other genogroup. The blast 
analysis revealed 96 – 98 % of identity with publicly available sequences of the new 
variant from Italy and France (GenBank accession numbers KC741409, HE800529-32, 
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FR819781, HE819400, JQ929052, KC345611-13, JX106022-23, KC907712), and an 
overall identity of 82 % with G1 strains. The analysis of the nucleotide identities between 
our dataset and genogroups showed an identity of 81.6 % (± 0.8 %) with G2, 82.1 % (± 
0.8 %) with RHDVa and 82.2 % (± 0.8 %) with G3-G5. Furthermore, our sequences 
presented a nucleotide identity of 81 % (± 1.0 %) with the weakly pathogenic MRCV, 
79.2 % (± 0.8 %) with the non-pathogenic RCV-A1 (strain MIC-07) and 70.0 % (± 0.9 %) 
with EBHSV (overall identity with strains O4021-9, BS89 and EBHSV-GD; GenBank 
accession numbers of these sequences are indicated in Fig. 2.4). The ML tree also 
confirmed that all samples belong to the new RHDV variant group (Fig 2.4), since all 
RHDV samples recovered from Portuguese rabbits cluster with publicly available 
sequences described as belonging to the new RHDV variant (bootstrap value of 99; Fig. 
2.4). Comparison with the partial sequences of the capsid obtained in the first reported 
cases of the new RHDV variant in Portugal (GenBank accession numbers KF442960-
64) [18], revealed that our sequences present between 0.0 % (± 0.2 %) and 2.5 % (± 0.6 
%) divergence. However, the small length of the analyzed fragment does not allow us to 
make any conclusions about the epidemiology and dispersal of the virus since the initial 
outbreaks. 
Indeed, the lack of epidemiological data on RHDV prevalence in Portuguese wild 
rabbit populations impairs a precise comparison between G1 and the new variant 
virulence/pathogenicity. However, the number of dead animals found in the field in 2013 
and 2014 seems to have substantially increased, as has been described in Spain by 
Delibes-Mateos et al [32]. Our results show that these RHD outbreaks were caused by 
the new variant and no apparent cases of G1 (or other genogroup) were detected. This 
indicates that the new variant is the main variant currently circulating in Portugal and has 
potentially replaced G1; the factors contributing to this replacement are still unclear, but 
are currently under study. A similar situation has been described in France and Spain, 
where the new RHDV variant appears to be replacing G5 and G1, respectively 
[19,33,34]. 
After the first description of the new variant in Portugal in three Portuguese 
localities in 2012 and 2013 [18], the new RHDV variant was able to disperse to the center 
and south of Portugal (Fig. 2.2), suggesting a high capacity of dispersal in a very short 
period of time. The weak dispersal to the north of Portugal is possibly due to low rabbit 
densities. By contrast, in the south, the high densities of rabbits facilitate virus dispersal. 
The high capacity of dispersal, associated with the replacement of G1, suggests a 
selective advantage of the new variant over other genogroups, possibly by overcoming 
existing immunity to older strains. Le Gall-Reculé and colleagues [19] reported that the 
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new RHDV variant is less virulent than classical RHDV in experimental conditions and 
that this could be advantageous for the new variant, by giving more time to the virus to 
spread. The different mortality rates observed between studies [e.g., 17,19] make 
possible another scenario, where the new variant is still evolving to acquire its optimal 
virulence. Another possibility is that the new RHDV variant might be evolving towards 
higher levels of virulence, as observed in a recent study in Australia, where RHDV 
virulence has been increasing due to the development of genetic resistance in rabbits in 
Australia [35]. 
 
 
Figure 2.4 Maximum Likelihood tree of the capsid gene. Bootstrap values of the main nodes (≥ 80) are shown next to 
them. To facilitate visualization, the new variant group is collapsed (previously identified new variant strains have their 
accession numbers indicated). Samples were named according to the sampling locality, the year of collection and the 
number of the isolate (cf. Fig. 2.2); when known, month and year of collection are indicated. Scale bar indicates the 
nucleotide substitutions per site. GenBank accession numbers of the publicly available sequences used in this study are 
indicated. 
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The threat presented by the new RHDV variant to the European rabbit might be 
particularly high for O. c. algirus, since distribution of this subspecies is limited to the 
southwest of Iberian Peninsula. In addition, the presence and circulation of the new 
RHDV variant compromises the reintroduction of the most endangered felid in the world 
(Iberian lynx, Lynx pardinus) in Portugal, as rabbits represent 90 % of its diet. The 
European rabbit is also economically important as game species, being a traditionally 
coveted prey, with high social value. Since the epidemiological outcome of G1 
replacement by the new variant is unpredictable, and the new variant is causing 
important ecological and economical losses in Portugal, rabbit translocations should also 
be highly restricted, and continued monitoring of natural rabbit populations is strongly 
recommended. 
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Full genomic analysis of new variant rabbit hemorrhagic 
disease virus revealed multiple recombination events 
 
A. M. Lopes, K. P. Dalton, M. J. Magalhães, F. Parra, P. J. Esteves, E. C. Holmes & J. Abrantes 
 
1. Abstract 
Rabbit hemorrhagic disease virus (RHDV), a Lagovirus of the family Caliciviridae, 
causes rabbit hemorrhagic disease (RHD) in the European rabbit (Oryctolagus 
cuniculus). The disease was first documented in 1984 in China and rapidly spread 
worldwide. In 2010, a new RHDV variant emerged, tentatively classified as ‘RHDVb’. 
RHDVb is characterized by affecting vaccinated rabbits and those < 2 months old, and 
is genetically distinct (~ 20 %) from older strains. To determine the evolution of RHDV, 
including the new variant, we generated 28 full-genome sequences from samples 
collected between 1994 and 2014. Phylogenetic analysis of the gene encoding the major 
capsid protein, VP60, indicated that all viruses sampled from 2012 to 2014 were RHDVb. 
Multiple recombination events were detected in the more recent RHDVb genomes, with 
a single major breakpoint located in the 5’ region of VP60. This breakpoint divides the 
genome into two regions: one that encodes the non-structural proteins and another that 
encodes the major and minor structural proteins, VP60 and VP10, respectively. 
Additional phylogenetic analysis of each region revealed two types of recombinants with 
distinct genomic backgrounds. Recombinants always include the structural proteins of 
RHDVb, with non-structural proteins from non-pathogenic lagoviruses or from 
pathogenic genogroup 1 strains. Our results show that in contrast to the evolutionary 
history of older RHDV strains, recombination plays an important role in generating 
diversity in the newly emerged RHDVb. 
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2. Introduction 
Rabbit hemorrhagic disease (RHD) is an acute fatal necrotizing hepatitis that 
affects wild and domestic European rabbits of both the Oryctolagus cuniculus cuniculus 
and Oryctolagus cuniculus algirus subspecies [1]. The disease was first detected in 1984 
in China following the importation of commercially bred Angora rabbits from Germany 
[2]. RHD rapidly spread worldwide and is currently endemic in several countries including 
Portugal, Spain and France. The economic burden of RHD on rabbit farming and hunting 
industries and the negative ecological impact on the wild rabbit populations and in their 
dependent predators, particularly in the Mediterranean ecosystem, are well known and 
of major concern [3]. In contrast, in Australia, RHD has been successfully exploited as a 
form of biocontrol to reduce rabbit numbers, although there is mounting evidence for host 
resistance [4-6]. 
RHD is caused by rabbit hemorrhagic disease virus (RHDV), a Lagovirus of the 
family Caliciviridae. RHDV has a non-enveloped single-stranded (ss) RNA genome 
organized into two narrowly overlapping open reading frames (ORFs). ORF1 
encompasses nucleotide residues 10–7044 and encodes a large polyprotein that is 
cleaved by a virus encoded protease to generate several non-structural (NS) proteins 
and the major capsid protein, VP60 or VP1 (for convenience, we use VP60). ORF2 
comprises nucleotide residues 7025–7378 and produces VP10 (or VP2), a minor 
structural protein [7]. At the 5’ region, the RHDV genome presents a covalently linked 
protein, VPg, and is polyadenylated at the 3’ region [8,9]. Viral particles also package an 
abundant subgenomic RNA (sgRNA) that contains the coding sequences of VP60 and 
VP10. As is the case for the RHDV genomic RNA, the sgRNA is VPg-linked and 
polyadenylated [9-11]. 
Despite the importance of RHDV for animal health and ecosystem well-being, its 
origin and emergence as a pathogenic virus in the European rabbit is not well 
understood. On current data the most likely explanation is direct evolution from a non-
pathogenic form of the virus [12]. Indeed, a number of non-pathogenic and a weakly 
pathogenic rabbit caliciviruses have been described in Europe, America and Australia 
[13-16], and there is evidence for the existence of RHDV as a non-pathogenic form 
before the first documented outbreak [reviewed by 1]. To date, however, the mutations 
(or recombination events) responsible for the profound change in virulence are unknown. 
It is also theoretically possible that a cross-species transmission event was central to the 
emergence of RHDV as a pathogenic form. Indeed, in the 1990s, RHDV affected a 
species other than the European rabbit [17]. 
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More recently, a new variant of RHDV was detected in France [18]. As a definitive 
RHDV nomenclature has not yet been agreed (various terms such as ‘new variant’, 
‘RHDVb’ and ‘RHDV2’ have been used), for simplicity we use the term ‘RHDVb’. RHDVb 
resulted in atypical RHD outbreaks in that it led to mortality in both vaccinated adult 
rabbits [18] and young rabbits [19,20] that are typically resistant to RHDV. Phylogenetic 
relationships inferred from the VP60 gene showed that RHDVb formed a novel 
phylogenetic group that fell between the RCV-like viruses, i.e. European non-pathogenic 
viruses and the weakly pathogenic Michigan rabbit calicivirus (MRCV) and the Australian 
non-pathogenic rabbit caliciviruses (RCV-A1) [18]. Further work demonstrated that 
RHDVb is antigenically different from other RHDVs [19,21], although its genesis is 
uncertain. Importantly, the recent detection of RHDVb in leporid species other than the 
European rabbit [22,23] indicates that it might infect a wider range of host species. 
Both host jumping and changes in virulence have been associated with the ability 
of RNA viruses to rapidly produce genetic diversity through mutation [24,25]. However, 
it is also possible that the genotypes associated with successful emergence are 
generated by recombination [26]. Because it requires template switching, (homologous) 
RNA recombination generally involves regions of high sequence similarity. Although 
homologous recombination has been detected in RHDV [27,28], its impact on fitness and 
hence long-term importance remains uncertain. Notably, the RHDV strain isolated in 
1984 in China had a recombinant origin [28], which may have been in part responsible 
for the marked change in virulence observed in this virus. 
RHDV has been divided into six genogroups, denoted G1–G6 [29]. In the Iberian 
Peninsula, RHDV is characterized by a high degree of virus isolation with only G1 
detected in wild rabbit populations [30-32], which differs from the epidemiological pattern 
seen in other European countries [29]. However, in 2011 and 2012, RHDVb was 
detected in both Spain and Portugal [19,33]. To better understand the evolution of RHDV 
and particularly the occurrence and impact of recombination, we determined the 
complete coding sequences of Iberian RHDV strains collected between 1994 and 2014.  
 
3. Methods 
Virus samples and genome amplification 
Liver samples were collected from wild rabbits found dead in the field in different 
regions of Portugal and from domestic rabbits from Spanish rabbitries, and were kept 
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frozen at -20 ºC. No live animals were shot, trapped or handled to obtain tissues; as 
such, no animal ethics permit was required. Each frozen liver was thawed and up to 30 
mg of the liver was collected. The tissue was homogenized in a rotor-stator homogenizer 
(Mixer Mill MM400; Retsch) at 30 Hz for 7 min. Total RNA was extracted using the 
RNeasy Mini kit (Qiagen) according to the protocol provided by the manufacturer. 
Reverse transcription was performed using oligo(dT) as primers and SuperScriptTM III 
Reverse Transcriptase (Invitrogen) according to the provided protocol. The complete 
genome of each RHDV strain was obtained by the amplification of several overlapping 
fragments ranging from ~ 700 to 1700 bp using 1 µL cDNA reaction mix, 2 pmol of each 
oligonucleotide, 5 µL Phusion Flash High-Fidelity PCR Master Mix (Thermo Scientific) 
and water to a final volume of 10 µL. The primers and PCR conditions used are 
summarized in Table 2.1. For recombinant sequences, each PCR was performed at least 
twice independently. After purification, PCR products were sequenced on an automatic 
sequencer ABI PRISM 310 Genetic Analyzer (Applied Biosystems). Sequences were 
determined using the amplification primers and are available in GenBank.  
No incongruences were detected between the overlapping fragments that could 
indicate preferential amplification of templates in each PCR. While it is highly unlikely 
that the Phusion DNA Polymerase generates crossovers at the same position 
repeatedly, a long range PCR was also performed to obtain complete genomic 
sequences and exclude the possibility of PCR-mediated artefacts in generating the 
recombinant sequences. This PCR was conducted with the following conditions: 0.25 µL 
of Takara LA Taq (Clontech), 2.5 µL buffer, 2.5 mM MgCl2, 2.5 mM of each dNTP, 0.4 
µM of each primer, 1 µL of template and water to a final volume of 25 µL. Cycle conditions 
consisted of 2 min at 94 ºC, 35 cycles of 30 s at 94 ºC, 30 s at 63 ºC and 8 min 30 s at 
68 ºC and a final extension of 15 min at 68 ºC. The amplicons were sequenced as 
described above using amplification primers listed in Table 2.1 (primer 5’-
GTGTATGCCATGACTCCGAT-3’ covers the regions located both upstream and 
downstream of the recombination breakpoint). 
 
Recombination analysis 
The complete genome sequences obtained (excluding the 5’ and 3’ UTRs) were 
aligned using the BioEdit software, version 7.0.9.0 [34]. Full-length RHDV genome 
sequences available in public databases were retrieved and included in the alignment. 
This produced a final dataset of 68 sequences of 7369 nt, including representatives from 
all major groups of RHDV. This sequence alignment was screened for recombination 
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using the RDP, GENECONV and BootScan methods implemented in the RDP software 
(version 4.26) [35] under the following parameters: sequences were set to linear, 
Bonferroni correction, highest acceptable p-value 0.05 and 100 permutations. Only 
recombination events detected by all three methods were considered as viable and 
hence merited additional analysis (see Phylogenetic analysis section). Strains detected 
as recombinants were further analyzed using the SimPlot software (version 3.5.1) [36] 
with the default parameters (window size, 200 bp; step, 20 bp; Ts/Tv ratio, 2 : 0). 
 
Table 2.1 List of primers and PCR conditions used in the amplification of the RHDV genome. Ta: annealing 
temperature. 
Forward primer (5’-3’) Reverse primer (5’-3’) Ta (ºC) Extension time 
GTGAAAGTTATGGCGGCTATGTCG TTCCCAAGGACCATGGTGTGT 55 1 min 30 s 
AGGTGCACCCTGCCATCATACAA ATGAGCGTGGTCTGTGAGTGGAA 53 1 min 15 s 
CAACATCTTTGGCGCATGGT TACGCCAGCACGTCAATCTT 51 1 min 
GCAAACCACCTTGTCAACCT ATGGCGTCAAGTATGGTCATGG 48 1 min 30 s 
GTTGGCGTTGACATGACATC CTAGTAGTGGCCACAACACC 52 1 min 15 s 
GTGTATGCCATGACTCCGAT GCGTCGATGACAACATGAG 48 1 min 30 s 
TGCTGAGCCAGATGTACGCT AGTCCAATTGTCACTGGCAG 52 1 min 15 s 
CACCTGTGGGTAAGAACACA ATAGCTTACTTTAAACTATAAACCCAA 50 45 s 
 
 
Phylogenetic analysis 
An initial reconstructed phylogenetic tree was inferred for the VP60 gene to provide 
a provisional picture of the evolutionary relationships of RHDVb to the remaining 
pathogenic and non-pathogenic lagoviruses. For this analysis, all available VP60 
sequences were retrieved from public databases, producing a final dataset of 211 
sequences of 1740 nt. A phylogenetic tree was then estimated using the ML method 
available in PhyML program [37] utilizing the GTR+I+Γ model of nucleotide substitution 
and employing a combination of nearest-neighbor interchange (NNI) and subtree pruning 
and regrafting branch-swapping. The support for each node was determined from 1000 
bootstrap replicate ML trees, employing the same substitution model and parameter 
values as above, and with NNI branch-swapping. For the complete genome sequences, 
the dataset was partitioned at the putative recombination breakpoint(s) detected in the 
recombination analysis described in the Results and Discussion section and then 
subjected to phylogenetic analysis. This partitioning was as follows: (i) ORF1 except 
VP60 (nucleotide residue positions 10–5304) and (ii) VP60 and VP10 (nucleotide residue 
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positions 5305–7378). Phylogenetic trees were then estimated for both partitions using 
the same phylogenetic procedure as described above (i.e. ML trees in PhyML). 
 
4. Results and Discussion 
We determined the complete coding sequence (excluding the 5’ and 3’ UTRs) of 
28 RHDV strains from rabbits found dead in the Iberian Peninsula. Based on their 
position in the Maximum Likelihood (ML) tree of the capsid gene (VP60) (Fig. 2.5), 24 
strains were identified as RHDVb and four as genogroup 1 (G1). Considering the 
distribution of the European rabbit subspecies in the Iberian Peninsula [38,39], these 
results further confirm that both O. cuniculus algirus and O. cuniculus cuniculus are 
susceptible to this new virus [33]. Interestingly, the co-circulation of RHDVb and other 
RHDV genogroups, particularly G1, was not detected. This supports the notion that G1 
has been replaced by RHDVb [40] and is compatible with the rapid spread of this new 
variant through the Iberian Peninsula [20]. 
The complete coding sequences of RHDVb exhibited some length variation due to 
deletions in the non-structural proteins p16/NS1 and p37/NS3: a deletion of codon 68 
(p16) in CBAnd1/Spain/04-2012 and deletions of codons 134–135 (p16/NS1) and of 
codon 714 (p37/NS3) in several strains. While the biological role of p16/NS1 is unknown, 
a recent study of RHDV in Australia revealed a relatively high number of mutations in 
this protein, which were tentatively associated with increased virulence [41]. Protein p37 
has an ATPase activity and may be a member of the helicase superfamily III [42]. 
Although helicase activity is crucial for replication [43], this deletion is located some 
distance from the Walker motifs A (amino acid positions 522–529 in RHDV) and B (amino 
acid positions 566–567 in RHDV) which are typical of NTP-binding proteins, and from an 
additional conserved C motif (amino acid positions 600–614 in RHDV), which is also 
involved in ATP hydrolysis [42]. This indicates that the main biological functions of p37 
are not compromised by the deletion. Additionally, the deletion is present in MRCV, RCV-
A1 and in European brown hare syndrome virus (the other member of the genus 
Lagovirus), further suggesting that the replication activity of p37 is maintained. A 
mutation in the initiation codon (T to C in codon ATG, nucleotide positions 7025–7027) 
of ORF2 was observed in one strain, but expression of VP10 is not expected to be 
affected as translation of ORF2 relies on the presence of a sequence element at the 3’ 
end of ORF1 and not on a particular initiation codon [44]. Additionally, another ATG in 
this region (nucleotide positions 7037–7039) may act as the start site for translation of 
ORF2. 
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Figure 2.5 ML phylogenetic tree for 211 VP60 sequences of RHDV. Major genetic groups (genogroups) are indicated. For clarity of presentation, the sequences in genogroups G2–G5 and G6 
(RHDVa) have been collapsed and have the following GenBank accession numbers: AB300693, AF231353, AF258618, AJ006019, AJ302016, AJ303106, AJ495856, AJ535092, AJ535094, 
AJ969628, AM085133, AY925210, AY926883, AY928268, AY928269, DQ069280–DQ069282, DQ189077, DQ189078, DQ205345, DQ841708, EF363035, EF558572, EF558574, EF558575, 
EF558577, EF558581–EF558584, EU003578–EU003582, EU250330, EU650679, EU650680, FJ212322, FJ212323, FJ794179, FJ794180, FN552800, FR823354, FR823355, GU339228, 
GU373617, GU373618, GU564448, HE963222, HM623309, HQ917923, JF412629, JN165233–JN165236, JN851729–JN851735, JQ815391, JQ995154, JX393309–JX393312, KC345614, 
KC595270, KF270630, KF494906–KF494952, KF537692, KF537693, KF594474–KF594476, KF677011, KJ579156–KJ579160, KJ606958, KJ606959, KJ683893, KJ683900, KJ683902, 
KJ683905–KJ683908, KJ814617–KJ814622, M67473, RHU49726, RHU54983, X87607, Y15424 and Y15427. The accession numbers are indicated for the remaining sequences. Viruses 
sequenced here (in bold) fall into two distinct clusters, G1 and RHDVb. All horizontal branch lengths are drawn to a scale of nucleotide substitutions per site and the tree is mid-point rooted. Bootstrap 
values greater than 75 % are shown for key nodes. *The main group of sequences in genogroups G2–G5 clustered together with 99 % bootstrap support. 
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Table 2.2 Results of the recombination analysis.  
Recombinant strains 
Most likely ‘parental’ strain Genogroup Breakpoint† Average p-value 
NS* VP60 and VP10 NS* VP60 and VP10  RDP GENECONV BootScan 
CBAnd1/Spain/04-2012 
CBMontemor14-1/Portugal/02-2014 
CBEstoi13-7/Portugal/12-2013 
CBMora14-1/Portugal 
CBEstremoz14-1/Portugal/01-2014 
CBEstremoz14-3/Portugal 
CBLavra10-13-1/Portugal/10-2013 
CBAlgarve1/Portugal/01-2013 
CBAlgarve3/Portugal/01-2013 
Barrancos7-13/Portugal/01-2013 
Barrancos10A-13/Portugal/01-2013 
CBCoruche14-1/Portugal 
CBCoruche14-2/Portugal/02-2014 
EU871528/RCV-
A1/Australia/2007 
Seg08-
12/Spain/08-2012 
NP‡ RHDVb 5305 (5267-5326) 4.272x10
-125
 2.898x10-132 2.971x10-137 
CBMertola14-2/Portugal/01-2014 
CBMertola14-1/Portugal/01-2014 
CBAlgarve14-1/Portugal 
CBAlgarve14-3/Portugal 
CBAlgarve14-4/Portugal 
JX886001/CB194/ 
Chaves/Portugal/2
006 
Seg08-
12/Spain/08-2012 
G1 RDHVb 
5336 
(5264-5343) 6.283x10
-109
 3.610x10-106 6.316x10-109 
*Non-structural proteins. 
†99% confidence interval is indicated. 
‡Non-pathogenic strain. 
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The most striking result of our study was the occurrence of recombination in a 
number of recent RHDVb viruses with strong statistical support (p-values < 0.001, Table 
2.2). In these recombinant viruses, there was consistent evidence for a single 
recombination breakpoint located in a region close to the VP60 initiation codon (although 
two recombination breakpoints were detected they fall in very similar and overlapping 
locations, which is strongly suggestive of a single recombination event; Table 2.2). This 
was further confirmed with the SimPlot analysis (Fig. 2.6). Notably, this recombination 
breakpoint is located within a region of high sequence similarity (data not shown) and 
divides the genome into two regions that include different protein subsets: one that 
includes the non-structural proteins and another that comprises the structural proteins 
VP60 and VP10. To confirm this recombinant history, ML phylogenetic trees were 
inferred for the different genome fragments on either side of the recombination 
breakpoint identified above. For simplicity, we based this phylogenetic analysis on the 
recombinant breakpoint at nucleotide position 5305. For the phylogenetic tree of the 
genes encoding the structural proteins (VP60 and VP10 genes; Fig. 2.7a), all viruses 
previously identified as RHDVb (Fig. 2.6) clustered together in a single strongly 
supported monophyletic group (identified as RHDVb and shaded light grey). This cluster 
fell deep in the VP60 and VP10 phylogeny, close to the position of the mid-point root of 
the tree and between the non-pathogenic Australian strain (RCV-A1) and the weakly 
pathogenic MRCV. Hence, RHDVb is phylogenetically distinct from the pathogenic 
RHDV sequences that form a separate highly supported cluster. In contrast, in the 
phylogeny inferred for the non-structural proteins (Fig. 2.7b), the RHDVb sequences fall 
into three distinct clusters: (i) one comprising likely non-recombinant RHDVb sequences 
(shaded light grey) that share a common ancestor with pathogenic RHDV strains, (ii) 
another composed of likely recombinant RHDVb sequences that cluster with MRCV and 
RCV-A1 (medium grey) and (iii) a group of RHDVb recombinant sequences that cluster 
closely with recently sampled pathogenic G1 viruses (dark grey). 
The occurrence of multiple recombination events, i.e. RHDVb clusters (i) and (ii) 
mentioned above, makes it difficult to clearly distinguish recombinants from parents, but 
it is clearly necessary to invoke at least two independent recombination events involving 
RHDVb to explain these phylogenetic data. Moreover, the divergent position of the 
CBAnd1/Spain/04-2012 sequence within the RHDVb cluster (ii) may be indicative of an 
additional recombination event. It is also evident that one of the recombination events 
involved the combination of the RHDVb VP60 and VP10 coding sequences with a 
backbone composed of the coding sequences of the non-structural proteins of a G1-like 
strain, while in the other the RHDVb VP60 and VP10 coding sequences became linked 
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with the coding sequences of the non-structural proteins of non-pathogenic lagoviruses 
(Fig. 2.7b). 
 
(a) 
 
 
(b) 
 
Figure 2.6 Similarity plot for two types of RHDVb recombinants. (a) CBAlgarve1/Portugal/01-2013 (non-pathogenic 
lagovirus/RHDVb) and (b) CBAlgarve14-1/Portugal (G1/RHDVb). The vertical axis represents the percentage of sequence 
identity of each putative parental strain (grey and black lines) with the recombinant. The horizontal axis indicates the 
nucleotide positions. A window size of 200 bp with a step size of 20 bp was used. The site where the parental strains are 
identical in sequence to the recombinant is the predicted recombination breakpoint. A scheme of the genomic organization 
is shown above each plot with the encoded proteins indicated (pro, protease); arrowheads indicate cleavage sites. 
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Since some of the recombinant viruses possess non-structural genes that are 
closely related to the Australian non-pathogenic virus (as supported by the clustering of 
such recombinant viruses with RCV-A1 with 98 % bootstrap support), this evolutionary 
history implies that lineages related to the Australian viruses must circulate in the Iberian 
Peninsula but have not yet been detected (indeed, it is clear that RCV-A1 was imported 
into Australia [45]). In addition, recombinant sequences were retrieved from animals 
found dead in the field with lesions compatible with RHD, and thus these strains are likely 
pathogenic despite their genome deriving mostly from non-pathogenic viruses. 
 
(a) 
 
Figure 2.7 ML phylogenetic trees for the genome regions defined by the recombination analysis. Major genetic 
groups (genogroups) are indicated and strains sequenced here are shown in bold. Accession numbers of the sequences 
retrieved from GenBank are indicated. All horizontal branch lengths are drawn to a scale of nucleotide substitutions per 
site and the tree is mid-point rooted. Bootstrap values greater than 75 % are shown for key nodes. (a) ML tree based on 
the sequence fragment including VP60 and VP10 (nucleotide positions 5305-7378). RHDVb sequences are shaded light 
grey. (b) ML tree based on non-structural proteins sequences (nucleotide positions 10-5304). RHDVb strains fall into three 
distinct clusters corresponding to: (i) non-recombinant RHDVb sequences (shaded light grey), (ii) non-pathogenic 
lagovirus/RHDVb recombinants (medium grey) and (iii) G1/RHDVb recombinants (dark grey). 
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Figure 2.7 (cont.) 
(b) 
 
 
Although circulation of ‘true’ G1 viruses has not been detected in this study from 
2011 onwards, the co-circulation of G1-like and RHDVb strains within the same 
geographical region and time-frame must have occurred for recombination to take place. 
Interestingly, the two different types of recombinants were detected from the same 
geographical area only one year apart (e.g. CBAlgarve14-1/Portugal, detected in 
January 2014, and CBAlgarve1/Portugal/01-2013, detected in January 2013). These 
observations indicate that there is a relatively high diversity of RHDV strains circulating 
in this region, which clearly merits additional surveillance. In addition, the same type of 
recombinant was observed in several and distantly located populations and in different 
years, confirming its viability and capacity to spread at the epidemiological scale. 
Two mechanisms of RNA recombination are possible for RNA viruses: replicative 
and non-replicative. The (copy-choice) replicative mechanism involves template 
switching by the viral polymerase during RNA synthesis. In other Caliciviridae genera, 
such as Sapovirus, Vesivirus and Norovirus (NoV), a recombination hotspot is similarly 
observed between the non-structural proteins and the capsid junction [46]. In the case 
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of NoV, a template switching mechanism has been proposed that reflects a combination 
of the copy-choice and the internal initiation model [47]. Accordingly, recombination 
occurs in the second round of replication when the polymerase starts the synthesis of a 
positive-sense RNA strand from a full-length negative strand. Due to the presence of 
complex secondary structures, such as stem–loops, at the ORF1/ORF2 overlap that 
coincides with the RNA promoter sequence, the polymerase loses processivity and 
switches to a negative strand of sgRNA synthesized by a co-infecting virus, thereby 
creating a hybrid virus [47]. Alternatively, the polymerase switches from a genomic RNA 
to another in regions with high sequence homology, such as the one found where ORF1 
and ORF2 overlap [47]. Although the genomic organization of NoV differs from RHDV 
with the non-structural proteins and the capsid protein encoded by separate ORFs, the 
synthesis of the sgRNA by an internal initiation mechanism and the presence of a 
subgenomic promoter upstream of the sgRNA starting site in RHDV [9] suggests that a 
similar recombination mechanism may occur. In addition, the presence of a region of 
high sequence homology upstream of the initiation codon of VP60 in RHDV [48], which 
is compatible with the location of the sgRNA promoter [9,49-51], as well as the presence 
of a stem–loop [48], tentatively suggest that the recombination events observed could 
have been due to the template switching mechanism. 
However, it is also possible that the recombinant RHDV genomes observed might 
have been generated by a non-replicative recombination mechanism. Such a 
mechanism, demonstrated for other positive-sense ssRNA viruses such as polioviruses 
and pestiviruses [52,53], involves the cleavage of the recombining RNAs that are then 
ligated to form the recombinant molecule. In contrast to the template switching 
mechanism of recombination that is promoted by sequence conservation, the non-
replicative recombination seems to be largely mediated by the presence of a RNA 
secondary structure [54] such as the stem–loop predicted for RHDV in the sgRNA 
promoter region [48]. 
While the impact of recombination on the fitness of RHDVb remains to be 
assessed, this process has clearly created substantial changes in the viral genome, 
although whether this has led to differences in virulence is unclear. Indeed, the 
recombination events described involve the combination of structural and non-structural 
protein subsets with different ancestries: protein coding sequences are combined as 
‘modules’ with non-structural proteins originating either from non-pathogenic forms or G1 
viruses and structural proteins originating from RHDVb. A similar model of modular viral 
evolution has been described for enteroviruses (family Picornaviridae), in which the 
structural and non-structural regions of the genome evolve semi-independently [55-57], 
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giving rise to new virus variants. RNA signals and sequence similarity are among the 
factors that might impose such a recombination pattern [58], although other constraints 
exist at several stages of viral infection and replication in the host. These constraints 
most likely reflect functional protein ‘blocks’ that work together for protein compatibility. 
Interestingly, previous studies revealed recombination breakpoints throughout the RHDV 
genome [27,28], although most of these recombination events occurred between closely 
related RHDV strains. Hence, it is likely that the sequence similarity between the 
recombining strains allows the functional integrity to be maintained. As there is prior 
evidence that recombination may have been central to the emergence of RHDV as a 
pathogenic form [28], we contend that more effort should be directed toward revealing 
the frequency and fitness consequences of recombination in lagoviruses. 
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Tracking the evolution of the G1/RHDVb recombinant strains 
introduced from the Iberian Peninsula to the Azores islands, 
Portugal 
 
T. Almeida, A. M. Lopes, M. J. Magalhães, F. Neves, A. Pinheiro, D. Gonçalves, M. Leitão, P. J. Esteves & 
J. Abrantes 
 
1. Abstract 
Previous genetic characterization of rabbit hemorrhagic disease virus (RHDV) from 
Azores, Portugal, revealed the presence of genogroup 3–5 (G3–G5) like strains. These 
strains differed from the genogroup 1 (G1) strains circulating in mainland Portugal, 
suggesting an independent evolution of RHDV in Azores. More recently, the new variant 
RHDV (RHDVb) was detected in Azores. In mainland Portugal, current circulating strains 
resulted from recombination events between RHDVb and non-pathogenic or pathogenic 
G1 strains. To characterize the RHDVb strains from Azores, a ~ 2.5 kb fragment of the 
RHDV genome (nucleotide positions 4873–7323), including the complete sequence of 
the capsid gene VP60 (nucleotide positions 5305–7044), was amplified and sequenced. 
Samples were obtained from rabbits found dead in the field between December 2014 
and March 2015 in the Azorean islands Flores, Graciosa, São Jorge, Terceira, Faial, 
Pico, São Miguel and Santa Maria. For VP60, the highest homology was found with 
Iberian RHDVb strains, while the upstream fragment revealed high similarity (~ 95 %) 
with Iberian G1 strains. Phylogenetic reconstruction based either on VP60 or VP10 
grouped the Azorean strains with Iberian RHDVb strains. For the fragment upstream of 
VP60, the Azorean strains grouped with G1. Our results show that the RHDVb strains 
circulating in Azores are G1/RHDVb recombinants and we hypothesize that such strains 
had their origin in Iberian strains. The geographic isolation of Azores suggests that arrival 
of RHDVb was man-mediated. A network analysis further allowed us to trace virus 
dispersion in Azores: from an initial outbreak in Graciosa, RHDVb spread to São Jorge 
and Faial, to Terceira, Flores and Santa Maria, and finally to Pico; dispersion to São 
Miguel occurred later from Terceira. As the consequences of the presence of G1/RHDVb 
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strains in Azores are unpredictable, we suggest a continued monitoring and 
characterization of RHD outbreaks. 
 
2. Introduction 
In the Iberian Peninsula, two refuges originated two European rabbit subspecies: 
Oryctolagus cuniculus algirus and Oryctolagus cuniculus cuniculus [1]. The subspecies 
O. c. cuniculus is present throughout Europe, Australia and South America and 
originated all rabbit domestic breeds [1]. The subspecies O. c. algirus is restricted to the 
southwestern part of the Iberian Peninsula, and the islands of Azores, Madeira and 
Canary [1]. In the last 60 years, the Iberian wild rabbit populations suffered a great 
decline, mainly due to two viral diseases, myxomatosis and rabbit hemorrhagic disease 
(RHD) [2]. RHD is caused by a calicivirus, the rabbit hemorrhagic disease virus (RHDV), 
that was first reported in China in 1984 and rapidly spread worldwide, reaching the 
Iberian Peninsula in 1988 [reviewed in 3].  
The study of the genetic diversity of RHDV allowed the distinction of six 
genogroups, G1–G6 [4]. Until 2011, only G1 strains were recovered from Iberian wild 
rabbit populations [5-7]; G6 (RHDVa) has also been detected, sporadically, in domestic 
rabbits [8,9]. This epidemiological pattern contrasts with that from other European 
countries where G1 was successively replaced by strains from other genogroups [4]. 
Recently, a new variant of RHDV, named RHDV2 or RHDVb, was described in France 
[10]. This new variant has unique features and dispersed quickly throughout Europe and 
now circulates in Spain, Portugal, Italy and United Kingdom [11-15]. In the Iberian 
Peninsula, RHDVb reduced rabbit numbers in ~ 80 % [16]. Characterization of full 
genomic sequences of Iberian RHDVb strains showed that these strains differ ~ 15 % in 
the capsid and ~ 22 % outside of the capsid from the other pathogenic and non-
pathogenic strains [17]. Lopes et al. [18] further showed that Iberian RHDVb strains 
resulted from multiple recombination events involving non-pathogenic strains and 
pathogenic G1 strains. Indeed, while for the gene encoding the major capsid protein, 
VP60, and for the gene of the minor structural protein, VP10, all RHDVb viruses clustered 
together and apart from all the other strains, for the region encoding the non-structural 
proteins these strains appeared in three different clusters. Further analysis supported 
the existence of a single recombination breakpoint located in the 5’ region of VP60 
compatible with the recombination pattern described. 
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The Portuguese Azores archipelago is located in the middle of the North Atlantic 
Ocean and is composed by nine islands (Fig. 2.8). Graciosa, São Jorge, Terceira, Faial 
and Pico constitute the central group; Flores, along with Corvo, compose the occidental 
group; São Miguel and Santa Maria belong to the oriental group. The European rabbit 
was introduced in Azores more than 500 years ago by the Portuguese settlers. Although 
the presence of RHD has been detected in the late 1980s, only in 2014 the circulating 
strains were characterized [9,19]. These strains were related to G3–G5 strains, but had 
unique features and differed at least 8 % from other RHDV strains and ~ 15 % from 
RHDVb, suggesting an independent evolution of RHDV in the Azorean islands after an 
initial introduction more than 17 years ago [19]. The presence of RHDVb was recently 
reported in the Azorean islands Graciosa, Terceira, São Jorge and Flores [20]. Since this 
report was based on a short fragment of the capsid gene (347 nucleotides, nt) and 
recombination clearly plays a role in shaping RHDVb diversity [18], we sequenced and 
analyzed a 2451 nt fragment, including the complete capsid gene, of RHDV strains 
recovered from rabbits found dead in Flores, Graciosa, Terceira, São Jorge, Faial, Pico, 
São Miguel and Santa Maria between December 2014 and March 2015. 
 
 
Figure 2.8 Map of the Portuguese Azores archipelago. Location of the islands is shown on the insert on the left (shaded 
light grey). Distances between Graciosa, where the first outbreak was detected, and Flores, Terceira, São Jorge, Pico, 
Faial and Santa Maria are indicated as well as between Terceira and São Miguel. RHDVb presence was detected in all 
islands except Corvo, where no rabbits exist. 
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3. Methods 
Amplification and sequencing 
Liver samples of 80 rabbits found dead in the field in the islands Flores (n = 12), 
Graciosa (n = 30), São Jorge (n = 7), Terceira (n = 4), Faial (n = 1), Pico (n = 2), São 
Miguel (n = 14) and Santa Maria (n = 10) were collected between December 2014 and 
March 2015 (Table 2.3), by the Direção Regional dos Recursos Florestais, Azores, and 
sent to the laboratory of CIBIO, InBIO-UP. No live animals were shot, trapped or handled 
to obtain tissues, such that no Animal Ethics permit was required. In the majority of the 
islands, dead rabbits were found in several places and carcasses were collected at the 
beginning of the outbreak (Table 2.3). At necropsy, the animals presented gross 
histopathological alterations compatible with RHD. A portion of liver sample (~ 30 mg) 
was homogenized in a rotor–stator homogenizer (Mixer Mill MM400, Retsch) at 30 Hz 
for 7 min. Extraction of viral RNA was performed using the RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s protocol. Reverse transcription was performed using 
oligo(dT) as primers and SuperScript™ III Reverse Transcriptase (Invitrogen) according 
to the provided protocol. PCRs were performed as described elsewhere [18]. Briefly, 
samples were first screened by PCR with a pair of primers specific for RHDVb; positive 
samples were further PCR-amplified to obtain a fragment upstream of the capsid gene, 
the complete capsid gene and VP10. PCR products were purified and sequenced on an 
automatic sequencer ABI PRISM 310 Genetic Analyzer (PE Applied Biosystems, Foster 
City, CA, USA) with the amplification primers. The sequences were deposited in 
GenBank under the following accession numbers: KT000290–KT000343. 
 
Phylogenetic and phylogeographic analysis 
The BioEdit software version 7.0.9.0 [21] was used to align the sequences along 
with other publicly available sequences, including from RHDVb (accession numbers are 
shown in Fig. 2.9). The alignment was screened for recombination using the RDP 
software version 4.26 [22] with the following parameters: sequences were set to linear; 
Bonferroni correction; highest acceptable p-value 0.05; 100 permutations. To infer the 
phylogenetic relationships, a first phylogenetic tree was drawn by using the full capsid 
sequences (nucleotide positions 5305–7044). A phylogenetic tree was also inferred for 
the region upstream of the capsid (nucleotide positions 4872–5304) and for VP10 
(nucleotide positions 7025–7323). These trees were estimated using the Maximum 
Likelihood (ML) method available in MEGA6 [23] under the best-fit nucleotide substitution 
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model determined by the same software. Node support was determined from 500 
bootstrap replicates of the ML trees. Pairwise genetic distances, between group mean 
distances and within group mean genetic diversity were also calculated in MEGA6. In 
order to represent the geographical dispersion and provide an alternative view of the 
phylogenetic relationships between the sequences retrieved from Azores, a phylogenetic 
network was constructed with the Phylogenetic Network Software version 4.6.1.3 
(Fluxus-Technology, www.fluxus-engineering.com), using the Median-joining algorithm 
[24]. 
 
Table 2.3 List of the samples collected in the different islands. 
Island 
(area in km2) Date Municipality Parish 
No. of 
samples 
Strains 
Graciosa 
(61) 
01-12-2014 Sta Cruz da Graciosa Luz 10 CBGraciosa14-5 to 14-14 
15-12-2014 Sta Cruz da Graciosa São Mateus 5 CBGraciosa14-15 to 14-19 
15-12-2014 Sta Cruz da Graciosa Luz 5 CBGraciosa14-20 to 14-24 
15-12-2014 Sta Cruz da Graciosa Guadalupe 10 CBGraciosa14-25 to 14-34 
Terceira 
(402) 
02-01-2015 Angra do Heroísmo Porto Judeu 2 CBTerceira15-1, 15-2 
02-01-2015 Angra do Heroísmo Posto Santo 2 CBTerceira15-3, 15-4 
Flores 
(142) 05-01-2015 
Laje das Flores Mosteiro 8 CBFlores15-1 to 15-8 
Sta Cruz das Flores Santa Cruz 4 CBFlores15-9 to 15-12 
São Jorge 
(238) 
02-02-2015 Velas Rosais 7 CBSJorge15-1 to 15-3, 15-5 to 15-7 
02-02-2015 Velas Sto Amaro 1 CBSJorge15-4 
Santa Maria 
(97) 
06-02-2015 Vila do Porto Sto Espírito 5 CBSMaria15-1 to 15-5 
09-02-2015 Vila do Porto Sto Espírito 3 CBSMaria15-6 to 15-8 
10-02-2015 Vila do Porto Sto Espírito 2 CBSMaria15-9, 15-10 
São Miguel 
(747) 
09-02-2015 Povoação Furnas 8 CBSMiguel15-1 to 15-6, 15-13, 15-14 
09-02-2015 Nordeste Lomba da Fazenda 6 CBSMiguel15-7 to 15-12 
Faial 
(173) 04-03-2015 Horta Capelo 1 CBFaial15-1 
Pico 
(445) 
07-03-2015 Lajes do Pico Piedade 1 CBPico15-2 
08-03-2015 Lajes do Pico Piedade 1 CBPico15-1 
 
 
4. Results and discussion 
A fragment of ~ 2.5 kb was amplified and sequenced for 12 strains from Flores, 11 
strains from Graciosa, five strains from São Jorge, three strains from Terceira, one strain 
from Faial, two from Pico, 11 from São Miguel and 9 from Santa Maria. A total of 55 
nucleotide changes were observed between these strains; of these, two were diagnostic 
of strains from Flores and three of strains from Santa Maria. Twelve non-synonymous 
substitutions were observed, with six located in the capsid gene. Two of these 
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substitutions correspond to codons previously detected as being under positive selection 
[25] and more than two different amino acids are found for these positions. Mean genetic 
distances between islands for the sequenced fragment ranged between ~ 0.009 % (São 
Jorge–Faial) and ~ 0.399 % (São Miguel–Santa Maria). The mean genetic diversity of 
each island was 0.000547 ± 0.000212 for Santa Maria; 0.002089 ± 0.000640 for São 
Miguel; 0.000889 ± 0.000283 for Flores; 0.001550 ± 0.000438 for Graciosa; 0.001223 ± 
0.000504 for São Jorge; 0.001086 ± 0.000570 for Terceira and 0.000814 ± 0.000530 for 
Pico (this was not computed for Faial as only one sequence was available). Comparison 
of each island with G1, G2, G3–G5 and G6 strains showed > 6 % of divergence for the 
fragment upstream of VP60, being more closely related to G1; > 18 % for the capsid and 
> 12 % for partial VP10. Both for VP60 and VP10, the Azorean strains were closely 
related to RHDVb strains from the Iberian Peninsula (divergences ranged from 2 % to 5 
%).  
A phylogenetic tree was inferred for the capsid sequences, including publicly 
available RHDV sequences of G1–G6, as well as non-pathogenic (RCV_Italy_1996; 
France_06-11_2006; Ashington_1998) and weakly pathogenic (MRCV_USA_2001) 
strains. Strains previously identified as belonging to G1–G6 clustered together in a highly 
supported group (Fig. 2.9a). The sequenced Azorean strains appear in a single highly 
supported subgroup closely related to the group composed of RHDVb strains from Spain 
and mainland Portugal (shaded light grey; Fig. 2.9a). The Azorean strains seem to be 
more closely related to Iberian RHDVb strains. This is in agreement with the results from 
the genetic distances and supports their identification as RHDVb. 
Following the observation of a recombination breakpoint in the 5’ region of the 
capsid gene in the recently characterized RHDVb recombinant strains [18], we have also 
reconstructed the phylogeny based on (i) the fragment sequenced upstream of the 
capsid gene VP60 and (ii) the minor structural protein gene VP10. For the fragment 
upstream of the capsid (Fig. 2.9b), the Azorean strains grouped with G1 strains (shaded 
light grey), including previously identified G1/RHDVb recombinant strains (CBAlgarve14-
1_Portugal; CBAlgarve14-3_Portugal; CBAlgarve14-4_Portugal; CBMert14-
1_Portugal_2014; CBMert14-2_Portugal_2014) [18]; none of the Azorean strains 
clustered with other RHDVb strains or with G2-G6 (Fig. 2.9b). For VP10, the phylogenetic 
tree inferred was similar to that obtained for VP60 with the Azorean strains clustering 
with high support with the RHDVb group (only Portuguese and Spanish sequences are 
available; data not shown). These results indicate that the Azorean strains are 
recombinants between G1 and RHDVb, as observed for the most recent RHDVb strains 
circulating in the Iberian Peninsula [18]. Consistent with this, RDP detected these 
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sequences as G1/RHDVb recombinants with strong statistical support (p-values << 
0.001; data not shown) and a recombination breakpoint was identified in the region 
upstream of the capsid initiation codon. 
 
 
(a) 
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Figure 2.9 (cont.) 
 
Figure 2.9 Maximum Likelihood (ML) trees of RHDV. (a) ML tree of the capsid gene and (b) ML tree of the region 
upstream of the capsid gene. The groups most closely related to the Azorean strains are shaded light grey; considering 
the low divergence between sequences, only one sequence per Azorean island was selected (in bold). Bootstrap values 
of the main nodes (≥ 75) are shown next to them. Scale bar indicates the nucleotide substitutions per site. To facilitate 
visualization, some groups were collapsed; GenBank accession numbers of the sequences used in this study are: 
KP090974-5, JF438967, EF558578, L48547, Z24757, Z29514, Z49271, KJ683894, KJ683903-4 (G1); AF231353, 
DQ189078, EU003579-80, EU650679-80, FJ212323, FR823355, GU373617-8, JN851735, M67473, RHU49726, 
RHU54983, KF594474-6, KJ606958-9, KF494906-52 (G2); AJ495856, AJ535092, AJ535094, AM085133, AY926883, 
AY928268-9, DQ189077, EF363035, EF558572, EF558574-5, EF558577, FN552800, FR823354, AY925210, X87607, 
Y15424, Y15427, KJ683893, KJ683900, KJ683906-8, KJ579156-60, KC595270, KC345614 (G3–G5); AB300693, 
AF258618, AJ302016, AJ303106, AJ969628, DQ069280-2, DQ205345, DQ841708, EF558581-4, EU003578, 
EU003581-2, EU250330, FJ212322, FJ794179-80, GU339228, GU564448, HE963222, HM623309, HQ917923, 
JF412629, JN165233-6, JN851729-34, JQ815391, JQ995154, KF270630, JX393309-12, KJ814617-22, KJ683902, 
KJ683905, KF537692-3 (G6); FR819781, HE819400, HE800529-32, FR819781, HE819400, HE800529-32 (RHDVb FR 
+ IT); EU871528 (RCV-A1_Australia_2007); GQ166866 (MRCV_USA_2001); X96868 (RCV_Italy_1996); EF558587 
(Ashington_1998); AM268419 (France_06-11_2006); KT000290 (Faial); KT000291 (Santa Maria); KT000306 (São 
Miguel); KT000313 (Flores); KT000329 (Graciosa); KT000337 (São Jorge); KT000339 (Terceira); KT000342 (Pico). 
KF442963-4, KM115714-6, KF442961-2, KM115697-8, KM115680-2, KM115711-3, KM115689, KM115683, KF442960, 
KM979445, KP090976, KM878681, KP129395-400 (RHDVb PT + SP; sequences identified in [18] as G1/RHDVb 
recombinants appear in italics). 
(b) 
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In Azores, the presence of RHD was detected in the late 1980s, but the circulating 
strains were only recently characterized [9,19]. These studies showed that RHDV strains 
from Azores were more closely related to G3–G5 than to G1. Since divergence to G3–
G5 strains was ~ 8 %, an independent evolution of RHDV in Azores was suggested 
following the initial introduction of an uncharacterized RHDV strain more than 17 years 
ago [19]. The Iberian strains were unlikely to be the source of those RHD outbreaks in 
Azores as, with the exception of the recent detection of RHDVb and some sporadic cases 
of G6 (RHDVa) in domestic rabbits, RHDV Iberian strains were typically G1 [6-9]. More 
recently, Duarte and co-workers reported the presence of RHDVb in the Azorean islands 
Flores, Terceira, Graciosa and São Jorge [20]. Our study confirms these results and 
extends the detection of RHDVb to the remaining Azorean islands Faial, Pico, Santa 
Maria and São Miguel (no rabbits exist in Corvo). 
 
 
Figure 2.10 Median-joining network of RHDVb strains from Azores. Pie charts represent viral haplotypes (nucleotide 
positions 4873–7323), with colors/patterns indicating the island of sampling and the sizes reflecting the frequencies of the 
haplotypes. Median vectors, corresponding either to extinct or non-sampled sequences, are represented by black circles. 
The number of mutations separating each sequence is shown by a black line between each pair of haplotypes. 
 
Since G1 strains no longer circulate in non-Iberian rabbit populations and 
G1/RHDVb strains are currently circulating in the Iberian Peninsula [18], it is highly 
plausible that the Azorean G1/RHDVb strains had their origin in the Iberian Peninsula. 
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Moreover, considering the geographic isolation of Azores, we hypothesize that arrival of 
RHDVb to Azores was man-mediated followed by a rapid virus spread. Our network 
analysis (Fig. 2.10) provides a picture into the virus dispersal route and epidemiology in 
the Azorean islands. An initial introduction seems to have occurred in Graciosa from 
where the virus rapidly expanded to other islands. According to official reports, the first 
dead rabbits in Azores were detected in Graciosa in late November 2014. Our results 
are in line with this: the highest haplotype diversity is found in Graciosa (Table 2.4) and 
a star-like topology is associated with the most ‘‘central’’ Graciosa haplotype consistent 
with a rapid viral expansion; in addition, viral sequences from Faial and São Jorge are 
identical to sequences from Graciosa supporting the colonization of those islands from 
Graciosa or with a strain identical to the strain circulating in Graciosa. Interestingly, while 
sequences from other islands appear in single clusters, sequences of São Jorge appear 
in different clusters, although always closely related to sequences from Graciosa. This 
might suggest multiple introductions from Graciosa to São Jorge. From Graciosa, the 
virus spread to Terceira, to Flores, to Santa Maria and finally to Pico (Table 2.3). 
Dispersion to São Miguel seems to have occurred from Terceira. Strikingly, the dispersal 
route does not always correlate with geographic proximity. While insects are considered 
important vectors for RHDV spread [26,27] and some of those vectors might be present 
in Azores (e.g. Musca spp., Culex spp., Xenopsylla spp. and Spilopsyllus cuniculi [28]), 
insect-mediated spread fails to explain the dispersion of RHDVb from Graciosa to Santa 
Maria, but not to São Miguel. Other vectors, such as birds [29-31], might account for 
RHDVb spread. In Azores, bird community is limited (currently 37 species and 
subspecies are considered regular breeders) and among island groups diversity 
decreases from east to west [32]. The common buzzard (Buteo buteo rothschildi) is the 
only resident raptor present in all Azorean islands and the yellow-legged Gull (Larus 
michahellis) was observed interacting with dead rabbits (personal observation). 
However, the role of these two species in the dispersion of RHDV in Azores is unknown 
and to our knowledge there are no regular movements of birds (migration) between 
islands; therefore, birds are also unlikely to have mediated RHDVb dispersion in Azores. 
Thus, considering the chronology of the outbreaks (Table 2.3), the distance between 
islands (Fig. 2.8) and the fact that arrival of RHDVb to Azores was man-mediated, it 
seems more likely that spread of RHDVb between islands was associated with 
anthropogenic movements. 
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Table 2.4 Frequencies of the haplotypes found on each island. Haplotypes shared between islands appear in bold. 
Island Haplotype (Frequency) 
Faial 1 (100 %) 
Graciosa 1, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33 (0.91 %) 
Santa Maria 2, 4, 5 (0.11 %), 3 (66.7 %) 
São Miguel 6, 7, 8, 9, 11, 12, 13, 14 (0.91 %), 10 (27.3 %) 
Flores 15, 16, 18, 19, 20, 21, 22, 23 (0.83 %), 17 (33.3 %) 
São Jorge 34, 35 (20 %), 31 (60 %) 
Terceira 36 (33.3 %), 37 (66.7 %) 
Pico 38 (50 %), 39 (50 %) 
 
 
5. Conclusions 
In the Iberian Peninsula, RHDVb quickly replaced G1 as the main circulating strain, 
possibly reflecting a yet to be described selective advantage [33]. The presence of 
RHDVb in Iberian Peninsula is associated with a negative impact in the ecosystem [16] 
and in the economy. In Azores, and in an effort to contain RHD outbreaks, the hunting 
activity is now suspended (indefinitely) in all islands. Since the consequences of the 
presence of RHDVb in Azores are unpredictable, continued monitoring of the RHD 
outbreaks and characterization of the circulating strains in the Azorean islands is 
advisable. In addition, the presence of RHDVb in Azores provides a unique situation to 
study the dynamics and the evolution of this new variant, including its ability to recombine 
with strains from genogroups other than G1. 
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Complete coding sequences of European brown hare 
syndrome virus (EBHSV) strains isolated in 1982 in Sweden 
 
A. M. Lopes, D. Gavier-Widén, G. Le Gall-Reculé, P. J. Esteves & J. Abrantes 
 
1. Abstract  
European brown hare syndrome (EBHS) is characterized by high mortality of 
European brown hares (Lepus europaeus) and mountain hares (Lepus timidus). 
European brown hare syndrome virus (EBHSV) and the closely related rabbit 
hemorrhagic disease virus (RHDV) comprise the genus Lagovirus, family Caliciviridae. 
In contrast to RHDV, which is well studied, with more than 30 complete genome 
sequences available, the only complete genome sequence available for EBHSV was 
obtained from a strain isolated in 1989 in France. EBHS was originally diagnosed in 
Sweden in 1980. Here, we report the complete coding sequences of two EBHSV strains 
isolated from European brown hares that died with liver lesions characteristic of EBHS 
in Sweden in 1982. These sequences represent the oldest complete coding sequences 
of EBHSV isolated from the original area of virus diagnosis. The genomic organization 
is similar to that of the published French sequence. Comparison with this sequence 
revealed several nucleotide substitutions, corresponding to 6 % divergence. At the amino 
acid level, the Swedish strains are 2 % different from the French strain. Most amino acid 
substitutions were located within the major capsid protein VP60, but when considering 
the amino acid sequence length of each protein, VP10 is the protein with the highest 
percentage of amino acid differences. The same result was obtained when Swedish 
strains were compared. This evolutionary pattern has not been described previously for 
members of the genus Lagovirus. 
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2. Introduction 
European brown hare syndrome (EBHS) is a highly contagious viral disease that 
affects wild and captive European brown hares (Lepus europaeus) and mountain hares 
(Lepus timidus). The disease was first diagnosed in Sweden in 1980 [1], but successful 
recovery of the causative virus was achieved from a sample collected earlier [2]. In 
addition, there are reports of outbreaks compatible with EBHS since 1976 in England [3], 
and antibodies against the virus have been detected in sera of hares archived since 1962 
[4]. Moreover, Scandinavian hunters were aware of the disease in the early 1970s [5]. 
This suggests that despite being unnoticed, the virus was circulating in European hare 
populations, most likely as a less virulent form. Since then, the disease has been 
recognized in several other European countries [6-15] and, more recently, in South 
America [16]. 
The etiological agent of EBHS, European brown hare syndrome virus (EBHSV), is 
a calicivirus that, along with the closely related rabbit hemorrhagic disease virus (RHDV), 
composes the genus Lagovirus [17]. The genome of EBHSV is a single-stranded 
positive-sense RNA, ~ 7.4 kb in length that encompasses two narrowly overlapping open 
reading frames (ORFs). ORF1 (nucleotides 9-7010) codes for the non-structural 
proteins, including the replicative machinery, and the structural capsid protein VP60. 
ORF2 (nucleotides 7006-7350) codes for VP10, the function of which remains unclear 
[18].  
Since the determination of the first complete genomic sequence of EBHSV from a 
strain isolated in France in 1989 (GenBank accession number Z69620) [18], molecular 
information on EBHSV has been limited and fragmented. Indeed, most studies, even the 
most recent, rely on partial sequences of the capsid protein [19]. Since the genome of 
lagoviruses is prone to recombination, which confounds the establishment of true 
phylogenetic relationships [20,21], determination of complete coding sequences is 
essential for understanding evolution of such viruses. Furthermore, this would allow a 
comparison between RHDV and EBHSV genetic diversity. Here, we have determined 
the complete coding sequences of two EBHSV strains isolated from liver tissue of hares 
collected in 1982 in Sweden. The sequences obtained correspond to the oldest complete 
coding sequences of EBHSV isolated in the original area of diagnosis of the virus.  
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3. Methods  
The samples consisted of livers from dead hares collected in Höör, Skåne County, 
Sweden, on November 11, 1982 by the National Veterinary Institute (SVA), Uppsala, 
Sweden, and were stored at -20 ºC. At necropsy, the hares presented with histological 
liver lesions characteristic of EBHS-infected animals, which consisted of coagulative 
periportal to massive hepatocellular necrosis [22].  
For RNA extraction, 30 mg of each liver tissue was used. The tissue was 
homogenized using a rotor-stator homogenizer (Mixer Mill MM400, Retsch) at 30 Hz for 
7 min. Total RNA was extracted using an RNeasy Mini Kit (QIAGEN) according to the 
manufacturer’s instructions. Viral RNAs were reverse transcribed using oligo(dT) as 
primers (Invitrogen) and SuperScriptTM III Reverse Transcriptase (Invitrogen).  
For the initial screening by PCR, the primer pair U38 (5’ 
CAGCGGGCACTGCTACCACAGCATC 3’) and EBHS9 (5’ 
CCAGCCCAACCAGCRTACAT 3’) was used. These primers amplified a fragment of 307 
base pairs (bp) of the gene encoding the capsid protein VP60. Complete genomic 
sequences were then obtained with eight pairs of primers (Table 3.1). Amplification by 
PCR was performed with 0.6 µL of the cDNA reaction in a final volume of 10 µL 
containing 5 µL of Phusion Flash High-Fidelity PCR Master Mix (Thermo Scientific) and 
2 pmol of each oligonucleotide. Cycle conditions were 3 min at 98 ºC, followed by 40 
cycles of 30 s at 98 ºC, 30 s at the annealing temperature and extension at 72 ºC (see 
Table 3.1 for the annealing temperatures and extension times). Final extension was 
carried out for 5 min at 72 ºC. After purification, PCR products were sequenced on an 
automatic sequencer (ABI PRISM 310 Genetic Analyzer, PE Applied Biosystems). The 
complete coding sequences of the two strains were deposited in GenBank under 
accession numbers KC832839 and KC832838 for O4021-9_1982 and O4022-10_1982, 
respectively.  
 
4. Results and discussion 
A total of 7342 nucleotides were sequenced for each strain, corresponding to the 
complete ORF1 and ORF2. Analysis of the genomic organization revealed a structure 
similar to that of the complete published sequence of EBHSV [18]. ORF1 codes for a 
polyprotein of 2334 amino acids that include the non-structural proteins (5’-p16, p23/p26, 
2C-like helicase, p29, VPg, 3C-like protease and RNA-dependent RNA polymerase 
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[RdRp]-3’) and the major capsid protein (VP60; 3’ of the polyprotein). ORF2 codes for 
VP10, a protein of 114 amino acids.  
 
Table 3.1 List of the primers used for PCR amplification and sequencing. Ta: annealing temperature. 
Primer Primer sequence (5’-3’) Position* Ta (ºC) Extension time 
EBHSV0001F 
EBHSV1085R 
GTGAAATTATGGCGGTTGCG 
GGACTGAGTCCTCAAACTTG 
1-20 
1085-1104 
54 1 min 15 s 
EBHSV0908F 
EBHSV1977R 
CCTGCTGGATTGGACAAATGAC 
GAAGGTGAGGTGAGACATGTC 
908-929 
1977-1997 
52 1 min 15 s 
EBHSV1761F 
EBHSV2745R 
CCTCTCAACTGTGACAAGGTTG 
GGTCACCAGAGTATCTCACAAG 
1761-1782 
2745-2766 
49 1 min 15 s 
EBHSV2615F 
EBHSV3835R 
CAATCCGGTGTGTGCATATG 
CCTGGAACCTTTGCATACCTTG 
2615-2634 
3835-3856 
49 1 min 15 s 
EBHSV3767F 
EBHSV4604R 
CATTGACTACCGTGGACTTG 
GAACGGTCATTGGAAGTGAC 
3767-3786 
4604-4623 
51 1 min 15 s 
EBHSV4503F 
EBHSV5320R 
GATTCCACGATGTCACCATG 
AGGAACAGATGCTGTGGTAG 
4503-4522 
5320-5339 
53 1 min 15 s 
EBHSV_VP60_0001F 
EBHSV_VP60_1728R 
ATGGAGGGTAAGCCWCGGGCTGA 
GACATAGGAATATCCAGTGGTGGC 
5283-5305 
6987-7010 
53 1 min 30 s 
EBHSV6911F 
EBHSV7337R 
GACAGACCTCATTGACGTG 
CAAAYCGCTAGGCGTTACTC 
6911-6929 
7337-7356 
54 45 s 
*According to the published EBHSV sequence (GenBank accession number Z69620) 
 
At the nucleotide level, comparison of the ORF1 sequences of the two isolates 
showed 168 differences that translated into 17 amino acid differences (0.7 %). No amino 
acid differences were observed between the Swedish sequences in RdRp, and most of 
the differences (5) were located in VP60. Interestingly, when considering the amino acid 
length of each protein, p16 had differences in ~ 2 % of the amino acids, p23/p26 and 
p29 in ~ 1 %, VPg and VP60 in ~ 0.9 %, 3C-like protease in ~ 0.7 % and 2C-like helicase 
in ~ 0.3 %. In ORF2, the two sequences differed by 11 nucleotides that corresponded to 
3 non-synonymous replacements, i.e., differences in ~ 3 % of the amino acids, if 
considering amino acid length.  
On average, classical RHDV isolates exhibit a maximum of 10 % nucleotide 
differences and 6 % amino acid differences [23]. Here, the comparison of the Swedish 
strains and the published French strain, which were collected 7 years apart showed 6 % 
of divergence at the nucleotide level and 2 % at the amino acid level. For ORF1, 490 
variable sites were observed, but multiple substitutions were detected at some of these 
sites, and thus, the total number of mutations was 494. This corresponded to 431 
synonymous substitutions and 63 non-synonymous replacements, mostly located in 
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VP60 (28 % of all non-synonymous substitutions). For ORF2, 23 polymorphic sites were 
detected, with a total number of 17 silent changes and 6 non-synonymous replacements. 
When considering amino acid length for each protein, ~ 5 % of the amino acid differences 
are found in VP10, ~ 4 % in p16 and p23/p26, ~ 3 % in 2C-like helicase, p29, VPg and 
VP60, and ~ 1 % in 3C-like protease and RdRp.  
Regarding the ability of the EBHSV 3C-like protease to cleave the ORF1-encoded 
polyprotein to give rise to the mature viral proteins, no experimental data exist. 
Nevertheless, a previous comparison with RHDV indicated that at least four cleavage 
sites are conserved (2C-like helicase/ p29; VPg/3C-like protease; 3C-like protease/RdRp 
and RdRP/VP60) [18]. For the Swedish strains, three of these sites are conserved, but 
the cleavage site ET between the 3C-like protease and RdRp is replaced by EN. This 
has also been reported for the French EBHSV strain, and cleavage efficiency is thought 
not to be affected [18,24]. The other cleavage sites that were identified for RHDV, 
p16/p23 and p29/VPg, are conserved [25], but variation was observed between the 
Swedish strains at the p23/2C-like helicase boundary (ED/EE; ED for RHDV). The 
implications of such substitutions for cleavage efficiency are unclear. 
 
5. Conclusions 
The genomic organization of the sequenced EBHSV strains is similar to that of the 
reported French sequence, and most of the cleavage sites are conserved. As expected, 
most amino acid differences were observed in the VP60 protein. However, when 
considering protein size, VP10 is the protein with the most amino acid differences, a 
pattern that has not been reported for lagoviruses. The sequences described correspond 
to the oldest sequences of EBHSV and should contribute to a better understanding of 
the evolution of EBHSV. In addition, the results obtained reinforce the importance of 
obtaining complete genomic sequences for other members of the genus Lagovirus. 
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1. Abstract  
European brown hare syndrome virus (EBHSV) is the etiological agent of 
European brown hare syndrome (EBHS), a disease affecting Lepus europaeus and 
Lepus timidus first diagnosed in Sweden in 1980. To characterize EBHSV evolution we 
studied hare samples collected in Sweden between 1982 and 2008. Our molecular clock 
dating is compatible with EBHSV emergence in the 1970s. Phylogenetic analysis 
revealed two lineages: Group A persisted until 1989 when it apparently suffered 
extinction; Group B emerged in the mid-1980s and contains the most recent strains. 
Antigenic differences exist between groups, with loss of reactivity of some MAbs over 
time, which are associated with amino acid substitutions in recognized epitopes. A role 
for immune selection is also supported by the presence of positively selected codons in 
exposed regions of the capsid. Hence, EBHSV evolution is characterized by replacement 
of Group A by Group B viruses, suggesting that the latter possess a selective advantage. 
 
2. Introduction 
European brown hare syndrome (EBHS) is a contagious disease characterized by 
severe necrotizing hepatitis in European hares (Lepus europaeus) and, to a lesser 
extent, in mountain hares (Lepus timidus) [1]. In the acute form hares die within a few 
hours after the appearance of clinical signs [1]. Although infected, young hares do not 
develop EBHS, possibly due to natural resistance [2-4]. The etiological agent of EBHS 
is the European brown hare syndrome virus (EBHSV), a non-enveloped, single-
stranded, positive-sense RNA virus. EBHSV belongs to the genus Lagovirus, family 
Caliciviridae [5]. The other member of this genus, rabbit hemorrhagic disease virus 
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(RHDV), is responsible for rabbit hemorrhagic disease (RHD), an acute lethal hepatitis 
first described in China in 1984 that affects wild and domestic adult European rabbits 
(Oryctolagus cuniculus) [6]. RHD and EBHS share similar clinical signs and 
histopathology, as well as a similar epidemiology [reviewed in 7]. Despite the close 
phylogenetic relationship between EBHSV and RHDV, their antigenic profiles are distinct 
[2,8,9]. They also differ in their evolutionary patterns with a strongest geographical 
structure for EBHSV [10]. EBHS was first reported in Sweden in 1980 [1] and in the 
following years in several other European countries [8,11-15]. Indeed, phylogenetic 
studies suggested that virus dispersion occurred from Sweden to west, east and 
southern Europe [13]. However, EBHSV likely emerged in the early 1970s, as suggested 
by descriptions of hares with lesions consistent with the disease in 1976 in England [16]. 
Antibodies against the virus have also been found in archived sera [17], and the virus 
was detected by PCR in samples collected in Sweden before 1980 [18], further 
supporting an earlier emergence. 
To understand the phylodynamics of EBHSV since its initial description in 1980 in 
Sweden, we analyzed hare samples collected between 1982 and 2008 in several 
Swedish geographic regions, as they reflect the spread of the virus in a naïve 
environment, along with samples from countries where the disease was later identified. 
In addition, the antigenic profiles of EBHSV strains were assessed with a panel of 
monoclonal antibodies (MAbs) and their association with patterns of virus evolution was 
determined. 
 
3. Methods 
Virus samples, RNA extraction and cDNA synthesis 
Liver samples from 95 Lepus europaeus and 9 Lepus timidus found dead in the 
field were collected in different regions of Sweden between 1982 and 2008 (Fig. 3.1), 
resulting from passive surveillance. Each frozen liver was thawed and either 100 µL of 
the obtained exudates or up to 30 mg of the liver were collected. When using liver pieces, 
the tissue was homogenized in a rotor-stator homogenizer (Mixer Mill MM400 from 
Retsch) at 30 Hz for 7 min. Total RNA was extracted using the RNeasy Mini Kit (Qiagen) 
according to the manufacturer's instructions. Reverse transcription was performed using 
oligo(dT) as primers (Invitrogen) and SuperScriptTM III Reverse Transcriptase 
(Invitrogen) according to manufacturer's instructions. Sixteen Lepus europaeus liver 
samples collected throughout France between 2001 and 2008 by the SAGIR network 
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(French Wildlife Health Surveillance Network) [19] were also analyzed. The presence of 
EBHSV in these samples was confirmed by ELISA in a laboratory of veterinary analyses 
(Anjou Laboratoire, Angers, France). The five samples collected before 2003 were 
previously partially sequenced and genotyped [10]. For the other samples, RNA 
extraction and cDNA synthesis were performed as described above except that 
SuperScriptTM II Reverse Transcriptase (Invitrogen) was used for the reverse 
transcription. 
 
Amplification and sequencing 
The complete sequence of the gene encoding the capsid protein was amplified 
using the primers EBHSV_VP60_0001F+EBHSV_VP60_0885R and 
EBHSV_VP60_0813F+EBHSV_VP60_1728R for the Swedish samples and EBHSV-
29F+EBHSV-1795R for the French samples (Table 3.2). After purification, PCR products 
were sequenced on an automatic sequencer ABI PRISM 310 Genetic Analyzer (PE 
Applied Biosystems). The Swedish and French sequences were determined using the 
PCR primers as well as several primers designed in the inner region of the DNA template 
(primer sequences available upon request). These sequences have been deposited in 
GenBank and assigned the following accession numbers: KJ679513-KJ679566; 
AJ971301; AJ971304-6; AJ971311; AJ971315; FN689419-21; AM408588; AM887765; 
AM933648-50; HF571039-40. Samples fully sequenced for the VP60 gene were aligned 
using BioEdit version 7.0.9.0 [20]. Four reference EBHSV public sequences that were 
collected in 1989 and 1992 in France, Italy and Germany (GenBank accession numbers 
Z69620, X98002, KJ923230 and U09199, respectively) were also included in the study. 
In total, 74 complete VP60 sequences were available for evolutionary analysis. 
 
Analysis of recombination events 
Prior to phylogenetic analysis, the sequence alignment was screened for 
recombination using the RDP, Geneconv and Bootscan methods implemented in the 
Recombination Detection Program (RDP) version 3.44 [21] with the following 
parameters: sequences were set to linear, Bonferroni correction, highest acceptable p-
value=0.05, 100 permutations. Only recombination events detected by all three methods 
(p < 0.05) were considered as significant. 
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Figure 3.1 Map of Southern Sweden. Location of the EBHSV positive sequenced samples is shown and counties are 
indicated. 
 
Phylogenetic and phylogeographic analysis  
The phylogenetic relationships among the capsid sequences were first estimated 
using the Maximum Likelihood (ML) method available within the PhyML package [22]. 
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This analysis utilized the GTR+Γ model of nucleotide substitution and a combination of 
SPR and NNI branch-swapping, along with a bootstrap resampling analysis (1000 
replications). 
 
Table 3.2 Sequence and nucleotide position of the PCR and sequencing primers.  
Primer Primer sequence (5’-3’) Position* 
EBHSV_VP60_0001F ATGGAGGGTAAGCCWCGGGCTGA 5283-5305 
EBHSV_VP60_0813F CAGRCACTGGAAYATGAATGG 6095-6115 
EBHSV_VP60_0885R CTTGGATGRTCAATGTCGTC 6147-6166 
EBHSV_VP60_1728R GACATAGGAATATCCAGTGGTGGC 6987-7010 
EBHSV-29F CGGACGATAGTTTTGTGAATGT 5260-5281 
EBHSV-1795R TAGAAGCTCCAGCCAATGTT 7026-7045 
* Position relative to GenBank accession number Z69620. 
 
A second phylogenetic analysis was then performed using the Bayesian Markov 
chain Monte Carlo (MCMC) method available in the BEAST package [version 1.7.5; 23], 
which also allowed us to estimate the rate of nucleotide substitution and time to the Most 
Recent Common Ancestor (tMRCA) of our EBHSV sequences. The GTR+Γ+I (i.e. 
general time reversible substitution matrix; Γ, distribution of among-site rate variation, 
and I, proportion of invariant sites) substitution model and a variety of coalescent 
(constant population size, Bayesian skyline, Bayesian skyride) models were used with 
relatively uninformative priors, all of which produced highly comparable results (see 
Results). To allow for rate variation among lineages, an uncorrelated lognormal relaxed 
molecular clock was used in all cases. Posterior probabilities were determined after 100 
million generations, after which parameters had converged. Statistical uncertainty was 
reflected in values of the 95 % highest posterior density (HPD). Finally, a Maximum 
Clade Credibility (MCC) tree was summarized in TreeAnnotator using the posterior 
distribution of trees and excluding a 10 % burn-in. 
To reveal general aspects of phylogeography, EBHSV sequences were classified 
to either their country of origin (France, Germany, Italy) or their county (n=13) of origin 
within Sweden (Fig. 3.1), producing a total of 16 different geographic states. To 
determine whether there was more EBHSV clustering by place of sampling than 
expected by chance alone, we utilized two phylogeny-trait association tests (Association 
Index – AI, Parsimony Score – PS) available in the BaTS package [24]. In addition, the 
Maximum Clade (MC) statistic was used to determine which individual countries/counties 
showed the strongest spatial clustering. Phylogenetic uncertainty in the data was 
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incorporated through the use of the posterior distribution of trees determined from the 
BEAST analysis above, with 1000 random permutations of sampling locations 
undertaken to create a null distribution for each statistic. 
 
Analysis of selection pressures 
Selection pressures acting on EBHSV capsid sequences were assessed as the 
ratio of non-synonymous (dN) to synonymous (dS) nucleotide substitutions per site (i.e. 
dN/dS). A variety of methods available in the HyPhy package were run on the 
Datamonkey web interface [25,26]: single likelihood ancestor counting (SLAC), fixed 
effects likelihood (FEL), random effects likelihood (REL), mixed effects model of 
evolution (MEME) and the fast unbiased Bayesian approximation (FUBAR). Only sites 
detected by at least two methods with statistically significant values were considered as 
being subject to positive selection under these criteria (p-value < 0.05 for SLAC, FEL 
and MEME; posterior probability > 0.95 for REL and FUBAR). The Branch Site-REL 
method was also employed to detect selection on individual branches of the EBHSV tree 
[27].  
 
Antigenic analysis of EBHSV strains 
The antigenic profile of nine PCR-positive strains was determined using a panel of 
specific monoclonal antibodies (MAbs) produced against Bs91/Italy/1991 strain [28]. 
Four to five samples from each main branch of the EBHSV phylogeny were selected. 
The antigenic profile of the strains was obtained using a sandwich ELISA as previously 
described [29] with a hare anti-EBHSV immune serum adsorbed to the plate and MAbs 
at a concentration of approximately 100 ng/mL. For each MAb, the absorbance values 
were transformed in percentage of reactivity using as 100 % of reactivity the average OD 
values of all the samples with an OD value equal to the strain used as standard 
(Bs91/Italy/1991; ± 0.2 OD). 
 
MAbs epitope prediction 
Nucleotide sequences of the nine strains used in the antigenic analyses, as well 
as that of the strain Ita92/Italy/1992, were aligned and translated. The epitope of each 
MAb was inferred comparing the variable amino acid positions between reactive and 
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non-reactive strains. Intermediate values of MAb reactivity were not considered as they 
might result from other interfering factors. Indeed, the results were obtained from livers 
of dead hares collected in the field and stored frozen for several years, which might have 
caused a partial virus degradation. Nevertheless, most of the older samples used were 
fully reactive for all the MAbs tested, indicating an intact viral capsid. Inferred epitopes 
were then mapped on the VP60 structural model (see below).  
 
Homology modelling of EBHSV strains 
Secondary structure prediction was performed with Jpred 
(http://www.compbio.dundee.ac.uk/www-jpred), Prof 
(http://www.aber.ac.uk/phiwww/prof/) and Psi-pred (http://bioinf.cs.ucl.ac.uk/psipred). 
Structure templates were selected according to e-value criterion using the WU-BLAST 
tool (http://www.ebi.ac.uk/Tools/sss/wublast/). X-ray crystallographic structures with a 
resolution less than 2.1 Å were arbitrarily retained. Sequence alignment of selected 
templates and the sequence of the capsid protein of EBHSV strain O282/Sweden/1984 
was first calculated from a pairwise structure alignment automatically generated by the 
Align123 algorithm implemented under Discovery Studio 4.0 (DS4.0, Accelrys, San 
Diego), and then manually optimized (see Supplementary Fig. 1). 
Homology modelling was performed with the Modeler program under DS4.0 using 
X-ray crystallographic structures of domain S and P of the major capsid protein from 
RHDV (PDB codes: 4EJR and 4EGT, respectively). The generated models were 
checked using Verify3D (http://nihserver.mbi.ucla.edu/Verify3D), ProsaII 
(http://prosa.services.came.sbg.ac.at/prosa.php) and Pro-check 
(http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/Generate.html) programs, and 
the structures with the best stereo-chemical and folding qualities were retained. A series 
of energy minimizations was carried out with CHARMm force field implemented under 
DS4.0 in a three-step procedure to relax progressively the structures (1: all heavy atoms 
fixed; 2: heavy atoms of the backbone fixed; 3: heavy atoms of the secondary structure 
backbone fixed) using 200 steepest descent steps with convergence obtained at 0.1 
rmsg, followed by conjugate gradient steps with convergence obtained at 0.001 rmsg. 
The refined structures of both the S and P domains were then superimposed into the 
atomic model of RHDV (PDB code 3J1P) to correctly position the two domains relative 
to each other. Capsid monomers are divided into a buried shell (S) domain connected to 
the protruding (P) domain that is exposed on the surface; the P domain is subdivided 
into P1 (stem of arc) and P2 (top of arc) [reviewed in 7]. The other strain models were 
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then obtained from the minimized model structure of O282/Sweden/1984 using the “Build 
Mutant” tool of DS4.0 with secondary structure restraints and a distance cut-off of 5 Å 
centered on the mutated residues for including neighboring residues in optimization 
(Supplementary Fig. 2). 
 
4. Results 
Seventy-five Swedish samples were positive for EBHSV by PCR (72 % of the 
original dataset) and, of those, 54 were successfully sequenced for the complete capsid 
VP60 gene. The final dataset included EBHSV strains from 52 Lepus europaeus and 
from two Lepus timidus specimens. Additionally, 16 French samples were also amplified 
and sequenced for the complete VP60 gene. 
Both the Maximum Likelihood (ML) and Bayesian (MCC) trees revealed the 
presence of two main phylogenetically distinct groups (Group A and Group B), with no 
evidence for recombination. The MCC tree (GTR+Γ+I substitution model, constant 
population size coalescent prior) is shown in Fig. 3.2, while the ML tree is available from 
the authors on request. Group A comprises Swedish strains from 1982 to 1989, thus 
representing the early evolutionary history of EBHSV. In contrast, Group B contains two 
Swedish strains from 1988, all those from the 1990s and 2000s, as well as strains 
sampled from other European countries (France, Germany and Italy). The strong time-
dependence (i.e. clock-like evolution) in the data, such that older strains occupy a more 
basal phylogenetic position than those sampled more recently, was confirmed in a 
regression of root-to-tip genetic distances against year of sampling inferred from the ML 
tree (correlation coefficient = 0.96). 
Our Bayesian MCMC analysis revealed that the mean rate of evolutionary change 
in EBHSV was approximately 3 x 10-3 nucleotide substitutions per site per year 
(subs/site/year), with little variation across coalescent models (range of 95 % HPD values 
of 2.6–3.6 x 10-3 subs/site/year across all models). Under this evolutionary rate, the 
tMRCA for EBHSV was estimated to be between 28 and 39 years (range of 95 % HPD 
values), which accords to the years 1969–1980. Additionally, our phylogeographic 
analysis revealed a significant clustering of sequences by country/province of origin 
under both the AI and PS phylogeny-trait association statistics (p < 0.01), such that there 
is restricted viral traffic across this spatial region. Similarly, the MC statistic revealed 
significant clustering in France and in six of the 13 Swedish counties (Blekinge, Gotland, 
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Örebro, Östergotland, Uppsala and Västra Götaland) that also had the largest sample 
sizes. 
 
Figure 3.2 MCC tree estimated for the 54 Swedish and assorted European EBHSV samples. The country and year 
of collection are shown for each sample, while reference sequences retrieved from GenBank have their accession number 
indicated. Posterior probabilities > 0.9 are shown for selected nodes. Tip times reflect the time (year) of sampling while 
node bars depict the 95 % HPD values on node times. 
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The nine EBHSV samples selected for the antigenic study presented five distinct 
antigenic profiles on the basis of differences in reactivity of four MAbs 
(O282/Sweden/1984; O1000/Sweden/1984 ≈ V1223/Sweden/1987 ≈ 
V1519/Sweden/1988 ≈ V24/Sweden/1998 ≈ Ita92/Italy/1992 ≈ Bs91/Italy/1991; 
V1571/Sweden/1988; V58/Sweden/1994; V708/Sweden/2008 ≈ V2070/Sweden/2008; 
Table 3.3). The loss of reactivity in MAbs 4E3, 1H1 and 6F9 in some samples from Group 
B results from epitope modification, probably due to the substitution of one or more amino 
acids responsible for epitope conformation. 
 
Table 3.3 Antigenic results for the 11 monoclonal antibodies tested. Ita92/Italy/1992 and Bs91/Italy/1991: EBHSV 
positive controls. Black squares: full reactive; dark grey squares: medium reactive; light grey squares: low reactive; white 
squares: not reactive. Location of each strain within the major groups of the phylogenetic tree is indicated. 
Sample 1C5 4A4 3H6 5F5 2B2 3D6 1F8 1G8 4E3 1H1 6F9 Group 
O282/Sweden/1984           A 
O1000/Sweden/1984            A 
V1223/Sweden/1987            A 
V1519/Sweden/1988            A 
V1571/Sweden/1988            B 
V58/Sweden/1994            B 
V24/Sweden/1998            B 
V708/Sweden/2008            B 
V2070/Sweden/2008            B 
Ita92/Italy/1992            B 
Bs91/1991            - 
 
 
Strains in Group A (1984–1988) exhibited relatively conserved antigenic profiles, 
being fully reactive for all MAbs but 3D6 (Table 3.3; Fig. 3.2). In contrast, strains from 
Group B, collected in a range time of 20 years (1988–2008), showed a progressive 
variation in antigenic profile. Indeed, the two strains from 2008 presented the most 
distinct antigenic profile comparing to the original, likely as a consequence of fixation of 
mutations that caused the loss of reactivity in MAbs 1H1, 6F9 and, finally, 4E3. 
Since EBHSV does not grow in vitro, the classical approach of producing escape 
mutants to map the epitopes is not possible. However, comparison of the antigenic 
profiles and the genetic differences between the strains allowed us to identify the location 
of some MAbs epitopes. For MAbs 1C5, 4A4, 3H6 and 5F5 no variation in reactivity was 
observed among strains, such that we could not predict the epitopes recognized. For 
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MAbs 2B2, 1G8, 4E3 and 6F9, several amino acid substitutions could be responsible for 
the antigenic variation, but none could be confidently associated with epitope location. 
Prediction of epitopes was possible for MAbs 3D6, 1F8 and 1H1 (Fig. 3.3), and 
further supported by their location in exposed regions of the P2 subdomain of the capsid 
(Fig. 3.4A). A complete loss of binding of MAb 1H1 is associated with the S383N 
mutation, as all five 1H1 positive strains have a serine at position 383, whereas 1H1 
negative strains have an asparagine. This is likely due to the bulky size of the asparagine 
extending outward compared to that of serine. In addition, the L378T mutation might 
interfere with 1H1 reactivity, since strain O282/Sweden/1984 presents a lower reactivity 
for this MAb. According to this and our capsid structural model, for MAb 1H1 we could 
demonstrate the associated conformational epitope (Fig. 3.4B). However, this should be 
treated with caution as the L378T mutation is not associated with a complete loss of 
reactivity. MAb 1F8 was not fully reactive for strains V58/Sweden/1994 and 
V24/Sweden/1998. Although no unique substitutions occur in these strains compared to 
the other strains tested, the mutations at two adjacent positions (T302A and S304G) 
could independently cause loss of the epitope. With respect to 3D6, the total loss of the 
epitope in the strain O282/Sweden/1984 might be related with the S408N mutation, since 
the serine is present only in this strain. 
 
 
Figure 3.3 Amino acid alignment of the P domain of the nine strains used for the antigenic analyses. Numbers on 
the top of the figure correspond to the variable amino acid positions found between strains; (.) means identity with the 
reference sequence. Location of the predicted MAbs epitopes is indicated at the top. Positions under putative positive 
selection are shown by stars. Amino acids are coloured based on their properties: light blue for hydrophobic amino acids 
(I, L, A, V, F, Y, M, W); dark blue for amino acids polar uncharged (N, T, Q, S); dark green for amino acids positive charged 
(R, H, K); light green for amino acids negative charged (D, E) and orange for amino acids with special characteristics (G, 
P, C). Regions are according to [30] and [31]. 
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Our analysis of site-specific selection pressures acting on VP60 revealed codons 
383, 410 and 476 to be under putative positive selection; codons 383 and 410 had a 
posterior probability > 0.95 for positive selection under the REL and FUBAR models; 
codon 476 had a posterior probability of 1 for REL, a p-value of 0.001 for FEL, and a 
posterior probability > 0.95 for FUBAR. No episodic diversifying selection was observed 
on any individual branch. Assuming the organization of Caliciviridae genomes proposed 
by Neill [31], codons 383 and 410 are located in region E of the capsid while codon 476 
is located in the region F. For codon 383 two different amino acids – S or N – are 
observed, but the physiochemical properties are maintained. For codon 410 five different 
amino acids are found (A, T, S, P and N); interestingly, this codon can be part of a 
putative N-glycosylation motif. For codon 476 eight different amino acids were found in 
the sequences studied (A, E, T, S, D, V, G and N); although the physiochemical 
properties might change with these mutations, the phenotypic effect is uncertain. 
According to our model of the capsid structure, the positively selected codons are located 
at exposed regions of the capsid P domain (Fig. 3.4C). 
 
5. Discussion 
Despite an increasing interest in calicivirus evolution [32-34], few studies have 
considered EBHSV even though it is an important agent of disease in Europe. The first 
recognized and diagnosed EBHSV outbreak occurred in the early 1980s in Sweden [1]. 
However, there are indications of the presence of the virus within hare populations since 
at least 1976 [16-18]. 
Our phylogenetic analysis revealed striking evolutionary patterns in EBHSV. A 
single viral lineage was apparently dominant at the time of EBHSV emergence (Group 
A; Fig. 3.2). This lineage spread throughout Sweden, evolving in separated genetic sub-
groups that clustered in distinct geographical areas. Group A persisted until 1989 when 
it was seemingly replaced within a few years by a new lineage (Group B) that emerged 
in the mid-1980s. While Group A included only Swedish samples from 1982 to 1989, 
Group B included Swedish samples from the late 1980s and all the Swedish samples 
from the 1990s and 2000s, along with the other European samples (Italy, France and 
Germany). Thus, this lineage contains strains detected in several European countries, 
suggesting that an increased fitness may have enabled it to diffuse over a wider 
geographic area, at the same time out-competing the pre-existing Group A viruses. This 
evolutionary pattern resembles that observed for the antigenic variant of RHDV (RHDVa) 
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in several countries associated with domestic rabbit production, where it replaced earlier 
RHDV strains [35,36]. 
 
 
Figure 3.4 Molecular model of the P subdomain of EBHSV capsid protein VP60. (A) Positions of the putative epitopes 
identified for MAbs 1F8 (red), 1H1 (green) and 3D6 (blue). (B) Details of the conformational epitope defined by Mab 1H1 
involving positively selected site 383. The two amino acids that modulate MAb binding are highlighted in orange for the 
recognized O1000/Sweden/1984 strain and in green for the non-recognized V58/Sweden/1994 strain. (C) Location on 
exposed loops of the P domain of putative positively selected sites (codons 383, 410 and 476). The S domain positioned 
below the P1 subdomain is not shown, since it did not harbor positively selected sites or mutations affecting MAbs binding. 
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Antigenic variation in EBHSV is observed from as early as 1984, with strains 
presenting distinct antigenic profiles circulating in the same year. This variation is also 
observed in 1988, coincident with co-circulation of Groups A and B strains 
(V1519/Sweden/1988 and V1571/Sweden/1988; Fig. 3.3). In contrast, similar antigenic 
profiles exist in both groups, but while the phylogenetic analysis is based on the entire 
capsid sequence, the antigenic analysis only shows differences at specific locations (i.e., 
within epitopes). The lack of reactivity for the MAbs 4E3, 1H1 and 6F9 that characterizes 
the antigenic profiles of the most recent Group B strains, makes it possible that the 
successful persistence of lineage B and the replacement of lineage A is due to a change 
in antigenicity among these lineages (Fig. 3.3). Indeed, a relationship between antigenic 
variation and emergence of new outbreaks is well-established for other caliciviruses, 
such as GII.4 norovirus [37-41]. 
According to our prediction of the EBHSV secondary structure and considering the 
similarities with the RHDV atomic model [30], the positively selected codons 383, 410 
and 476 are located in exposed loops of P2 and P1 subdomains of VP60, suggesting 
that, as for RHDV [42], they are associated with host immune pressure. Codon 410 is 
also located within a putative N-glycosylation motif; a similar observation was made for 
RHDV and an association with virulence was hypothesized [42]. Interestingly, position 
383 appears to dictate reactivity of MAb 1H1, strongly suggesting that it corresponds to 
a major epitope under immune pressure. Our prediction is supported by a previous study 
on Italian strains [28]. For MAb 1F8, the amino acids at positions 302 and 304 correspond 
to the epitope recognized by this MAb. Both T>A and S>G correspond to a loss of the 
OH group that seems to be associated with the lack of reactivity. Barbieri [28] observed 
a T>S change at position 302, but the reactivity is not affected since the OH group is 
maintained. The epitope recognized by MAb 1F8, but also by MAb 3D6, is located in the 
P2 subdomain, which is the most exposed region of the calicivirus capsid and a highly 
variable region, being involved in the interaction with host antibodies and histo-blood 
group antigens [30,43]. It is likely that the changes on the EBHSV capsid influence 
receptor binding and potential host resistance as described in RHDV [44]. 
The mean rate of nucleotide substitution for EBHSV estimated in this study, which 
ranges from 2.6 to 3.6 x 10-3 subs/site/year, is relatively high for an RNA virus [45,46], 
although similar to that recently observed for RHDV in Australia where the virus was 
introduced as a novel biocontrol agent in 1995 [47]. Under this rate the estimated tMRCA 
for EBHSV is between 1969 and 1980 (95 % HPD values) which is concordant with its 
circulation a few years before the original diagnosis in 1980. This time-scale is further 
supported by (i) the reports of hares that died with lesions consistent with EBHS in 
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England in 1976, (ii) the identification of EBHSV in samples collected in the 1970s, and 
(iii) the detection of anti-EBHSV antibodies in sera of hares collected previously [16-18]. 
Finally, the phylogeographic results reveal a significant clustering by country and 
Swedish county of origin, such that there are constraints to viral traffic both within 
Sweden and more broadly across Europe. This sites in contrast to the lack of 
geographical structure and rapid spatial spread of the related RHDV in some European 
countries such as Portugal, Spain and France [32,48-50]. 
In sum, our results show clear replacement of Group A by Group B strains that is 
likely to be selectively mediated and which may at least in part be associated with 
antigenic variation. The position of Italian, German and French strains within this Group 
highlights the successful dispersal and persistence of this lineage throughout Europe. 
Preliminary data indicate that this lineage is still dominant in Europe and hence merits 
continued monitoring. 
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Supplementary Figure 1. Sequence alignment of the domain S and P of the major capsid protein of RHDV (PDB codes: 4EJR and 4EGT, respectively) and EBHSV strain O282/Sweden/1984. 
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Supplementary Figure 2. Scheme of the mutations from O282/Sweden/1984 to all the other strains used in the model. 
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A new attachment factor in the Lagovirus genus: the European 
brown hare syndrome virus (EBHSV) uses N-acetylglucosamine 
terminated O-glycans to attach to host cells 
 
A. M. Lopes, M. Lora, B. Le Moullac-Vaidye, N. Ruvoën-Clouet, A. Breiman, O. E. Galanina, N. V. Bovin, 
P. J. Esteves, J. Abrantes & J. Le Pendu 
 
1. Abstract 
The European brown hare syndrome virus (EBHSV) is a Lagovirus (family 
Caliciviridae) responsible for a hemorrhagic disease affecting hares (Lepus europaeus 
and L. timidus). This highly pathogenic virus is similar to rabbit hemorrhagic disease virus 
(RHDV). The first contact between RHDV and its host, Oryctolagus cuniculus, is 
established via carbohydrates present on the epithelial cells of the upper respiratory and 
digestive tracts, namely the A, B and H type 2 antigens. The phylogenetic proximity of 
the two viruses, as well as the similar epidemiological course of the diseases, might 
foresee the same pathways of virus entry for EBHSV. We tested EBHSV binding to 
synthetic sugars, and the effect of the removal of key carbohydrates from the tissues on 
EBHSV attachment. Our results show that EBHSV does not use the same glycans as 
RHDV, but it seems to prefer GlcNAc-terminated O-glycans to establish the first contact 
with host cells. These data is central for understanding EBHSV infection cycle. 
 
2. Introduction 
European brown hare syndrome virus (EBHSV) is the etiological agent of 
European brown hare syndrome (EBHS), a fatal disease affecting the European brown 
hare (Lepus europaeus) and the mountain hare (Lepus timidus). The disease was first 
identified in Sweden in 1980 [1] and thereafter in many European countries, becoming 
endemic in wild hare populations. EBHS causes severe hepatic necrosis and dysfunction 
in several organs [1], usually leading to death 3-4 days after infection [2]. The mortality 
rates are highly variable, but can reach up to 100 % in farms, albeit young hares do not 
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develop the disease [3]. An evolutionary study focused on EBHSV revealed that the early 
Swedish strains disappeared and that the other European strains are derived from a 
second group of isolates [4].  
EBHSV is a small, non-enveloped, positive-sense, single-stranded RNA virus, with 
~ 7.4 kb in length. Viral particles were first identified in the liver of dead hares in 1989 
[5]. These particles were recognized as closely related to those of rabbit hemorrhagic 
disease virus (RHDV) [5], a virus that also emerged in the 1980s [6] and that is 
responsible for the decline of European rabbit (Oryctolagus cuniculus) populations. 
These two viruses share extensive similarities [7-9], although with a genetic distance of 
~ 30 % [10],  and were assigned to the genus Lagovirus, family Caliciviridae [11]. 
The hosts of these two viruses are both members of the order Lagomorpha. In 
Europe, three lagomorph genera are found, with Sylvilagus as a non-native species, 
since it was introduced in several occasions in the 1960s and 1970s [12]. The genera 
Oryctolagus and Lepus separated ~ 12 million years ago [13] and are represented in 
Europe by seven species: O. cuniculus, L. europaeus, L. timidus, L. capensis (only in 
Sardinia), L. corsicanus, L. granatensis and L. castroviejoi [14]. Although L. granatensis 
has a contact zone with L. europaeus (EBHSV susceptible), no cases of EBHSV had 
been reported in this species. Strikingly, a spillover infection of RHDV was described in 
L. granatensis [15].  
Virus attachment to host cell receptors is a key factor to successfully infect the host 
and initiate the virus life cycle. This acquires special importance on virus evolution since 
changes in receptor binding motifs impose constraints on viruses, which ultimately can 
lead to the emergence of new strains with different receptor requirements. RHDV 
attaches to histo-blood group antigens (HBGAs) of the upper respiratory and digestive 
tracts to start infection [16] and its ability to bind to the A, B and H type 2 epitopes is 
dependent on the virus’ genogroup [17]. For example, while the Iberian G1 has affinity 
for A, B and H, the French G2 does not show affinity for the A antigen, but only for the B 
and H antigens [17].  
More recently, a dominant-negative mechanism was shown for the 
α1,2fucosyltransferase Sec1 over Fut1, a key enzyme for the synthesis of RHDV ligands 
in the host. The study also showed an extensive gene conversion involving the genes of 
this family for the leporids analyzed [18]. This study represented a significant step 
forward in understanding the RHDV infectious process and the rabbit resistance 
mechanisms. On the contrary, little is known about how EBHSV initiates this process. 
Given the similarities between RHDV and EBHSV regarding morphology, genome 
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organization and antigenicity, we investigated the attachment requirements of EBHSV to 
the host and the possible role of HBGAs in this process. We further investigated if any 
dissimilarity between EBHSV binding to L. europaeus and L. granatensis could explain 
the absence of EBHSV infection in the latter. 
 
3. Methods 
Ethic statement 
Tissue samples were collected from two hares shot by hunters from Idanha, 
Portugal (L. granatensis), one hare reared in captivity and humanely euthanized (L. 
granatensis) and four L. europaeus from Spain also reared in captivity. Samples of 
trachea and duodenum from two additional L. europaeus hunted in western France were 
used for immunohistochemistry. Rabbit duodenums were collected from freshly hunted 
wild rabbits from the Pyrénnées Orientales, France. These samples had previously been 
phenotyped for HBGAs [17]. 
An anti-EBHSV polyclonal antibody was generated by serial inoculation of two rats 
with EBHSV virus-like particles (VLPs) produced from the sequence of a French strain, 
kindly provided by Ghislaine Le Gall-Reculé (ANSES, Ploufragan, France). 
Experimentation was performed at the animal experimentation core facility, University of 
Nantes. Recognition of target VLPs using the generated antibody was confirmed by 
ELISA. Use of rats was approved by the national ethic review board from the French 
Ministry of ‘Enseignement Supérieur et de la Recherche’ (project license number 
01322.01). The animal care and use protocol adhered to the European Directive number 
2010/063 and to the national French regulation (Décret nº 2013-118 du 1er février 2013 
relatif à la protection des animaux utilisés à des fins scientifiques). 
 
Preparation of samples and VLPs 
Samples of hare duodenum and trachea were collected and immediately fixed in 
10 % buffered formalin and later paraffin-embedded and sectioned. Hare duodenum 
scrapings were prepared from 1 cm of duodenum for three L. granatensis and four L. 
europaeus and ABH phenotyped by ELISA as described in [17]. 
VLPs of an EBHSV strain were generated using a previously described method 
[19]. Briefly, recombinant baculoviruses were generated containing the VP60 protein, 
then VLPs were produced by infection of Sf9 insect cells. VLPs were released from the 
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infected Sf9 cells by three rounds of freeze-thawing, and then clarified by removal of 
cellular debris (6,000 x g for 30 minutes) and baculovirus (14,000 x g for 30 minutes). 
VLPs were partially purified through a 30 % (w/v) sucrose cushion in TNC buffer (50 mM 
Tris HCl pH 7.4, 150 mM NaCl, 10 mM CaCl2) containing the protease inhibitor leupeptin 
for 150,000 x g for two hours. The pelleted VLP was resuspended in TNC buffer and 
further purified by isopynic centrifugation in caesium chloride (150,000 x g for 18 hours). 
The resultant VLP bands were collected by puncture and the solution containing VLPs 
was dialyzed against PBS prior to quantification in nanodrop and kept at -20 ºC. 
 
EBHSV binding assays 
EBHSV binding to tissues was assessed using ELISA and immunohistochemistry 
(IHC). For ELISA, Nunc Maxisorp plates were coated with hare scrapings diluted 10-5 
and 10-7 in 100 mM sodium carbonate buffer, pH 9.5, and incubated at 4 ºC overnight. 
All the following incubations were at 37 ºC in humid atmosphere; samples and antibodies 
were diluted in sterile PBS; plates were washed three times with 0.05 % Tween 20 in 
PBS after each incubation. Plates were blocked with 5 % non-fat dry milk diluted in sterile 
PBS for one hour. The wells were then incubated with EBHSV VLP at 12 µg/mL for two 
hours, followed by a one-hour incubation with the rat anti-EBHSV serum diluted 1/500. 
One last incubation with an anti-rat IgG HRP-conjugated 1/1000 for one hour was 
performed. Finally, TMB was used as substrate and the reaction was stopped after 8 min 
with 1 M phosphoric acid. Optical density (O.D.) values were read at 450 nm. 
For IHC, hare tissue sections were deparaffinized through LMR-SOL baths and 
rehydrated with ethanol. Endogenous peroxidase activity and non-specific binding were 
blocked with room temperature baths of 20 min with 0.3 % (v/v) hydrogen peroxide in 
PBS and of 30 min with 3 % (w/v) bovine serum albumin (BSA) in PBS, respectively. A 
10 % (w/v) liver homogenate prepared from a hare that tested positive for EBHSV and 
diluted 1/5 was incubated with the tissue sections at 4 ºC overnight. Samples and 
antibodies were diluted in 1 % (w/v) BSA in PBS; after each incubation, slides were 
washed 3 x 5 min in PBS. A 1/100 dilution of the EBHSV-specific monoclonal antibody 
(MAb) 5F5 (kindly provided by Lorenzo Capucci) was then incubated with the tissue 
sections for two hours at 37 ºC. MAb binding was followed by an incubation with 
biotinylated anti-mouse antibody diluted 1/1000, one hour at 37 ºC. Slides were then 
incubated with HRP-conjugated avidin D, one hour at room temperature, and finally 
substrate (AEC kit) was added to the slides. After 25 min, slides were washed as 
described above and Mayer’s hematoxylin was used for contrast staining. 
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Test of EBHSV binding to histo-blood group antigens 
A panel of PAA-conjugated and BSA-conjugated synthetic sugars was used to 
screen EBHSV binding to HBGAs, according to RHDV binding patterns [16,17]. Sugars 
were coated at 1 µg/well and incubated overnight at 4 ºC. All subsequent steps were 
performed as described for EBHSV binding to tissue scrapings, except for the VLP 
binding step for PAA-conjugated sugars with the incubation steps being performed at 4 
ºC. 
 
Enzyme treatments on tissues and EBHSV binding 
Rabbit duodenum samples were coated in Nunc Maxisorp plates at 1/100 dilution 
at 4 ºC overnight. Prior to the blocking step, plates were incubated two hours at 37 ºC 
with the following enzymes: α-N-acetylgalactosaminidase (New England Biolabs), 50 
U/well; α-galactosidase from green coffee beans (Sigma), 0.2 U/well; 1,2-α-L-fucosidase 
from Bifidobacterium bifidum, 0.5 µg/well. After incubation with each enzyme, ELISA 
steps were performed as described above for binding to tissue scrapings. The same 
protocol was applied for PNGase F (New England Biolabs), but duodenum tissue was 
from a hare and used at 1/400 dilution; incubation with the enzyme lasted six hours. 
For α2-3,6,8 Neuraminidase (New England Biolabs) and O-sialoglycoprotein 
endopeptidase (OSGE; Cedarlane) a slightly modified protocol was adopted. Hare 
duodenum samples were incubated overnight at 37 ºC with each enzyme and then 
coated in Nunc Maxisorp plates at 4 ºC overnight at a final dilution of 1/400. After blocking 
the plate, steps were carried out as described above. A treatment with sodium 
metaperiodate was also performed, using the same protocol as for A, B and H enzymes. 
Sodium metaperiodate was added to the wells in concentrations ranging from 1 mM to 
100 mM, incubated for one hour at 37 ºC and then, prior to blocking, glycine 1 % in PBS 
was added to the wells for 30 min. 
 
Printed glycan array (PGA) 
Printed glycan array slide fabrication and high-throughput profiling was performed 
as previously described [20]. Briefly, 360 monomeric glycans as ω-aminopropyl 
glycosides of 95-98 % purity (Lectinity) were diluted in 300 mM phosphate buffer pH 8.5, 
containing 0.005 % Tween 20 and printed by robotic pin deposition on N-
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hydroxysuccinimide activated glass slides (Nexterion Slide H, Schott, Jena, Germany). 
Glycans were printed at a 50 µM concentration in six replicates. Free N-
hydroxysuccinimide activated groups were blocked with 50 mM ethanolamine in 50 mM 
borate buffer at a final pH of 9.2. Slides were then rinsed with deionized water, dried and 
stored at room temperature in a desiccator. VLPs diluted in PBS containing 0.1 % (v/v) 
Tween 20 and 3 % (w/v) BSA were incubated on the array slides and gently rocked in a 
humidified incubator at 37 ºC for two hours. Unbound VLPs were washed with a series 
of 0.1 % and 0.001 % Tween 20 in PBS. Anti-EBHSV diluted 1/1000 in PBS containing 
0.1 % (v/v) Tween 20 and 3 % (w/v) BSA was added and slides were incubated at room 
temperature in a humidified chamber for 45 minutes and then washed. Bound antibodies 
were visualized by incubating slides with Cy5-labeled anti-rabbit IgG 1/1000 in PBS/0.1 
% Tween 20 at room temperature for 30 minutes. Following further washings, 
fluorescence signals corresponding to glycan-bound antibodies were measured using an 
Agilent scanner G2565CA and analyzed using ImaGene analysis software version 7.5 
(BioDiscovery, El Segundo, USA). Signals were measured as total signal intensity 
(medTSI) per glycan and were expressed as median across six intra-array replicates. 
 
4. Results and Discussion 
The first step for a successful viral infection is the attachment of the virus to host 
cell surface receptors. This virus-host interaction is of extreme importance, dictating 
tissue tropism and pathogenicity, and might be mere electrostatic and non-specific, albeit 
allowing the virus the establishment of a contact point to further attract specific receptors 
responsible for cell entry [21]. Several studies on rabbit hemorrhagic disease virus 
(RHDV) entry disclosed that histo-blood group antigens (HBGAs) A, B and H type 2 are 
involved in virus attachment to epithelial cells of the upper respiratory and digestive tracts 
[16,17]. Despite the close relationship between RHDV and European brown hare 
syndrome virus (EBHSV), the means used by the latter to attach to host cells are 
unknown. 
Our first approach to understand EBHSV attachment was to determine the binding 
pattern on tissues of the upper respiratory and digestive tracts. We observed that EBHSV 
binds to the epithelial layer of trachea and to the surface layer of the duodenal mucosa 
(Lieberkühn crypts) (Fig. 3.5), as has been shown for RHDV [16]. No differences in the 
binding pattern were observed between the two hare species used in this study, L. 
europaeus and L. granatensis, despite their apparent different susceptibility to EBHSV. 
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Figure 3.5 EBHSV binding to hare trachea and duodenum. The virus binds to the epithelial layer of trachea (A) and to 
the Lieberkühn crypts (D) in the duodenum, as the other member of the genus, RHDV. (B) and (E) are the negative 
controls (same treatment as the other slides, but omitting the incubation with the virus) for trachea and duodenum, 
respectively. (C) and (F) represent RHDV binding to rabbit trachea and duodenum, respectively, and are shown for 
comparison. Scale bar is indicated for each case. 
 
 
Figure 3.6 EBHSV binding to different ABH phenotypes. Bars represent values obtained for binding to tissue 
extracts from three individual rabbits for each ABH phenotype (A+B+, A+B- and A-B-). OD: optical density. 
 
As all phenotyped hares revealed to be negative for the presence of the B antigen 
(data not shown), ABH phenotype-dependent binding of EBHSV was tested on rabbit 
tissues. For this, EBHSV binding to rabbits with different phenotypes (A+B+, A+B- and A-
B-) was performed by ELISA. No significant preference for any phenotype or trend was 
observed (Fig. 3.6). When tissues were treated with specific enzymes that remove the 
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α-linked N-acetylgalactosamine and galactose (for A and B antigens, respectively) and 
the α1,2-linked fucose residues (for H antigen), no significant decrease in binding was 
observed for EBHSV (Fig. 3.7), reinforcing the absence for a preference of a specific 
ABH phenotype/antigen. 
 
          (a) α-N-acetylgalactosaminidase                  (b) Galactosidase 
 
(c) Fucosidase 
 
Figure 3.7 EBHSV binding to tissues following enzyme treatments. (a) α-N-acetylgalactosaminidase treatment, 
specific for A antigen; (b) galactosidase treatment, specific for B antigen; (c) fucosidase treatment, specific for H antigen. 
For each enzyme, a control of the enzyme activity was used: the anti-A antibody for α-N-acetylgalactosaminidase; the 
anti-B antibody B49 for galactosidase and the anti-H Ulex for fucosidase. Negative controls (NC) were performed by 
incubating the wells as the treatments but without the VLP and positive controls (No enz) were performed by incubating 
the wells as the treatments but without the enzyme; Enz: OD results for treated wells. 
 
A range of synthetic sugars was then selected for testing the EBHSV binding, 
according to previous data on RHDV [16,17]. Strikingly, EBHSV did not bind to any of 
the tested sugars (data not shown). Thus, as no significant decrease in tissue binding 
after enzyme treatments and no binding to synthetic sugars that are used by RHDV to 
0
0.2
0.4
0.6
0.8
1
1.2
EBHSV 2A21
R
a
tio
 
si
gn
a
l/b
a
ck
gr
o
u
n
d No enz
Enz
NC
0
0.2
0.4
0.6
0.8
1
1.2
EBHSV B49
R
a
tio
 
si
gn
a
l/b
a
ck
gr
o
u
n
d No enz
Enz
NC
0
0.2
0.4
0.6
0.8
1
1.2
EBHSV Ulex
R
a
tio
 
si
gn
a
l/b
a
ck
gr
o
u
n
d No enz
Enz
NC
FCUP 
EBHSV: virus evolution and attachment factors 
169 
 
 
attach epithelial cells were observed for EBHSV, we hypothesized that EBHSV uses 
alternative attachment factors, rather than using HBGAs. This led us to perform the 
glycan arrays experiments that allow to assay a large number of glycan structures. The 
glycan arrays revealed a significant binding signal to terminal N-acetylglucosamine 
residues, and to heparin (Table 3.4). Consistent with the above described results, no 
significant binding was observed on glycans of the fucosylated histo-blood group type 
that constitute ligands for RHDV. Likewise, no binding was recorded to glycans 
containing sialic acid residues that constitute ligands for many viruses. Therefore, 
EBHSV seems to use alternative glycans as attachment factors to start the infectious 
process. 
 
Table 3.4 Glycan array results. Only glycans with a ratio signal/background higher than 10 are shown. 
Common (short) name Structure Signal (S) Background (B) Ratio (S/B) 
Chitohexaose (Ch6) (GlcNAcb1-4)6-sp4 16673 722 23.1 
Chitopentaose (Ch5) (GlcNAcb1-4)5b-sp4 18697 847 22.1 
Heparin Heparin (NH4+ salt) 47739 3170 15.1 
Chitobiose-Asn (Ch2-Asn) GlcNAcb1-4GlcNAcb-Asn 17440 1553 11.2 
 
 
Glycosaminoglycans (GAGs) usually exist as O-linked chains of proteins. Heparin 
is structurally similar to another GAG, heparan sulfate. Virtually, all mammalian cells 
express heparan sulfate, a complex polysaccharide composed by repeating 
disaccharide units of glucoronic acid or iduronic acid linked to glucosamine, that can 
display a remarkable range of different sequence motifs and high structural diversity [22]. 
Interactions of heparan sulfate with proteins are established via hydrophobic interactions 
and hydrogen bonding [23-25], but mainly through electrostatic interactions of its 
negatively charged sulfate with basic amino acids [25,26]. 
Heparin-binding domains have been shown to contain consensus sequence 
motifs, such as XBBXB, XBBBXXBX or XBBXBX, where B is a basic amino acid and X 
is a neutral or hydrophobic amino acid. We analyzed the publicly available sequences of 
EBHSV capsid protein and although this protein does not possess any of these motifs, it 
has a 464RR465 motif that is exposed according to the structural model proposed for 
EBHSV [4]. Nevertheless, the binding pattern of EBHSV on tissue sections does not 
match with the distribution of heparan sulfate (Fig. 3.5). In addition, assay of the glycan 
specificity of VLPs from several other related viruses, including RHDV, showed binding 
to heparin, alongside the well described binding to fucosylated histo-blood group antigen 
170 FCUP 
EBHSV: virus evolution and attachment factors 
 
motifs (data not shown). The involvement of heparan sulfate in binding and infection by 
these viruses therefore remains to be assessed. 
To further delineate the nature of the glycans recognized by EBHSV, enzyme 
treatments were performed. When removing N-glycans or sialic acids, through 
treatments with PNGase F or Neuraminidase, respectively, EBHSV binding to tissues is 
not affected (Fig. 3.8a,b). The same is observed when incubating the tissues with 
increasing amounts of sodium metaperiodate, which degrades carbohydrate structures 
by cleaving C-C bonds (Fig. 3.8d). However, when the tissue was treated with the O-
sialoglycoprotein endopeptidase (OSGE) enzyme, EBHSV binding was significantly 
reduced (Fig. 3.8c). This enzyme removes proteins that have O-linked sugars on their 
surface, indicating that the motifs recognized by EBHSV are O-glycans carried by mucin-
type proteins. Interestingly, a structural analysis of mucin-type O-glycans from the 
duodenum of rabbits revealed the presence in limited amounts of GlcNAc-terminated 
motifs [17]. A similar analysis has not been performed in hares, but suggests the 
presence of potential EBHSV ligands on O-glycans from the small intestine of a 
lagomorph species. EBHSV and RHDV, the two viruses of the family Lagovirus, are very 
similar in terms of morphology, antigenicity, genome organization and disease progress 
[7,9,27,28] despite their ~ 30 % genetic distance [10]. Therefore, the reason why EBHSV 
uses different sugars to attach host cells remains unclear. 
The majority of caliciviruses uses carbohydrate ligands to attach host cells, but the 
type of carbohydrate varies across genera. For example, several human norovirus 
strains, mainly those derived from GII strains, were also reported to bind to heparan 
sulfate [29]. Heparan sulfate is a primary or co-receptor for viruses from other families, 
for example, adeno-associated virus, family Parvoviridae [30], human immunodeficiency 
virus, family Retroviridae [31], herpes simplex virus, family Herpetoviridae [32], and 
filoviruses [33]. However, it is unknown if heparan sulfate, and glycosaminoglycans in 
general, play a role in caliciviruses attachment and entry. Caliciviruses such as 
noroviruses can also use HBGAs to attach to host cells [34], and this has clearly been 
associated with infection [35]. Likewise, RHDV binds to fucosylated glycans and this too 
has been associated with infection [16-18]. However, some murine norovirus strains 
appear to require binding to sialic acid containing N- and O-glycans whilst others bind to 
N-glycans in a neuraminidase insensitive manner [36]. 
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                  (a) PNGase F                        (b) Neuraminidase 
 
 
(c) OSGE 
 
 
(d) Sodium metaperiodate 
 
Figure 3.8 Enzyme treatments on tissues followed by EBHSV binding. Lectins Concanavalin A (Conc A) and Maackia 
Amurensis Lectin II (MAA) were used to evaluate PNGase F (a) and Neuraminidase activity (b), respectively. Antibody 
A82 was used with the same purpose for OSGE enzyme (c). Antibody 2A21 recognizes A antigen and was used as control 
for the sodium metaperiodate activity (d). Controls were included as described in Fig. 3.6; Enz: OD values for treated 
wells. 
 
A common theme is that all caliciviruses tested so far bind to some type of glycans, 
but that distinct types may be recognized by different viruses. These differences in the 
type of glycans used for host attachment might also correlate with the different 
0
0.2
0.4
0.6
0.8
1
1.2
EBHSV Conc A
R
a
tio
 
si
gn
a
l/b
a
ck
gr
o
u
n
d No enz
Enz
NC
0
0.2
0.4
0.6
0.8
1
1.2
EBHSV MAA
R
a
tio
 
si
gn
a
l/b
a
ck
gr
o
u
n
d No enz
Enz
NC
0
0.2
0.4
0.6
0.8
1
1.2
EBHSV A82
R
a
tio
 
si
gn
a
l/b
a
ck
gr
o
u
n
d
No enz
Enz
NC
0
0.2
0.4
0.6
0.8
1
1.2
R
a
tio
 
si
gn
a
l/b
a
ck
gr
o
u
n
d EBHSV
2A21
172 FCUP 
EBHSV: virus evolution and attachment factors 
 
hemagglutination properties of EBHSV and RHDV. Indeed, for EBHSV the 
hemagglutination test requires some modifications when comparing to the protocol used 
for RHDV, such as mixing the samples with chloroform, carrying the test at 4 ºC and at 
pH 6.5 [7]. As GAGs and terminal GlcNAcs are not present in red blood cells, EBHSV is 
not able to agglutinate them, at least at the same extent as RHDV. 
Our study identified a GAG and GlcNAc-terminated O-glycans as potential new 
attachment factors in the Lagovirus genus and improved our knowledge on how the virus 
enters into host cells and other factors related to virus-host interactions. This data will 
additionally provide information on the evolution of EBHSV. 
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Detection of RHDV strains in the Iberian hare (Lepus 
granatensis): earliest evidence of rabbit lagovirus cross-
species infection 
 
A. M. Lopes, S. Marques, E. Silva, M. J. Magalhães, A. Pinheiro, P. C. Alves, J. Le Pendu, P. J. Esteves, 
G. Thompson & J. Abrantes 
 
1. Abstract 
Rabbit hemorrhagic disease virus (RHDV) is a highly lethal Lagovirus, family 
Caliciviridae, that threatens European rabbits (Oryctolagus cuniculus). Although a 
related virus severely affects hares, cross-species infection was only recently described 
for new variant RHDV in Cape hares (Lepus capensis mediterraneus). We sequenced 
two strains from dead Iberian hares (Lepus granatensis) collected in the 1990s in 
Portugal. Clinical signs were compatible with a Lagovirus infection. Phylogenetic 
analysis of the complete capsid gene positioned them in the RHDV genogroup that 
circulated on the Iberian Peninsula at that time. This is the earliest evidence of RHDV 
affecting a species other than European rabbits. 
 
2. Introduction, methods and results 
Wild and domestic European rabbits (Oryctolagus cuniculus) are severely affected 
by rabbit hemorrhagic disease (RHD), an acute hepatitis that causes death within 48–72 
h after infection [reviewed in 1]. RHD was first reported in 1984 in China and two years 
later was described in Italy, spreading to several European countries afterwards 
[reviewed in 1]. On the Iberian Peninsula (IP), the first reports of RHD date from 1988 
[reviewed in 1]. The etiological agent of the disease, rabbit hemorrhagic disease virus 
(RHDV), belongs to the Caliciviridae family, genus Lagovirus. The other member of this 
genus, European brown hare syndrome virus (EBHSV), causes the European brown 
hare syndrome (EBHS) in European and mountain hares (Lepus europaeus and L. 
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timidus, respectively) [2]. On the IP, EBHSV was first reported in L. europaeus in 1995 
(Gortázar C, personal communication). RHDV and EBHSV are non-enveloped, positive-
sense, single-stranded RNA viruses, with a similar genomic organization and ~ 70 % of 
nucleotide identity [3]. RHD and EBHS share clinical signs and pathological alterations, 
including congestion and necrosis of the liver and massive disseminated intravascular 
coagulation [reviewed in 1]. 
Two subspecies of O. cuniculus are found on the IP, O. cuniculus cuniculus in the 
northeast and O. cuniculus algirus in the southwest (Figure 4.1) [4]. Additionally, three 
hare species inhabit this region: L. granatensis, distributed along Portugal, mainland 
Spain and Majorca; L. castroviejoi, restricted to Cantabria; and L. europaeus, confined 
to the Pyrenees (Figure 4.1) [4]. Although EBHS was reported in Spain, there are no 
reports of the disease in L. granatensis and L. castroviejoi, both endemic to the IP. 
 
 
Figure 4.1 Map with the distribution of leporid species on the Iberian Peninsula. Light grey represents the distribution 
of Lepus europaeus. Dark grey corresponds to the distribution of L. castroviejoi. White represents the distribution of L. 
granatensis. The European rabbit (Oryctolagus cuniculus) is present all over the Iberian Peninsula; the contact zone 
between O. c. cuniculus and O. c. algirus (restricted to the southwest region) is in medium grey. The localities where P95 
(Torres Novas) and P151 (Pancas) were collected are indicated. 
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Despite their similarities, RHDV and EBHSV are restricted to their natural hosts, 
as has also been proven experimentally [5]; however, cross infection was recently 
described for a new RHDV variant (tentatively named RHDV2 or RHDVb) in Lepus 
capensis mediterraneus in Italy [6]. RHDV2 was originally described in France in 2010 
[7], and is antigenically and genetically different from the classical RHDV strains [7,8]. In 
this study we report the first and earliest evidence of cross-species infection of classical 
RHDV in the Iberian hare, L. granatensis. 
Liver samples of two hares found dead in the field were collected in Torres Novas 
and Pancas, south of Portugal, in 1996 and 1998, respectively (P95 and P151; Figure 
4.1). At necropsy, lesions compatible with an infection by a Lagovirus were observed. 
P95 showed congestion of the liver and lungs as well as non-coagulated blood in the 
chest cavity, trachea and lungs; P151 presented congestion of the kidneys and both the 
chest and abdominal cavity were filled with non-coagulated blood and presented dark 
red coloration. In both animals, blood vessels were dilated and filled with non-coagulated 
blood. Additionally, the livers of five dead rabbits collected in Pancas in November and 
December-1997 were included in this study (P129, P141-P144). These individuals also 
exhibited lesions compatible with a Lagovirus infection at necropsy: dark red coloration 
and congestion of the kidneys and spleen; heart in diastole and atria filled with blood; 
non-coagulated blood in the trachea, chest and abdominal cavity (P143 presented 
normal abdominal cavity). With the exception of P129, dilated blood vessels filled with 
non-coagulated blood were observed, as well as a hypertrophic, congested liver. P142-
P144 additionally presented congested lungs, filled with non-coagulated blood and P129, 
P141 and P142 presented nasal hemorrhages. 
To avoid any risk of contamination, RNA extraction, cDNA synthesis and PCR 
amplification of the two hare samples were performed independently from the other 
samples. Total RNA was extracted with the RNeasy Mini Kit (Qiagen, Hilden, Germany) 
and reverse transcription was performed using oligo(dT) as primers and Super-Script™ 
III Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA). Protocols were performed 
according to the manufacturer’s instructions. The samples were screened for the 
presence of RHDV and EBHSV by PCR with the primers U38 and EBHS9 as described 
elsewhere [9] as these primers amplify both RHDV and EBHSV. Sequencing of the 
fragments revealed that samples were positive for RHDV and negative for EBHSV. 
Additionally, and to ensure that only RHDV was present, RHDV and EBHSV-specific 
PCR were also performed (conditions available upon request). Amplification was 
successful for RHDV, but not for EBHSV. The gene encoding the capsid protein VP60 
of RHDV (1740 base pairs) was fully amplified by PCR using 1 μL of the cDNA reaction, 
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2 pmol of each oligonucleotide, 5 μL of Phusion Flash High-Fidelity PCR Master Mix 
(Thermo Scientific, Waltham, Massachusetts, USA) and water to a final volume of 10 μL, 
using several pairs of primers (PCR cycle conditions are available upon request). After 
purification, PCR products were sequenced on an automatic sequencer ABI PRISM 310 
Genetic Analyzer (PE Applied Biosystems, Foster City, CA, USA) with the amplification 
primers. Sequences were submitted to GenBank under the accession numbers 
KJ943791 and KJ943792 for the sequences from hares and KJ943793-KJ943797 for the 
sequences from rabbits. A Blast analysis of the sequences revealed 98 % identity of P95 
with strain AST89 (genogroup 1; accession number Z49271) and 97 % identity of P151 
with strain 00–08 (Iberian group 3 of genogroup 1 [10]; accession number AJ319594). 
The capsid sequences were aligned with publicly available sequences of Lagovirus 
(for simplicity, only part of the available sequences were used), namely RHDV 
genogroups 1–5 (G1-G5) [11], the antigenic variant RHDVa (G6), RHDV2, the weakly 
pathogenic MRCV, the non-pathogenic strain RCV-A1, and EBHSV (accession numbers 
of the sequences used are indicated in Figure 4.2). Furthermore, the alignment was 
screened for recombination as described elsewhere [12]. The phylogenetic relationships 
between the samples were estimated in MEGA6 [13], by using a Maximum Likelihood 
(ML) approach. The support of the nodes was assessed with a bootstrap resampling 
analysis (1000 replicates). The best-fit nucleotide substitution model defined by the same 
software (GTR + I + G) was used in the analysis. 
The inferred ML relationships were in agreement with those published, with 
EBHSV, RHDV2 and RHDVa forming well supported groups (bootstrap values of 1; 
Figure 4.2). Genogroups 1–5 cluster together, with G1, G2 and G3-G5 also forming well 
supported subgroups. The tree further shows the inclusion of P95 and P151 in the G1 
subgroup: P151 clusters with the rabbit samples collected in the same area (P129 and 
P141-P144), with the Portuguese strains CB137, CB156 and CB194, dating from 1995, 
1997 and 2006, respectively, and with the French strain 00–08 dating from 2000; P95 
appears to be more closely related to the older European strains belonging to G1, from 
Spain, France and Germany. The higher average nucleotide and amino acid identity of 
P95 and P151 is found with G1 (95.9 % - 96.6 % of nucleotide identity and 97.8 % - 98.4 
% of amino acid identity). Furthermore, P151 presents 99.8 % - 99.9 % of nucleotide 
identity and 100 % of amino acid identity with P141- P144. 
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Figure 4.2 Maximum Likelihood (ML) tree of the capsid gene VP60 for Lagovirus. Only bootstrap values ≥ 0.85 are 
shown. In order to facilitate visualization, major groups are collapsed, with the exception of the group containing the 
specimens analyzed in the study. The sequences retrieved from GenBank database for this analysis have the following 
accession numbers: KF494918, KF494921, KF494922, KF494924, KF494930, KF494932, KF494936, KF494943, 
KF494947, KF494950, KF494951, GU373618, EF558580, M67473, EU650679, EU003579, U49726, AF295785, U54983, 
FR823355, FJ212323, AF402614, EU003580, EF558579, JN851735, AF231353, DQ189078 (sequences from G2); 
AM085133, EF558576, EF558572, Y15424, EF558574, AJ535094, AJ535092, Y15426, X87607, FR823354, EF558577, 
EF558585, Y15441, EF558575, KC595270, AY928268, DQ189077 (sequences from G3-G5); AY523410, KF270630, 
AF258618, EU003582, DQ205345, DQ280493, AB300693, HM623309, EF558581, EU003578, EU003581, EF558583, 
EF558582, EF558584, JF412629 (RHDVa sequences); HE800529, FR819781, HE800532, HE800531, HE819400, 
HE800530, KC345612, JQ929052, KC345611 (RHDV2); Z32526, X98002, U09199, KC832838, KC832839, AM408588, 
AM933648, AM933649, AM933650, AM887765 (EBHSV sequences). RHDV sequences from Iberian hares appear in 
bold. 
 
In order to confirm the species identity of P95 and P151, one mitochondrial 
(cytochrome b) and three nuclear markers (CCR5, CXCR4 and CH2 domain of IGHG) 
were amplified for both samples. Total genomic DNA was extracted from the liver 
samples using the EasySpin Genomic DNA Minipreps Tissue Kit (Citomed, Lisbon, 
Portugal) according to the manufacturer’s instructions. The nuclear markers have been 
shown to present specific SNP for Oryctolagus and Lepus and their amplification 
followed the conditions described in [14-16]. The amplification of the mitochondrial 
marker was performed using the primers described in [17]. PCR was performed in a final 
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volume of 10 μL containing 1 μL of DNA, 3 pmol of each primer and 5 μL of Hot-StartTaq 
DNA Polymerase Multiplex PCR Master Mix (Qiagen) (PCR cycle conditions are 
available upon request). After purification, PCR products were sequenced with the 
amplification primers as described above. Sequences of P95 and P151 for all markers 
were deposited in GenBank under the accession numbers KJ943798-KJ943805. The 
obtained sequences were then visually inspected and aligned, and compared with 
publicly available sequences of lagomorphs. Genetic distances between P95 and P151 
and the other lagomorph sequences were calculated for each marker in MEGA6 [13], 
using the p-distance method and 500 replicates; all positions with less than 95 % site 
coverage were eliminated. Additionally, an ML approach was also used to confirm the 
phylogenetic position of P95 and P151 in the phylogeny of lagomorphs for each marker, 
using the best model estimated for each marker (Kimura2 + G for CCR5 and CXCR4; 
T92 for IGHG-CH2 and GTR + I + G for cytochrome b) and 500 replicates. The analysis 
of the genetic distances between P95 and P151 and other lagomorphs indicates that 
both specimens are closer to L. granatensis for all markers (genetic distance of 0.0 % 
for nuclear genes and 0.6 % for the mitochondrial gene; Table 4.1). Despite the lack of 
information for some markers, the overall highest genetic distance was observed for 
Ochotona spp: 8.4 % - 18 % for nuclear markers and 19.9 % - 20.3 % for cytochrome b. 
The phylogenetic analysis performed for each marker also supports the clustering of P95 
and P151 with L. granatensis (data not shown). 
 
3. Discussion 
Evolution of RHDV has been widely characterized, with strains grouping according 
to their year of isolation [10-12,18,19]. In France, strains are divided into six genogroups, 
G1-G6, and most genogroups have been successively replaced [11]. Interestingly, G1 
was able to persist only in the Iberian Peninsula (IP) [10] and, until 2011, it was the only 
genogroup found, most likely due to the Pyrenees acting as a major natural barrier that 
limits virus dispersal [10]. The antigenic variant RHDVa was also detected, but only in 
farms and never in wild populations [20]. From 2011, the new variant RHDV2 or RHDVb 
was detected and G1 seems to have been replaced [8,21,22]. Interestingly, RHDV2 was 
recently reported in Cape hares, L. c. mediterraneus [6], constituting the first evidence 
of cross infection in Lagovirus. Here we amplified and sequenced the complete capsid 
protein gene VP60 of a Lagovirus, confirmed to be RHDV, from Iberian hares found dead 
in the field in the 1990s in Portugal. 
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Table 4.1 Genetic distances of P95 and P151 relative to lagomorphs for nuclear markers CCR5, CXCR4 and IGHG-
CH2 and mitochondrial marker cytochrome b. 
 CCR5 CXCR4 IGHG-CH2 cytochrome b 
 
P95 P151 P95 P151 P95 P151 P95 P151 
Lepus granatensis 0.0 0.0 0.0 0.0 0.0 0.0 0.6* 0.6* 
Lepus europaeus 0.2 0.2 0.5 0.5 0.9 0.9 8.1* 8.1* 
Lepus timidus 0.2 0.2 - - 0.0 0.0 9.7* 9.7* 
Lepus americanus - - 0.4 0.4 0.9 0.9 9.8* 9.8* 
Lepus callotis 2.7 2.7 - - 1.1 1.1 9.1* 9.1* 
Lepus californicus - - 0.3 0.3 1.4 1.4 9.7* 9.7* 
Lepus townsendii 0.4 0.4 0.3 0.3 - - 9.4* 9.4* 
Lepus capensis - - - - 1.1 1.1 9.7* 9.7* 
Lepus saxatilis 0.0 0.0 0.3 0.3 1.1 1.1 9.8* 9.8* 
Lepus castroviejoi 0.4 0.4 0.4 0.4 0.9 0.9 10.9* 10.8* 
Sylvilagus brasiliensis 2.3 2.3 1.1 1.1 - - - - 
Sylvilagus floridanus 2.9 2.9 0.8 0.8 - - 15.9* 16.1* 
Bunolagus monticularis 5.1 5.1 1.0 1.0 - - 14.3* 14.5* 
Oryctolagus cuniculus 4.9* 4.9* 1.1* 1.1* 4.2* 4.2* 14.7* 14.9* 
Ochotona princeps 18.0 18.0 8.9 8.9 - - 19.9* 20.1* 
Ochotona dauurica - - 8.4 8.4 - - 20.2* 20.3* 
Only species with information for at least two markers are presented in the table. Values are given in percentages; “-“ 
means lack of information and “*” means average value (obtained by the mean of the genetic distances of three randomly 
selected sequences for that species). 
GenBank accession numbers: DQ146764, DQ146763, GU047870, GU047868, GU047869, GU047871, GU047867, 
GU047872, DQ017768, GU047865, AM051305, AM051298, DQ017767, GU047873 (CCR5); EU258270, EU258265, 
EU258269, EU258271, EU258266, EU258268, EU258267, EU258273, EU258272, EU258264, EU258287, EU258292, 
EU258304, EU258275, EU258274 (CXCR4); AJ295217, AJ295221, AJ295216, AJ431716, AJ295220, AJ295219, 
AJ295218, AJ295222, AJ431717, L29172, AY386696, AJ430862 (IGHG-CH2); AY942565, HQ596476, AF157465, 
AY745113, HQ596473, AJ421471, HM233015, AY599076, AB687529, KF781432, KF781431, KF781430, HQ596467, 
AF010159, HQ596468, KF781354, HQ596464, KF781357, HQ596485, JN037375, JN037374, HM233008, AY292732, 
EU729261, HQ596480, AF009731, AY292730, AY942569, JN037350, AY176235, AY292724, U58939, AF034257, 
AY292718, U58931, AY292717, HG810783, HG810780, EU591094, EU591077, EU590965, AF273000, JF911809, 
EF567059 (cytochrome b). 
 
The phylogenetic analysis of the complete capsid gene VP60 revealed that the 
sequences obtained from the two Iberian hare specimens group with RHDV genogroup 
1 (Figure 4.2). Since G1 was the only genogroup known to circulate in IP at the time of 
sample collection (1996 and 1998), this supports our finding of a cross-species infection 
of RHDV. Additionally, it appears that two different strains were able to infect hares: the 
sequences of P95 and P151 present 96 nucleotide differences that translate into 17 
amino acid differences in the VP60 (nucleotide genetic distance of 6 % and amino acid 
genetic distance of 2.8 %; data not shown). Moreover, the strains are located in different 
nodes of the phylogenetic tree: P151 clusters with a recent French strain and Portuguese 
strains, including RHDV strains sequenced from rabbits collected in the same location 
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that also experienced an RHDV outbreak, while P95 is basal to older Spanish, French 
and German G1 sequences. 
Species determination, achieved by the analysis of nuclear and mitochondrial 
markers, confirmed the hare specimens as being L. granatensis (Table 4.1), which is 
also consistent with the morphological characterization and species geographic range in 
Portugal [4] (Figure 4.1). Since all five living lagomorph taxa inhabiting the IP (L. 
granatensis, L. europaeus, L. castroviejoi and both subspecies of O. cuniculus – O. c. 
cuniculus and O. c. algirus) were represented in these analyses, further confidence is 
given to the species identification. 
L. europaeus is the main host of EBHSV, and L. timidus is affected only in regions 
where L. europaeus is also present [2]; no reports of EBHSV exist in L. granatensis 
despite the analysis of high numbers of animals (Gortázar C, personal communication). 
On the IP, L. europaeus is restricted to a region between the Ebro River and the 
Pyrenees, and a narrow contact zone exists between L. europaeus and L. granatensis 
[23] (Figure 4.1). Hence, despite some evidence of ancestral and ongoing hybridization 
between both species and with L. timidus [24], transmission of the virus between these 
species might be quite limited. In addition, and as for RHDV, the Pyrenees might also 
restrict EBHSV introduction on the IP. Thus, contact of Iberian hares is more likely to 
occur with RHDV than with EBHSV. 
Our results further show that the RHDV outbreak that occurred at the end of 1997 
in a rabbit population, as confirmed by the RHDV positive rabbit samples P141- P144, 
was the source of the Lagovirus that caused the fatal infection in P151. Indeed, P151 
was found dead in January-1998, only one month after those rabbits died. The high 
nucleotide and amino acid identity also confirmed this observation (99.8 % and 100 %, 
respectively). The possibility that the observed results were due to contamination was 
discarded given that RNA extraction, cDNA synthesis and PCR amplification of hare 
samples were performed independently from the rabbit samples. Also, none of the 
sequences obtained from hares was identical to previously amplified sequences in our 
facilities or any other sequences available in public databases. Thus, the susceptibility 
of Iberian hares (L. granatensis) to RHDV is confirmed by our results. Nevertheless, how 
RHDV is able to overcome species boundaries is unknown. 
At present, only glycans of the histo-blood group antigens family have been 
associated with rabbit susceptibility to RHDV [25]; however, preliminary data indicate 
that glycans are differently located in hare tissues (Le Pendu J, Abrantes J, Lopes AM, 
personal communication). Other factors could have promoted the cross infection. The 
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higher mutation capacity of RNA viruses might partially explain their ability to jump 
species boundaries [26]. Also, the closer the species are to the natural host, the more 
susceptible they are to the virus [27]. Despite this, the majority of virus transfers to new 
hosts do not cause severe outbreaks, but only single infections or limited outbreaks [26]. 
This seems to be the case in our study, where RHDV was able to infect the two hares 
analyzed, but not capable to cause easily detectable outbreaks. Additionally, viral 
recombination in unfavorable environments is associated with transmission to new hosts 
[26]. Although recombination is rare in RNA viruses, there are previous reports of 
recombination in RHDV [28,29]. Screening of our alignment showed no evidence of 
recombination; nevertheless, only a quarter of the total viral genome was investigated, 
so it is unclear if recombination contributed to the host switch. Nonetheless, on two 
occasions, classical RHDV spilled over into individual Iberian hares. While this is an 
interesting finding, it has not been reported in Iberian hares since then. Therefore, it is 
likely that these have been isolated “spillover” events in areas where the habitats of the 
two hosts overlap and host densities were high [30]. 
In sum, we report the identification of two different RHDV strains in L. granatensis 
that represent two independent infections, one in 1996 and the other in 1998. This finding 
of RHDV in Iberian hares represents the earliest evidence of a cross-species 
transmission of classical RHDV otherwise considered species-specific. 
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Leporids tissue binding and glycan specificities of the new 
RHDV variant and non-pathogenic related viruses 
 
A. M. Lopes, M. Lora, B. Le Moullac-Vaidye, O. E. Galanina, A. Breiman, T. Strive, S. Marchandeau, G. Le 
Gall-Reculé, N. V. Bovin, N. Ruvoën-Clouet, P. J. Esteves, J. Abrantes & J. Le Pendu 
 
1. Abstract 
The rabbit hemorrhagic disease virus (RHDV) and the European brown hare 
syndrome virus (EBHSV) are two lagoviruses from the family Caliciviridae that cause 
highly fatal diseases in two leporid genera, Oryctolagus and Lepus, respectively. In the 
last few years, several examples of host jumps of lagoviruses among leporids were 
described. The causes for these host shifts are unknown, but they are more likely among 
closely related species. Recombination is also frequently associated with the ability of 
viruses to establish in a new host and has been described for RHDV. Host jumps allow 
viruses to expand their host range and are far more common in single-stranded RNA 
viruses, which include RHDV and EBHSV. Understanding how and why viruses cross 
the species boundaries is important to predict future cases. Here, we studied the 
interaction between the pathogenic new RHDV variant and non-pathogenic lagoviruses 
from Europe and Australia with three lagomorph genera (Oryctolagus, Lepus and 
Sylvilagus). Binding of each virus to the upper respiratory and digestive tracts was similar 
to that observed for the classical RHDV. The glycans to which viruses attach to were 
compared and histo-blood group antigens (HBGAs) were the most common attachment 
factors, along with heparin. However, the binding pattern of each virus to HBGAs was 
variable and might be related with adaptation to host evolution.  
 
2. Introduction 
The high mutation rates, vast population sizes and short generation times make 
RNA viruses capable of rapidly adapt to a large number of hosts and thus prone to cross 
species boundaries [1]. Viruses are more likely to jump between closely related species 
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[2,3], which may result in unique spillover infections or severe epidemics, depending on 
how successfully the virus adapts to the new host population. Host switching constitutes 
an important mechanism on virus evolution [4,5] and is important in several families of 
viruses, including Caliciviridae. Caliciviruses comprise five recognized genera: 
Norovirus, Sapovirus, Vesivirus, Nebovirus and Lagovirus [6]. The genus Lagovirus 
encompasses two species: rabbit hemorrhagic disease virus (RHDV), highly fatal to the 
European rabbit (Oryctolagus cuniculus), and European brown hare syndrome virus 
(EBHSV), that affects European brown and mountain hares (Lepus europaeus and L. 
timidus, respectively). These two non-enveloped viruses have a single-stranded, 
positive-sense RNA genome [reviewed in 7]. 
Both RHDV and EBHSV emerged in the 1980s [8,9] and are similar in terms of 
morphology, genome organization and epidemiological course of the respective 
diseases, rabbit hemorrhagic disease (RHD) and European brown hare syndrome 
(EBHS) [10,11]. For EBHSV, only a single serotype is known [12] and no cases of non-
pathogenic forms of the virus circulating in hare populations are described. In contrast, 
several genogroups are recognized for RHDV [13], including the antigenic variant 
RHDVa [14], and several non-pathogenic and moderately pathogenic strains also 
circulate in rabbit populations from all over the world [15-18]. In 2010, a new pathogenic 
RHDV variant emerged and rapidly spread throughout Europe and Australia [19-26]. 
Virus attachment to the cells of the new host constitutes a crucial step for a species 
jump and will determine virus entry. Attachment factors include proteins, carbohydrates 
and lipids. Regarding caliciviruses, the most common ligands are carbohydrates: murine 
norovirus and feline caliciviruses use sialic acid [27,28], human norovirus recognizes 
heparan sulfate [29], histo-blood group antigens (HBGAs) are used by noroviruses and 
RHDV [30-33], and EBHSV is thought to bind to GlcNAc-terminated O-glycans (Lopes 
et al., unpublished results). 
In Europe, three genera of lagomorphs exist: Oryctolagus (rabbits), Lepus (hares) 
and Sylvilagus (cottontails), which recently diverged (~ 12 million years ago) [34]. 
Sylvilagus is a native American genus, but has been successively introduced in Europe 
in the 1960s and 1970s [35]. In Italy, it has adapted to the new environment and may 
have caused a decline in hare populations [36]. Six hare species are dispersed 
throughout Europe, with L. granatensis and L. castroviejoi in the Iberian Peninsula, L. 
timidus in the northern Europe, L. capensis in Sardinia, L. corsicanus in several regions 
of Italy, and L. europaeus widespread in central Europe [37]. Oryctolagus cuniculus is 
distributed all over Europe and may occur in sympatry with hares and cottontails. 
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RHDV and EBHSV experimental cross-infections in hares and rabbits have been 
attempted, but results were quite disparate with some studies failing to induce disease 
[e.g. 38,39,40], while others reported successful cross-infection [41,42]. Additionally, 
cottontail challenges with EBHSV resulted in infection and death of one animal [43]. More 
recently, several cases of cross-species infection occurring in natural conditions were 
reported: Iberian hare (L. granatensis) with RHDV infection [44]; eastern cottontail 
(Sylvilagus floridanus) susceptible to EBHSV [45]; and L. capensis and L. corsicanus 
were found to be fatally susceptible to the new RHDV variant [46,47] (see Table 4.2 for 
a summary of the available information). 
 
Table 4.2 Reported cases of cross-transmission in lagomorph species inhabiting Europe. Only pathogenic viruses 
are considered. 
 
RHDV RHDV2 EBHSV 
O. cuniculus Natural host [8] Natural host [19] No reports 
L. europaeus No reports Field evidence* Natural host [9] 
L. timidus No reports No reports Natural host [9] 
L. granatensis Field evidence [44] No reports No reports 
L. corsicanus No reports Field evidence [46] Field evidence [48] 
L. capensis No reports Field evidence [47] No reports 
L. castroviejoi No reports No reports No reports 
S. floridanus No reports No reports 
Field and experimental 
evidence [43,45] 
* Le Gall-Reculé et al., data not published 
 
Two hypotheses for the emergence of pathogenicity in lagoviruses are currently 
accepted. The first refers to the emergence of virulence from non-pathogenic circulating 
viruses that, by reasons not directly related with the host, acquired pathogenicity. This 
hypothesis is supported by the detection of antibodies against RHDV and EBHSV in 
samples collected before virus emergence [e.g. 49,50,51] and by the characterization of 
non-pathogenic forms of the rabbit caliciviruses [e.g. 15-17,18,52]. The other hypothesis 
involves a species jump, most likely from Sylvilagus [53], where viruses would circulate 
as benign forms. This is consistent with the dates of introduction of Sylvilagus floridanus 
in Europe and subsequent emergence of RHD and EBHS [8,9,54,55].  
We investigated the ability of the new RHDV variant and non-pathogenic 
lagoviruses from Europe and Australia to bind to leporids other than their natural hosts 
and the required host attachment factors to start infection. The close phylogenetic 
relationship of these leporids [34], together with an overlapping distribution [37] and an 
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overall conservation of glycans among vertebrates, prompted us to consider them as 
good models to test the cross-species hypothesis. 
 
3. Methods 
Sample collection 
Scrapings of rabbit duodenum were prepared from wild rabbits killed by hunters in 
the French Pyrenees and previously phenotyped for HBGAs [30]. Tissue samples of four 
L. europaeus and three L. granatensis were collected as part of a previous study (Lopes 
et al., unpublished results); tissue samples of O. cuniculus were obtained from 12 
laboratory animals and eight wild animals from France, and six S. floridanus samples 
were collected in a farm in southern France. Duodenum and trachea samples were either 
collected in 10 % buffered formalin for immunohistochemistry studies or in RNA later for 
ELISA. Tissue sections and scrapings were prepared as described in [30] and HBGAs 
phenotyped accordingly. 
Virus samples were obtained from liver homogenates (10 % (w/v) in phosphate 
buffered saline, PBS) of dead animals. 
 
Preparation of VLPs 
Virus-like particles (VLPs) were constructed for the European non-pathogenic 
caliciviruses strains 06-11 [17] and RCV-E1 (Le Gall-Reculé, unpublished observations) 
and for the new RHDV variant strain 10-28 [20]. VLPs were generated according to [56]. 
The Australian rabbit calicivirus (strain RCV-A1) VLP was previously prepared for 
another study [57]. Briefly, the complete capsid protein gene sequence was determined 
by PCR and sequenced for each strain; recombinant baculoviruses expressing the VLPs 
were generated and Sf9 cells infected. Cellular debris and baculovirus were removed by 
centrifugation (10,000 rpm, 30 minutes) and freeze-thawing cycles released VLPs from 
the cells. The supernatant was once again centrifuged at 27,000 rpm for 3h and pellets 
were resuspended in 200 µL of PBS. A caesium chloride solution (0.4 g/mL) was added 
to the preparation and ultracentrifuged for 18h at 36,000 rpm. VLPs’ fraction was 
collected by puncture and dialyzed against PBS. Caesium chloride was eliminated 
through serial washes in Vivaspin columns 30000 MWCO PES. The integrity and quality 
of the VLPs was checked by Coomassie blue staining of SDS-page gels and Western 
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blot. Protein amounts were quantified using a Nanodrop 2000 apparatus (Thermo 
Scientific). 
 
Production of hyperimmune antiserum 
A hyperimmune serum that recognizes the new RHDV variant and the rabbit 
caliciviruses 06-11 and RCV-E1 was produced. For this, two rats were serially inoculated 
with the 10-28 VLP. A monoclonal antibody (MAb 11F12) that recognizes the Australian 
rabbit calicivirus RCV-A1 was previously prepared [57]. Rat inoculation was performed 
at the animal experimentation core facility of the University of Nantes and was approved 
by the national ethic review board from the French Ministry of Enseignement Supérieur 
et de la Recherche (project license number 01322.01). Animal care and use protocol 
adhered to the European Directive number 2010/063 and to the national French 
regulation (Décret no. 2013-118 du 1er février relatif à la protection des animaux utilisés 
à des fins scientifiques). The antibody generated was tested by ELISA for the recognition 
of target VLPs. 
 
Immunohistochemistry and ELISA virus binding assays 
Tissue sections of O. cuniculus, L. granatensis, L. europaeus and S. floridanus 
were deparaffinized with LMR-SOL baths and rehydrated with successive ethanol baths. 
Hydrogen peroxide 0.3 % (v/v) in phosphate buffered saline (PBS) was added to the 
slides to block endogenous peroxidase activity, followed by bovine serum albumin (BSA) 
3 % (w/v) in PBS to block non-specific binding. VLPs at 10 µg/mL were incubated with 
the tissue sections at 4 ºC overnight. Monoclonal antibodies or hyperimmune sera (see 
Table 4.3) were then incubated with the tissue sections for one hour at 37 ºC, followed 
by a biotinylated or HRP-conjugated secondary antibody for one hour at 37 ºC. For those 
tissues incubated with the biotinylated antibody, a last incubation with HRP-conjugated 
avidin D was performed, for one hour at room temperature. In between incubations, 
slides were washed three times with PBS for 5 min. Substrate (AEC kit) was added to 
the slides and Mayer’s hematoxylin was used for contrast staining. 
Tissue scrapings of O. cuniculus, S. floridanus, L. europaeus and L. granatensis 
were coated in Nunc Maxisorp plates in 2-fold dilutions, starting at 10-2. Sodium 
carbonate buffer, pH 9.5, at 100 mM was used as coating buffer and samples were 
incubated overnight at 4 ºC. Blocking of the plates with 5 % non-fat dry milk diluted in 
distilled water or PBS was followed by the VLPs at 8 or 12 µg/mL. Monoclonal antibodies 
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or hyperimmune antisera used for each virus are indicated in Table 4.3. TMB substrate 
was used to reveal and 1 M phosphoric acid stopped the reaction. Optical density (O.D.) 
was measured at 450 nm. All incubations were at 37 ºC in humid atmosphere; samples 
and antibodies were diluted in PBS or distilled water according to the solvent of the 
blocking solution; plates were washed three times with 0.05 % Tween 20 in PBS after 
each incubation. 
 
Table 4.3 Antibodies and conditions used for IHC and ELISA binding of viruses to Oryctolagus, Sylvilagus and 
Lepus. 
VLP Primary antibody Secondary antibody 
10-28 α10-28 α-rat HRP* 
06-11 α10-28 / SD4 α-rat HRP* 
RCV-E1 α10-28 α-rat HRP‡ 
RCV-A1 11F12 α-mouse HRP# 
*A biotinylated secondary antibody was used and avidin D-HRP was added in IHC for Lepus binding. 
‡A biotinylated secondary antibody was used and avidin D-HRP was added in IHC for Sylvilagus and Lepus binding. 
#A biotinylated secondary antibody was used and avidin D-HRP was added in IHC for all genera. 
 
 
ABH phenotype-dependent binding  
The attachment ability of each virus for animals with different ABH phenotypes 
(A+B+, A+B- and A-B-) was tested by ELISA; rabbit samples representative of each 
phenotype were used to this end. Three to five samples of each phenotype were selected 
and the binding of each virus tested. ELISA protocol was performed as for the virus 
binding to the tissues referred above. 
 
Printed glycan arrays (PGAs) 
Printed glycan array slides were manufactured and profiled as described in [58]. 
Briefly, six replicates of 360 monomeric glycans (50 µM) as ω-aminopropyl glycosides of 
95-98 % purity were diluted in 300 mM PBS/0.005 % Tween 20 (pH 8.5) and printed by 
robotic pin deposition on N-hydroxysuccinimide activated glass slides. Free N-
hydroxysuccinimide activated groups were blocked with 50 mM ethanolamine in 50 mM 
borate buffer at a final pH of 9.2. Slides were then rinsed with deionized water, dried and 
stored at room temperature in a dessicator. Each VLP was incubated on the slides 
diluted PBS-Tween BSA (0.1 % (v/v) Tween 20 and 3 % (w/v) BSA) and incubated in 
humid chamber for 2h at 37 ºC with gentle shaking. Monoclonal antibodies or 
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hyperimmune sera also diluted in PBS-Tween BSA (see Table 4.3) were incubated at 
room temperature for 45 minutes. A final incubation with Cy5-labeled secondary 
antibodies diluted in PBS-Tween (0.1 % (v/v) Tween 20) was performed at room 
temperature for 30 minutes. In between incubations, slides were washed with a series of 
0.1 % and 0.001 % Tween 20 in PBS. Fluorescence signals were measured with an 
Agilent scanner G2565CA and analyzed using ImaGene analysis software version 7.5 
(BioDiscovery, El Segundo, USA). 
 
Virus binding to synthetic sugars 
The binding of each virus to selected synthetic sugars, based on the classical 
RHDV binding patterns [30,31], was evaluated. A panel of PAA-conjugated sugars were 
coated at 10 µg/mL and incubated overnight at 4 ºC. The plate was blocked with 5 % 
non-fat milk/H2O for one hour at 37 ºC and then incubated with the VLPs at 10 µg/mL. 
The specific antibodies for each virus, as indicated in Table 4.3, were then used as 
detailed above, as well as the remaining ELISA conditions. 
 
4. Results and Discussion 
RNA viruses are prone to cross the species boundaries, probably due to their high 
mutation rates, short generation times and large population sizes that enable them to 
quickly adapt to new hosts [1,59]. In addition, analysis of past host shifts accentuates 
single-stranded RNA viruses as being often involved in species jumps [60-62]. 
Phylogenetically related species are more likely to experience species jumps as they 
have more similarity in the cell types, receptors and other cell components key to the 
viral replication [2,5,63,64]. Recombination is also likely to influence the epidemiology of 
species jumps by allowing different genome combinations to be “tested” in the new host 
[65]. While in most cases it is not possible to directly relate recombination with host 
jumps, several examples are found [e.g. 66,67,68]. 
Caliciviruses are good models to study species jumps. Indeed, caliciviruses are 
single-stranded RNA viruses, recombination was detected in members of all genera of 
this family [69-77], and several indications of the possibility of host jumps have recently 
been described [78,79]. For Lagovirus, spillover infections have been reported, including 
the classical RHDV in L. granatensis [44], the new RHDV variant in L. corsicanus and L. 
capensis [46,47], and EBHSV in S. floridanus [43,45]. 
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Figure 4.3 Binding to leporids’ trachea (a) and duodenum (b) of lagoviruses. All viruses bind to the epithelial layer 
of trachea (a) and to the Lieberkühn crypts (b). Controls performed in the absence of VLPs presented no red/brown 
staining (not shown). 10-28: new RHDV variant; 06-11 and RCV-E1: European non-pathogenic caliciviruses; RCV-A1: 
Australian non-pathogenic calicivirus. 
 
(a) 
(b) 
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Our immunohistochemistry results showed that, similar to the classical RHDV, the 
viruses tested were able to bind to the epithelial cells of both the upper respiratory and 
the digestive tract of all the analyzed genera, and no obvious differential binding was 
observed (Fig. 4.3a and 4.3b). These results suggest that all leporids present appropriate 
attachment factors on their epithelial cells that might allow lagoviruses to initiate infection 
even in non-natural hosts. When comparing the attachment ability of these viruses to 
animals of different ABH phenotypes, variations in attachment preferences were 
observed. Indeed, the non-pathogenic 06-11, RCV-E1 and RCV-A1 showed an ABH-
phenotype dependent binding to rabbit tissues similar to that previously observed for 
some classical strains [30], with a rank of preferences from the A+B+ phenotype to A+B- 
and to A-B- (Fig. 4.4). 
 
 
Figure 4.4 ABH phenotype-dependent binding of the new RHDV variant (10-28) and the non-pathogenic strains 
(06-11, RCV-E1 and RCV-A1). Circles, squares and triangles represent the normalized OD value for rabbit individuals 
with the ABH phenotype identified on the x axis. Horizontal bars indicate median values for each group. 
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These results show that both (classical) pathogenic and non-pathogenic forms 
present the same binding preference for the B antigen, indicating that binding to this 
motif is not involved in virulence [30]. Interestingly, in hares, the B antigen is absent 
(Lopes et al., unpublished results), which likely led EBHSV to find an alternative 
attachment factor. Preliminary results showed that EBHSV preferentially uses N-terminal 
GlcNAc residues and heparin instead of HBGAs as attachment factors (Lopes et al., 
unpublished results). The new RHDV variant also showed no ABH phenotype preference 
(Fig. 4.4), which might suggest the use of alternative glycans, or a lesser dependence 
on the B blood group antigen. These alternative glycans probably facilitated the infection 
of new hosts. Indeed, hare species have been shown to be infected with the new RHDV 
variant [46,47], and maintenance of the B antigen as main attachment factor would have 
compromised the ability of the new variant to infect these species. 
 
 
Figure 4.5 Variation in attachment preferences of these viruses. (a) Printed glycan arrays results for the HBGA related 
glycans and for heparin. The structures corresponding to A type 2, B type 2, H type 2 and Ley are shown on the right, 
with blue squares representing N-acetylglucosamine, yellow circles representing galactose, red triangles representing 
fucose and yellow square representing N-acetylgalactosamine. (b) Binding of VLPs from the new RHDV variant (10-28) 
and the two non-pathogenic strains (06-11 and RCV-E1) to the HBGAs oligosaccharides conjugated to polyacrylamide 
by ELISA. In these conditions no binding was observed for the RCV-A1 strain (not shown). C- shows OD values obtained 
in the absence of polyacrylamide conjugate. 
 
 
 
(a) 
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Figure 4.5 (cont.) 
 
 
In order to improve our understanding of the viruses glycan-binding properties, 
printed glycan arrays were used. These arrays allow to assay simultaneously a large 
number of glycan structures. The main finding is that all lagoviruses, but EBHSV (Lopes 
et al., unpublished results), bind to histo-blood group antigens (HBGAs) with all the 
analyzed rabbit lagoviruses binding to B type 2 (Fig. 4.5a), which was established as the 
top binder for classical RHDV [30,31]. Binding to either A type 2 and H type 2 was also 
observed but was lower than to B type 2 for the non-pathogenic strains RCV-E1 and 
RCV-A1, consistent with their preferential recognition of A+B+ rabbits over A+B- rabbits 
and their very low binding to tissue extracts of A-B- animals that only possess the H type 
2 epitope [30]. Strong binding of the new pathogenic variant strain (10-28) to either B 
type 2, A type 2 and H type 2 explains the lack of preference for animals of a particular 
ABH phenotype. Indeed, A+B+ animals strongly express both the A and B type 2 epitopes 
that are well recognized and only small amounts of H type 2 which is masked by the A 
and B epitopes. Animals of the A+B- phenotype express strong amounts of the A type 2 
epitope, but no B type 2 and only small amounts of H type 2, whilst the A-B- animals 
express only H type 2 albeit in large amounts since it is not masked by the presence of 
the A and B epitopes. Thus, the broad specificity of the new variant for A, B and H type 
2 explains its broad recognition of rabbits regardless of ABH phenotypes. 
(b) 
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For the 06-11 non-pathogenic strain, an apparent discrepancy between the printed 
glycan array data and the ELISA data on rabbit duodenal scrappings was observed since 
that strain showed a clear preference for animals of the A+B+ > A+B- > A-B- phenotypes, 
whilst no preference for the B type 2 epitope over either the A type 2 or the H type 2 
epitopes was noticed. This might be explained by the array reading that was mistakenly 
performed at saturation so that no quantitative difference could be made between the 
positive glycan structures. To check for that possibility and to confirm results obtained 
for the other strains, the A, B and H type 2 oligosaccharides conjugated to 
polyacrylamide (PAA-conjugates) were immobilized on plates and VLPs binding was 
assessed by ELISA (Fig. 4.5b). This confirmed that the new pathogenic variant 
recognized the three motifs A type 2, B type 2 and H type 2, whilst the RCV-E1 non-
pathogenic strain showed a clear preference for B type 2 over A type 2 and lacked 
recognition of H type 2. As to the 06-11 strain, it showed binding to B type 2-PAA 
exclusively. No binding to A type 2 was detected in these conditions, indicating that its 
recognition on the printed glycan array reflected a weak binding detected due to the very 
high sensitivity of the system. Overall these data showed a remarkable consistency 
between recognition of synthetic HBGA motifs and binding to subgroups of rabbits 
defined by their expression of ABH epitopes. 
In addition to HBGAs, the printed glycan arrays revealed strong binding of all VLPs 
to heparin which represents a distinct type of glycan (Fig. 4.5a). It also revealed binding 
to several other sulfated glycan motifs (data not shown). Interestingly, all known 
lagoviruses, including EBHSV and the classical RHDV (data not shown), bind to heparin. 
Heparin is a highly sulfated glycosaminoglycan chemically related to heparan sulfate, a 
glycan ubiquitously expressed in virtually all cell types and used by many viruses to 
attach to host cells, including other caliciviruses [29,80-84]. In addition, the other glycans 
used by EBHSV as attachment factors are remarkably different from the other 
lagoviruses (Lopes et al., unpublished results). This might relate to the fact that EBHSV 
was never reported in the European rabbit. The comparison of the binding of each strain 
with HBGA-related and non HBGA-related glycans revealed different patterns. While the 
European non-pathogenic strains (06-11 and RCV-E1) have a preference for HBGA-
related glycans, the Australian non-pathogenic strain presents a preference for glycans 
non-HBGA related as can be seen from the very high binding to heparin relative to B 
type 2 (Fig. 4.5a) and the lack of binding to HBGA as PAA-conjugates (data not shown). 
Both pathogenic and non-pathogenic strains were able to recognize and bind to 
attachment factors present in the different leporids studied, including Sylvilagus (Fig. 
4.3). This suggests that all leporids are susceptible to both pathogenic and non-
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pathogenic strains, at least at the very first step of the virus life cycle, since the 
attachment factors seem to be shared between species, which might facilitate cross-
infection. However, some glycan preferences were observed indicating somewhat 
different binding requirements for the different lagoviruses which could explain the lack 
of reports of some cross-species infections (e.g. RHDV in Sylvilagus). Furthermore, 
when adapting to a novel host, virus fitness on the original host might be reduced [4]. 
This might explain why Sylvilagus is experimentally susceptible to EBHSV and not to 
RHDV [45] although no apparent barriers exist in the eastern cottontail that impair RHDV 
binding, since it is capable of attaching to the epithelial cells of Sylvilagus. Thus, factors 
other than the attachment might account for the lack of success of RHDV in Sylvilagus. 
The new RHDV variant has been remarkably successful in infecting species other 
than the natural host, since it was able to infect several Lepus species: L. capensis [47], 
L. corsicanus [46] and L. europaeus (Le Gall-Reculé et al., unpublished results). This is 
consistent with its broad HBGA specificity. HBGA expression of Sylvilagus is similar to 
that of Oryctolagus, and although hares do not express the B type 2 epitope, which is 
the best ligand for the classical RHDV and the non-pathogenic strains, the ability of the 
new variant to strongly recognize A type 2 and H type 2 that are expressed by hares 
might contribute to the reported cross-infection events with that strain. Alternatively, the 
new RHDV variant might have acquired the ability to bind to several attachment factors, 
including non-HBGA related glycans. Whether recombination had a role in crossing the 
species barrier remains to be determined, but the high rate of recombination [77] and the 
maintenance of recombinant and non-recombinant forms in wild rabbit populations 
suggest some adaptive advantage. Interestingly, all these reports of species jumps 
occurred in areas where these Lepus species live in sympatry with O. cuniculus. This 
might explain the absence of reports of the new RHDV variant on L. timidus as this 
species’ distribution only slightly overlaps O. cuniculus distribution. However, no cases 
of the new RHDV variant have been reported in Iberian Lepus species (L. granatensis 
and L. castroviejoi) despite an overlapping distribution with O. cuniculus. The case of L. 
granatensis is particularly interesting, since there is a report of two hares that died from 
RHD caused by an infection with classical RHDV [44], but no widespread infection was 
detected, suggesting this was a dead-end spillover infection. In addition, hundreds of 
Iberian hares were tested for EBHSV and no cases were detected (C. Gortázar, personal 
communication). This is likely because L. europaeus and L. granatensis have only a 
narrow contact zone near the Pyrenees hindering transmission of EBHSV [37]. 
Whether Lagovirus attachment factors are determinant for successful species jump 
is unknown, but it is clear that they play a role in RHDV infection [30,85,86]. Our results 
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show that the leporids studied have, at least at the first step of the virus life cycle in the 
host, the attachment factors required for both pathogenic and non-pathogenic strains to 
initiate infection. However, lagoviruses species jumps seem to be limited by other factors 
that might include overlapping distribution, viral loads and population density, but also 
the existence of appropriate receptors or the existence of species-specific anti-viral 
factors. For example, a novel mechanism of RHDV resistance involving the 
neofunctionalization of Sec1 was suggested [85]. Interestingly, Sec1 is a pseudogene in 
several mammals but in leporids is involved in an extensive gene conversion with Fut1 
and Fut2 [85,87]. 
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1. General discussion 
 
The new RHDV variant in Iberian Peninsula: major consequences and 
implications at the molecular level 
A major goal of this dissertation was to contribute to the characterization of the new 
RHDV variant, tentatively named RHDV2 or RHDVb. After its emergence in France in 
2010 [1], the new variant spread to Spain, Italy, Germany, United Kingdom and, more 
recently, to Australia [2-6]. In Portugal, RHDV2 is present in wild rabbit populations since 
2012, and occurs all over the country, with special incidence in the south, where wild 
rabbits are abundant. Both Oryctolagus cuniculus cuniculus and O. c. algirus populations 
are affected. Prior to 2012, only G1 was circulating in Iberian wild rabbit populations [7-
10] and a few cases of G6 were detected in rabbitries [9,11]. 
A scenario of replacement of G1 by RHDV2 in Portugal was observed, since G1 
was no longer detected after the emergence of RHDV2 [7-10,12,13]. The high dispersal 
ability of RHDV2 [14] and the replacement of G1 suggest a selective advantage of the 
new variant. The replacement of older strains by RHDV2 was also described in other 
countries [2,14,15]. This phenomenon of replacement of older strains by new strains that 
present a selective advantage is described for several viruses [16,17], including human 
norovirus [18]. These strains are usually antigenically different and escape the host herd 
immunity, a scenario that might be compatible with the one observed for RHDV2. The 
replacement of strains has also been previously described for RHDVa [19,20] and for 
classical RHDV in France [21].  
Whether the emergence of RHDV2 had an impact on the host immune system and 
its repertoire, as a result of the co-evolution between host and pathogen, is uncertain at 
the moment. However, in light of the Red Queen hypothesis, it is expected that the high 
virulence of RHDV2 will increase selection for resistant hosts. Thus, in a few years, 
resistant/surviving rabbits will start to appear and increase in frequency and the cyclical 
process of adaptive genetic change will proceed [22]. This is consistent with the 
increased selective pressure of RHDV after the first epidemic [7]. However, even in the 
presence of strong selective pressures, several generations will likely be needed to 
detect the molecular signatures of the genetic conflict in the host. This asymmetry in the 
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arms race results from the longer generation times of the host compared to the pathogen, 
along with the lower evolution rates and smaller population sizes [23]. 
 
Recombination and its role in the emergence of virulence in the new 
RHDV variant 
In this last five years, several authors have worked on the description of the new 
variant, including on the associated pathology and the characterization of the virus [e.g. 
2,24,25]. One of the most striking findings of this thesis was the report of several 
recombination events in RHDV2 genomes from the Iberian Peninsula. Recombination is 
associated with the emergence and increases in virulence of several viruses [26-31]. 
Why recombination occurred in the new RHDV variant is difficult to assess, but it 
might be linked to its emergence. Molecular evidence suggest that the RHDV strain from 
the first highly lethal outbreak in China in 1984 [32] is the product of a recombination 
event [33]. Nevertheless, not all pathogenic forms are directly descendants of this first 
strain [34] and recombination is not widespread in all RHDV lineages [35], although this 
might be due to non-systematic sampling or the lack of full genome sequences for older 
strains. Other recombination events scattered throughout the genome were detected for 
the classical RHDV [36,37].  
Recombination might also be at the origin of RHDV2. The factors underlying 
pathogenicity and virulence of RHDV2 are not clear, but mutations in the non-structural 
protein p16 were recently associated with virulence of RHDV [38]. However, inferring the 
origin of RNA viruses is extremely difficult [39]. Recombination may have assisted the 
spread of RHDV2 by helping the virus to acquire mutations more rapidly than mutation 
alone [40]. Moreover, if we consider that recombination played a role in the origin of 
RHDV2, leaving the door open for the possibility of other European strains actually being 
recombinants, the increased virulence of RHDV2 and its high capacity of host jump (that 
will be analyzed in more detail further on) might be related to recombination [reviewed in 
41,42]. 
The specific pattern of recombination with a consistent recombination breakpoint 
between non-structural and structural proteins is likely to produce viable recombinants 
[43] and was reported for other caliciviruses [44], but never for lagoviruses. Nonetheless, 
when recombining strains are very similar, these events remain undetected [45]. Thus, 
recombination might have occurred frequently in the past history of RHDV, but the lack 
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of full-genome sequences and the similarity between strains impaired its detection. 
Furthermore, the homologous recombination occurring in RHDV2 implies that co-
circulation of the strains that gave rise to the recombinants must have occurred, i.e., co-
circulation of G1 and RHDV2 and co-circulation of a non-pathogenic strain and RHDV2. 
The former event was detected only once in a Spanish farm [14] whilst the later was 
undetectable since non-pathogenic strains have not yet been described in the Iberian 
Peninsula. 
 
The new RHDV variant in the islands and its impact in wild rabbit 
populations 
Outbreaks caused by RHDV2 were also reported in wild and domestic rabbits of 
the Portuguese archipelago of Azores [46-48]. Rabbits were introduced in Azores by 
Portuguese settlers in the 15th century [49] and belong to the subspecies O. c. algirus. 
RHD occurs in these islands since the late 1980s, but until recently little was known on 
which RHDV strains were circulating in the archipelago. The genomic analysis revealed 
the presence of G3-G5 like strains, with more than 17 years of independent evolution 
[9,50]. After the arrival of RHDV2, no more cases of G3-G5 like strains were observed.  
The origin of Azorean RHDV2 strains is likely the Iberian Peninsula, since the 
genomic characterization revealed that all Azorean strains are G1/RHDV2 recombinants. 
Indeed, G1 only persisted in Iberian Peninsula [7-10] and, more importantly, G1/RHDV2 
recombinants were described in Portugal in the beginning of 2014. In the archipelago, 
the first cases of RHDV2 date back to November 2014, and in a few months RHDV2 was 
present in eight out of the nine islands (no wild rabbits being present on the last island, 
Corvo). In contrast, the arrival of the G3-G5 like may have had an origin outside of Iberian 
Peninsula, given the characteristics of the strains that circulated in Azores and the 
absence of reports of such strains in the Iberian Peninsula. 
The remarkable spread of RHDV2 was certainly helped by anthropogenic factors, 
in at least two different moments: (i) in the introduction of RHDV2 in Azores itself, since 
the archipelago is geographically isolated (~ 1500 km apart from mainland Portugal) and 
thus translocation of rabbits for hunting purposes or contaminated clothes, for example, 
are the most likely sources of the virus; and (ii) in the dispersal between islands, since 
transmission by vectors such as insects and birds is not compatible with the dispersal 
routes, and with the Azorean fauna [51]. Moreover, rabbits from Flores had never been 
in contact with the disease, indicating that RHDV did not arrive to that island by natural 
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vector transmission (P. J. Esteves, personal communication). Surprisingly, the RHDV2 
strain that arrived to Australia in May 2015 is a G1/RHDV2 recombinant, and the analysis 
of the genome indicates that it likely originated in southern Europe [6]. At the moment, 
this seems to be the most widespread of the described RHDV2 recombinant forms. 
The new RHDV variant seems to have changed the epidemiology of RHD. The 
devastating effects on wild rabbit populations from Azores determined the prohibition of 
hunting in all islands in March 2015. In the Iberian Peninsula, the new RHDV variant has 
also been decimating wild rabbit populations [52], probably not as dramatically as the 
first RHDV outbreaks due to the partial cross-protection between RHDV and RHDV2 [2]. 
In a cascade effect, endangered predators highly dependent on wild rabbits, such as the 
Iberian lynx (Lynx pardinus), had also been affected [52]. In Portugal, control programs 
were implemented to monitor the status of wild rabbit populations. Unfortunately, 
vaccination is unfeasible and ineffective in wild rabbits [53]. Regarding domestic rabbits, 
a new vaccine has already been implemented in France and Spain to control outbreaks 
in farms [54]. However, as rabbit kittens are also affected by the new variant, a revision 
of the vaccination protocol should be performed to ensure more adequate vaccination 
programs. 
 
Insights into the evolution of EBHSV 
Our first approach of sequencing the whole genome of EBHSV samples from the 
first outbreaks in the area of original diagnosis, Sweden, intended to provide information 
for a deeper virus characterization. Comparing to RHDV, the number of full-genome 
sequences publicly available is remarkably lower (ca 100 for RHDV vs. three for EBHSV; 
data accessed in January 2016). Nonetheless, we confirmed that EBHSV and RHDV 
genomes have a similar structural organization, as previously reported by other authors 
[55,56]. 
The availability and analysis of whole genome sequences of viruses might shed 
light on fundamental aspects of their biology, but might also benefit vaccine design and 
vaccination strategies by giving further insights into transmission traits, viral evolution 
and its association with pathogenesis [57,58]. In light of the recent findings for RHDV, 
the importance of analyzing full-genome sequences instead of partial portions of the 
genome is confirmed by (i) the occurrence of recombination outside of the RHDV VP60 
[13,33] and (ii) the association of mutations in the non-structural protein p16 and higher 
virulent RHDV strains from Australia [38]. 
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The characterization of the molecular evolution and antigenic variation of EBHSV 
further provided insights into the characterization of this virus. The use of sequences 
from the area of original diagnosis was a significant step in understanding EBHSV 
molecular evolution. The sequencing of EBHSV samples from European brown hares 
(L. europaeus) and mountain hares (L. timidus) also supported that occurrence of EBHS 
in mountain hares is only residual [59] and no significant differences exist in the genome 
of strains circulating in these species. European brown hares and mountain hares occur 
in different habitats, with the former living predominantly in agricultural fields and the 
latter inhabiting forests. Therefore, contact between them is limited to the margins of 
forest areas, which reduces the likelihood of occurrence of EBHS outbreaks in mountain 
hares [59]. 
No recombination events were yet detected for EBHSV that might have assisted 
the origin of pathogenicity, contrarily to what happens for RHDV [33,36,37]. However, 
our study focused only in sequences of the capsid protein VP60 and not in full-genome 
sequences. We further attempted to estimate for the first time the nucleotide substitution 
rate and the tMRCA of EBHSV, setting EBHSV emergence in the 1970s. Our results 
were in line with a recent estimation for RHDV, which proposes dates coincident with 
emergence only a few years before the first description in China in 1984 [32,60]. 
Inclusion of more EBHSV sequences from other European countries would certainly 
improve our estimation, since Eden and co-workers [60] showed that these estimations 
are sample-dependent and small changes in sample composition have an important 
impact on the final results. 
Regarding the antigenic characterization of EBHSV strains, a scenario of arms 
race between host and pathogen can be hypothesized based on the results obtained. 
The replacement of Lineage A by Lineage B was likely accompanied by an increased 
fitness of the latter. Amino acid substitutions in previously recognized EBHSV epitopes 
occurred as a result of host immune response and consequent selection pressure from 
the host, leading to a response of immune evasion from the pathogen by epitope 
modification. This scenario is further supported by the existence of sites in the exposed 
regions of EBHSV capsid protein that are hypothetically under positive selection. Indeed, 
these sites might be involved in the arms race between host and pathogen. A similar 
finding was observed in the RHDV capsid protein [61,62]. 
The hypothetical positively selected sites identified in our study are located in 
exposed regions of the capsid, mostly in the P2 subdomain. For RHDV, variation in the 
amino acids of the P2 subdomain relates to HBGAs binding specificity [63]. Thus, the 
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variability in amino acids of the EBHSV capsid, likely under positive selection pressure, 
might influence receptor binding. An effective binding to host cells is crucial for virus entry 
and replication, and usually viruses achieve this by using cell surface molecules as 
attachment factors. Previous works disclosed that HBGAs A, B and H type 2 are 
attachment factors for RHDV [64,65], and fucosylated glycans were associated with 
RHDV infection [66]. Therefore, given the similarities between these two viruses, we 
attempted to characterize the glycans used by EBHSV to have a foothold on host cells. 
EBHSV seems to bind to terminal N-acetylglucosamine (GlcNAc) residues and to 
heparin, which is a glycan related to heparan sulfate. The absence of a specific relation 
between ABH phenotype and EBHSV binding set EBHSV apart from RHDV in terms of 
host binding. Terminal GlcNAc residues were shown to be important for the attachment 
of other viruses [67,68], and heparan sulfate is used by many viruses, including members 
of the Caliciviridae family [e.g. 69,70-72]. Terminal GlcNAc residues are present in the 
duodenum of rabbits [64] whilst heparan sulfate distribution on tissues is not compatible 
with EBHSV binding patterns. Thus, the role of heparan sulfate in EBHSV attachment 
remains to be assessed. The absence of the B antigen in the upper respiratory and 
digestive tissues of hares (not fully confirmed due to the small number of hares available 
for this study) might help to explain why EBHSV evolved towards the usage of different 
attachment factors. 
Why some Lepus species are susceptible to EBHSV while others are not is still 
uncertain. For example, the Iberian hare (L. granatensis) is not susceptible to EBHSV, 
despite (i) the high number of hares analyzed (C. Gortázar, personal communication), 
(ii) having a contact zone with the main host of EBHSV, the European brown hare (L. 
europaeus) [73], and (iii) European brown hares from Spain being susceptible to EBHSV 
[74]. Consistent with this, no antibodies against EBHSV were detected in Iberian hares 
(P. J. Esteves, personal communication). In our study, no differences in the binding of 
EBHSV to L. granatensis and L. europaeus tissues were observed that may account for 
the lack of EBHS cases in the Iberian hare. Therefore, factors other than the ability to 
attach to host cells must be involved, such as other steps of the virus life cycle or the 
limited contact between these species that does not allow the virus to infect Iberian 
hares. 
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The origins of lagoviruses 
The high mutation rates of RNA viruses such as RHDV and EBHSV make them 
useful models to study evolution. One of the main aims of this thesis was to contribute 
to a better understanding of the evolutionary mechanisms of lagoviruses. Currently, two 
hypotheses for the emergence of pathogenicity in lagoviruses have been put forward: 
the evolution from a non-pathogenic virus or a species jump, each supported by several 
lines of evidence [75-83]. 
Our report of a cross-species infection of G1 in hares corresponds to the earliest 
evidence of a cross-species transmission in lagoviruses. Two strains presenting 6 % 
nucleotide divergence were able to infect hares, in different years and locations. Why 
RHDV was able to cross the species boundaries twice independently but was not able 
to adapt to the new host has not yet been disclosed. However, the strong selection 
pressure RHDV might be subject to can increase the likelihood of disease emergence in 
a novel host species. Our study, together with the recent evidences of EBHSV infection 
in Sylvilagus and of RHDV2 infection in Lepus species [84-86], showed that species 
jumps are possible in lagoviruses, and support the hypothesis of a species jump at the 
origin of pathogenicity in lagoviruses. 
The binding of pathogenic and non-pathogenic viruses to all leporids, especially to 
Sylvilagus, also reinforces the hypothesis of a species jump from Sylvilagus floridanus 
after its introduction into Europe [87]. Although lagoviruses bind to the same tissues of 
the potential hosts (epithelial layer of trachea and Lieberkühn crypts in the duodenum), 
the affinity to different glycans varies. While non-pathogenic strains prefer the B type 2 
antigen, as reported for the classical RHDV [64,65], RHDV2 has no preference among 
the HBGAs. These differences might not only be related to an adaptation to host 
evolution, but also to the ability of RHDV2 of infecting new hosts, such as hares. On the 
other side, our results may also support the evolution from non-pathogenic lagoviruses, 
since the non-pathogenic strains tested used the same attachment factors as RHDV. 
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2. Future perspectives 
 
The research associated with this thesis shed light on several aspects of 
lagoviruses’ evolution. However, as a consequence of this work, there are also many 
questions that were raised and remain unanswered. From that, future lines of work can 
be delineated that should be addressed in future research: 
 
1. What was the role of recombination in the emergence of 
lagoviruses? 
One of the main findings of this research was the existence of recombination 
in the new RHDV variant. Former studies indicate that recombination is present 
in the first pathogenic strains of RHDV [33], thus it is possible that 
recombination also played a role in the emergence of the new variant and in 
the expansion of host range. The analysis of RHDV2 strains from different 
regions and time points might help to disclose the events at the origin of this 
new variant.  
 
2. Are there any differences in the fitness of the recombinant RHDV2 
forms? 
In the Iberian Peninsula, RHDV2 currently circulates (at least) as non-
recombinant, as G1/RHDV2 recombinant and as non-pathogenic/RHDV2 
recombinant. No data exist on the relative fitness of all these forms, a feature 
that will be interesting to assess. In order to do that, experimental infections 
would be needed to evaluate infection rates, clinical evolution of RHD and 
mortality rates for each form, as well as determination of virus replication 
efficiency through quantitative real-time PCR. Likewise, analysis of strains 
recovered from rabbits found dead in the field would allow to investigate the 
relationship of each RHDV2 form with the time of the year, the geographical 
location and the mortality. 
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3. Are there non-pathogenic strains circulating in the Iberian 
Peninsula? 
The detection of recombining strains between non-pathogenic non-structural 
proteins and RHDV2 structural proteins in Portugal indicates that non-
pathogenic strains must circulate in Iberian Peninsula, albeit never detected. 
The existence of non-pathogenic strains circulating in other regions of Europe 
[77,78] further reinforces the possibility of an Iberian non-pathogenic 
calicivirus. We propose to search for the non-pathogenic Iberian strains, by 
screening rabbit samples following the protocol described in Strive et al. [79]. 
The detection and further analysis of these non-pathogenic strains will uncover 
the genetic variability of lagoviruses and complete the information available, 
which will in turn help to disclose how they emerged as pathogenic forms. 
 
4. How are wild rabbit populations responding to the new RHDV 
variant? 
The devastating effects of the new RHDV variant in Iberian Peninsula and in 
Azores were discussed in this thesis. The response of wild rabbit populations 
is particularly important in the subspecies O. c. algirus, more geographically 
restricted. The resulting data of this thesis reinforce the importance of 
monitoring wild rabbit populations and evaluate the impact of RHDV2. At the 
moment, monitoring with systematic collection of samples constitutes the most 
effective measure to determine RHDV2 epidemiology and control rabbit 
populations. After the implementation of this system, conservation planning 
should be redefined accordingly. 
 
5. Will RHDV2 evolve similarly in Azores and in mainland Portugal? 
The co-evolution process results from the interactions between the virus and 
its host. Thus, the evolution of a virus is dependent on the nature of the 
populations in which it is circulating. The occurrence of similar strains of 
RHDV2 in mainland Portugal and in Azores at the same time is an exceptional 
opportunity to study how the virus will evolve in the two regions in response to 
different environmental and biotic factors. Similarly, possible alterations in the 
immune system of rabbits should be studied and compared. 
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6. How to continue improving knowledge for EBHSV? 
Although this work brings new contributions to the knowledge of EBHSV 
evolution and interaction with its host, the results on EBHSV binding to host 
cells require further supporting evidence and clarification. The lack of a proper 
cell culture system to make EBHSV grow in vitro impairs faster advances in the 
area. Furthermore, detection and characterization of non-pathogenic forms of 
EBHSV would be important to complete the information on EBHSV, and to 
study potential past recombination events that led to the emergence of more 
virulent strains. In order to achieve that, full-genome sequences should also be 
obtained, instead of only partial fragments that might mask the existence of 
recombination. 
 
7. What is the impact of EBHSV in the genetic variation of the host? 
The secondary structure prediction of EBHSV capsid protein is now available. 
Therefore, regions and amino acids of the EBHSV capsid protein that are more 
likely to establish contact with the host cell surface are easily identified. On the 
host side, the cell surface molecules that participate in the attachment of 
EBHSV to the cells, as well as components of the immune system, may foresee 
host candidate genes to be under selective pressure. Integration of our data 
with evolutionary analysis of the host will help to disclose which host genes are 
involved in the arms race. 
 
8. How can we predict future host shifts? 
The nature and genetic details of host shifts are still unresolved: for example, 
it is unclear if the mutations found in the new host result from de novo mutations 
or standing variation in the original host [88]. Recombination might help host 
jumps, but it does not appear central to the cross-species transmission [39]. It 
would be interesting to study the nature of RHDV and EBHSV strains that were 
able to overcome the species boundaries, to determine the existence of 
recombination or other features that might distinguish them, such as specific 
sites in the sequence or positively selected codons. Likewise, the study of the 
factors that impair some lagoviruses to infect species other than their natural 
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host(s) may provide useful insights into how leporids are able to overcome the 
lagovirus infection. 
 
9. How can we integrate research in lagoviruses with advances in 
scientific techniques? 
Although in the last years we developed an efficient genome-walking 
amplification process of lagoviruses, we intend to start taking advantage of the 
high-throughput sequencing technologies that allow the generation of a very 
large volume of genetic data. This includes whole-genome sequences of 
several host species, such as the rabbit, but also of the viruses. Next 
Generation Sequencing technologies, when implemented, have the potential 
of being faster and cheaper than our current approach.  
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